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EIS Alumni Association
The Epidemic Intelligence Service Alumni Association (EISAA) represents more than 3,000 alumni worldwide, and all 
EIS officers who have graduated from the program are eligible to join. EISAA promotes and supports the EIS Program 
and also provides opportunities for alumni to remain connected through a variety of networking and support activities 
throughout the year. 
While it’s true that EISAA supports the food and beverages between scientific sessions — that is not the only, or even 
most important, thing that we do at the EIS Conference! EISAA also supports several awards and events throughout 
the week, including the Alexander D. Langmuir Prize named in honor of the illustrious founder of the EIS Program, 
and awarded to the outstanding manuscript completed during EIS; the Distinguished Friend of EIS Award honoring 
an individual who has provided exceptional mentoring and support to EIS Officers; the Donald C. Mackel Memorial 
Award recognizing the EIS investigation that best exemplifies collaborative work between epidemiology and laboratory 
scientists; the J. Virgil Peavy Memorial Award named in honor of a wonderful CDC statistician and beloved EIS mentor 
and recognizing the investigation that most effectively uses innovative statistics and epidemiologic methods; and the new 
EIS Champion Award initiated in 2013 in honor of Dr. Steven B. Thacker, an inspirational leader who championed the 
EIS Program and its officers throughout his career. Each year EISAA also provides competitive travel scholarships for 
prospective applicants to attend the EIS Conference through the David J. Sencer Scholarships. These scholarships, named 
in honor of a public health giant who was the longest serving director of CDC and devoted to the EIS Program, help support 
public health students interested in applying to EIS in the future. This year EISAA received 74 applications and awarded 8 
travel scholarships. Finally, EISAA provides funding to help support some of our most treasured EIS Conference traditions, 
such as the Prediction Run and the Skit Night done by the graduating class. 
Learn More! All EIS alumni and second-year EIS officers are invited to attend the EISAA Annual Meeting on Wednesday 
in the Dunwoody Suites at 5:30–7:30 pm. EISAA is not just about the EIS Conference! The organization provides 
important support to the EIS Program and our members throughout the year. You can learn more about EISAA and its 
goals by attending the Annual Meeting and talking to members over yummy food and beverages. We hope to see you there!
Enthusiastic and engaged alumni are crucial to our continued strength as an organization and our ability to support the EIS 
Program. We have much to gain from staying connected, both personally and professionally. Your membership strengthens 
a network of EIS alumni in diverse career paths, geographic locations, and interests. It also ensures a continued cadre of 
support for development of future EIS officers.
If you are not already a member, consider joining TODAY! 
 • Membership is easy and inexpensive. Annual dues are $25; a lifetime membership is $350. If you are a past member 
and have lapsed in paying your dues, please consider coming back!
 • Join Now! You can join at the EISAA table during the conference, during the EISAA Annual meeting, or online at 
http://www.cdcfoundation.org/eisaa/eisabout.htm (select Pay Membership Dues).
 • Stay Connected! Join the LinkedIn® (http://www.linkedin.com) Epidemic Intelligence Service (EIS)—Alumni and 
Current group (more than 700 members and growing)!
We hope you will join EISAA and stay engaged to better support the EIS Program and stay connected with colleagues and 
friends. While enjoying the Conference this week, please stop by the EISAA table or the Wednesday meeting to say hello. 
We can’t wait to meet you!
Sincerely,
Mary Kamb, MD, MPH 
President, EIS Alumni Association, EIS 1989 
Aimee Ahmed 
Director of Stewardship, EIS Alumni Association Liaison, CDC Foundation
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PREFACE 
Dear Friends of EIS,
Welcome to the 2014 EIS Conference! We appreciate your participation and ongoing 
support of the EIS Program. The contributions of our alumni, stakeholders, and friends 
have always been the heart of the EIS Program and have made it the excellent program 
that is at the core of CDC’s work.
Although this year’s conference has changed in length and structure, the ultimate goal remains unchanged — providing 
opportunities for scientific exchange regarding the most current epidemiologic topics, highlighting the breadth of 
epidemiologic activities at CDC, and providing a setting for strengthening the EIS professional network among new, 
current, and former EIS officers and others. We trust you share our enthusiasm about this venue for current officers to meet 
and learn from epidemiologic leaders and for us all to learn about the responsive and emergent work of EIS officers.
Let me provide some information about the 2014 EIS class. Our selection process used the same key tenets as prior years 
for selecting excellent and well-qualified EIS officers who are eager to advance their epidemiologic skills through training 
and service. This year, we reviewed 531 completed applications, and of those, we invited 209 applicants to be interviewed. 
Seventy-eight new officers were selected, of whom 44 are physicians, 26 are PhD-level scientists, 6 are veterinarians, and 2 
are nurses. In keeping with recent trends, 75% are female, and 10 are citizens of other countries (2 from Nigeria, 2 from the 
United Kingdom,  and 1 each from India, Japan, Uganda, Sweden, and Canada). We prematched 10 officers to state and local 
assignments and 1 to the Centers for Medicare and Medicaid Services. That leaves 67 EIS officers still looking for the perfect 
assignment while at the conference this week.
The conference format has structural changes and is 1 day shorter this year. Thus, to keep the number of accepted abstracts 
the same as prior years, we are offering more concurrent sessions. We are also featuring a new pilot poster symposium that 
gives poster presenters the same visibility as oral presenters. Of the 125 EIS officer presentations, 101 will be oral and 24 will be 
posters. During the first 30 minutes of each poster session, each EIS officer will give a 2-minute oral presentation about his or 
her study from the podium before a seated audience. The remaining time allows viewing of posters and individual Q&A.
We also are featuring cross-cutting special sessions from different centers each day during the lunch break. On Monday, 
NCIRD will present Novel Viruses/Pandemic Threats: Influenza and MERS Coronavirus. On Tuesday, NCEZID will be 
discussing Creative Solutions for Outbreak Data Management and Contact Tracing with Epi Info™: Viral Hemorrhagic 
Fever Outbreaks and Beyond. We especially hope you will join us for Wednesday’s lunch-time session offered by CSELS and 
the EIS Program when we will be seeking your input regarding the challenges and opportunities in epidemiology training. 
Finally, on Thursday, CGH will present Syria Crisis: Epidemiology of Civil War and Refugee Crisis.
The EIS matching interviews will be held on Friday this year. The EIS Program staff will then work tirelessly to complete 
the matches over the weekend, and the results will be sent by e-mail no later than 11 AM EDT on Monday. As a result, the 
government will save resources, and travelers will be able to return home to friends and family sooner.
We hope you will be invigorated by the 2014 EIS Conference and depart feeling better connected, with new ideas and new 
knowledge. We look forward to reconnecting with many of you and to meeting new friends and colleagues for the first time!
Diana M. Bensyl, PhD, MA
Acting Chief, Epidemic Intelligence Service
Division of Scientific Education and Professional Development 
Center for Surveillance, Epidemiology, and Laboratory Services
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Scientific Program Committee
Chair, Tracie Gardner, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Chair Elect, Marie de Perio, National Institute for Occupational Safety and Health
Center for Global Health  ....................................................................................................................................................  Fred Angulo
National Center on Birth Defects and Developmental Disabilities  ....................... Daisy Christensen, Late-Breaker Committee
National Center for Chronic Disease Prevention and Health Promotion  ............................................ Henraya Davis McGruder
National Center for Emerging and Zoonotic Infectious Disease  ................................................  Dianna Blau and Matthew Wise
National Center for Environmental Health/Agency for Toxic Substances and Disease Registry  ................................. Kanta Sircar
National Center for Health Statistics  ......................................................................................................................................  Brian Kit
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention  ..........  Elizabeth Torrone, Late-Breaker Committee
National Center for Immunization and Respiratory Diseases  .................................................................................. Jennifer Verani
National Center for Injury Prevention and Control  .................................................. Kevin Vagi, Late-Breaker Committee Chair
National Institute for Occupational Safety and Health  ........................................  Cammie Menendez, Late-Breaker Committee
Center for Surveillance, Epidemiology, and Laboratory Services  .................................................  Rachel Avchen and Julie Magri
Front row, left to right: Henraya Davis McGruder, Daisy Christensen, Rachel Avchen, Marie de Perio, Tracie Gardner, 
Julie Magri, Matthew Wise
Back row, left to right: Brian Kit, Jennifer Verani, Kevin Vagi, Kanta Sircar, Dianna Blau, Elizabeth Torrone, Cammie 
Menendez, Fred Angulo
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Program Production
Rachel Avchen, Anthony Jordan, Kristen Nichols, Kate Mollenkamp, C. Kay Smith 
Acknowledgments/Disclaimer
The EIS Program extends a special thank you to the EIS Alumni Association and the Council of State and Territorial 
Epidemiologists for their generous support of this year’s 2014 Annual EIS Conference. The EIS Program gratefully 
acknowledges the valuable assistance and cooperation of the editorial and support staff of all CDC administrative units 
participating in the 2014 EIS Conference.
Abstracts in this publication were edited and officially cleared by the respective national centers. Therefore, the EIS Program 
is not responsible for the content, internal consistency, or editorial quality of this material. Use of trade names throughout 
this publication is for identification only and does not imply endorsement by the U.S. Public Health Service or the U.S. 
Department of Health and Human Services.
The findings and conclusions in this report are those of the author(s) and do not necessarily represent the official position of 
the Centers for Disease Control and Prevention.
Purpose Statement
The primary purpose of the EIS Conference is to provide a forum for EIS officers to give scientific presentations (oral or 
poster), increase their knowledge of recent investigations and the significance to public health, and maintain and increase 
their skills in determining the appropriateness of epidemiologic methods, presenting and interpreting results clearly, and 
developing appropriate conclusions and recommendations.
Overall Conference Goals
 • To provide a forum for EIS officers, alumni, and other public health professionals to engage in the scientific exchange 
of current epidemiologic topics. 
 • To highlight the breadth of epidemiologic investigations at CDC.
 • To provide a venue for recruitment of EIS graduates into leadership positions at CDC and state and local 
departments of health.
Registration and Information
Staff are available at the conference registration desk. Check-in and onsite registration are available Monday–Wednesday, 
7:30 am–5:00 pm. Please wear your conference badge at all times during the conference. Conference staff are wearing purple 
badges and are available to assist if you need additional information or misplace your badge.
Cyber Café/Message Center 
To facilitate conference networking, computers with Internet access are located in Camellia Room. Preregistered attendees 
have immediate access to find, communicate, and network with other conference participants, speakers, and staff. You can 
also upload a picture of yourself to facilitate easy identification. Please see conference staff for assistance if you have any 
questions about the system. Please limit computer time to 10 minutes per session to allow other conference attendees an 
opportunity to use the system as well. The Cyber Café will be open Monday–Wednesday, 8:00 am–5:30 pm and Thursday 
from 8:00 am–3:00 pm.
Speaker Ready-Area
Speakers must drop off their presentations (U.S.B transfer preferred) by 3:00 pm the day before their scheduled talk. 
Designated computers inside the Camellia Room are available for presenters who need to review or make changes to 
their presentations. Computers will have PowerPoint® and printer access. Dedicated computers will be available Monday–
Wednesday, 8:00 am–5:30 pm and Thursday from 8:00 am–3:00 pm.
Environmental Considerations
Smoking is not permitted in any of the conference sessions, hallways, or meeting rooms. As a courtesy to presenters and all 
meeting attendees, please mute cellular phones during conference sessions. Please limit use of cellular phones to public areas 
outside the meeting rooms.
Lactation Room
Please visit the EIS information table, near the registration area to sign-up for lactation room access. A schedule and key will 
be available at the table Monday–Thursday, 8:00 am–5:00 pm.
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Instructions for Completing Online Conference Evaluations
April 2014 Course Evaluation
Continuing education credit for this conference is available through the CDC Training and Continuing Education Online 
system only. Please follow the instructions provided on this page. You must complete the online evaluation by May 31, 2014, 
to receive your continuing education credits or your certificate of completion. 
To complete online evaluation
 • Go to the CDC Training and Continuing Education Online site at http://www.cdc.gov/tceonline/. If you have not 
registered as a participant, select New Participant to create a user ID and password; otherwise select Participant 
Login and login.
If you do not remember your login name or need further assistance,
 • E-mail at: ce@cdc.gov
 • Fax at 404-498-6045
 • Phone: 1-800-41-TRAIN or 404-639-1292, during business hours (Monday–Friday) 8 am–4:00 pm ET. After hours, 
you may leave a voice message, and your call will be returned the next business day.
 • After logging in to the CDC/ATSDR Training and Continuing Education Online website, you will be on the 
Participant Services page. Select Search and Register. Select CDC Courses at the bottom right side of the page.
 • You will be prompted to enter the CDC Center/Course Code. The code for this training is EISCONF14. Enter 
the course code and then select View. Select the course. The course information page will appear. Scroll down to 
Register Here. Select the type of CE credit that you would like to receive and then select Submit. Three demographic 
questions will display. Complete the questions and then select Submit. 
 • A message thanking you for registering for the conference will display. You will then be prompted to select the 
sessions that you wish to attend.
 • After attending your selected conference sessions, return to the CDC Training and Continuing Education Online 
site. Select Participant Login and log onto the site. Select Evaluations and Tests, and then select Conferences. The 
conference will be listed with the sessions you selected. You may Add/Edit Sessions until you have completed the 
evaluation for a particular session. After completing all of the session evaluations, you will be prompted to complete 
the overall conference evaluation. A record of your conference completion will be located in the Transcript and 
Certificate section of your record. 
If you have any questions or problems, contact
CDC/ATSDR Training and Continuing Education Online 
1-800-41TRAIN or 404-639-1292
E-mail at: ce@cdc.gov
The printed evaluation form is for tracking purposes only. CE credits will not be issued for completing the printed form.
PLEASE DO NOT HAND IN THE PRINTED VERSION
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2014 EIS Conference Schedule
Monday, April 28, 2014
7:00 Registration Desk Opens
8:15 Welcome and Call to Order  ............................................................................................  Ravinia Ballroom
 Moderator: Michael Iademarco, Director, Center for Surveillance, Epidemiology, and Laboratory 
Services 
Presentation of the Stephen B. Thacker EIS Champion Award
8:30 SESSION A: Stephen B. Thacker Opening Session  ........................................................  Ravinia Ballroom
 Moderators: Michael Iademarco and Diana Bensyl
8:35 Febrile Illness at a State Correctional Facility—Illinois, 2013. M. Allison Arwady
8:55 Workplace Secondhand Smoke Exposure Among Nonsmoking Women of Reproductive Age—
United States, 2010. Candice Johnson
9:15 The First U.S. Cryptosporidiosis Outbreak Associated with a Surface Water-Supplied Municipal 
Water System in 20 Years—Baker City, Oregon 2013. Malini DeSilva
9:35 Heroin-Related Overdoses and Deaths—Wisconsin, 2003–2012. Jon Meiman
9:55 Risk Factors for Influenza A(H7N9) Disease—China, 2013. Fiona Havers
10:15 BREAK — Sponsored by the EIS Alumni Association
10:45 CONCURRENT SESSION B1: Antimicrobial Use and Resistance  ...............................  Ravinia Ballroom 
Moderator: Lauri Hicks
10:50 Evaluation of Antibiotics Administered for Acute Upper Respiratory Tract Infections—Oregon, 
2011. Kara Levri
11:10 Outpatient Antibiotic Prescribing for Children—United States, 2011. Alicia Demirjian
11:30 Vaccines for a “Pièce de Résistance”: Prevention of Antimicrobial Resistance Among Children Aged 
<5 Years with the 13-valent Pneumococcal Conjugate Vaccine—Selected U.S. Areas, 2004–2012. Sara 
Tomczyk
11:50 Vancomycin-Resistant Enterococcus faecium in a Neonatal Intensive Care Unit—Utah, 2013.  
Joanna Watson
10:45 CONCURRENT SESSION B2: Environmental Health   ...................................................  Dunwoody Suite 
Moderator: Judith R. Qualters
10:50 Trouble on the Tracks: Chemical Exposure, Health Effects, and Communication After a Train 
Derailment—New Jersey, 2012. Alice Shumate
11:10 Formaldehyde Levels and Respiratory Allergies Among Urban, Low-Income Children—United 
States, 2011–2012. Joy Hsu
11:30 Illness Associated with Dietary Supplements—New York, 2013. Nina Ahmad
11:50 Acute Hepatitis and Liver Failure of Unknown Etiology—United States, 2013. Kevin Chatham-
Stephens
12:10–1:30 LUNCH
12:10–1:30 SPECIAL SESSION: Novel Viruses/Pandemic Threats:  
Influenza and MERS Coronavirus  ...................................................................................  Dunwoody Suite
 Moderator: Stephen Redd
 Speakers: Dan Jernigan, Sue Gerber, and David L. Swerdlow
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1:30–2:45 POSTER SYMPOSIUM I  ................................................................................................  Ravinia Ballroom
 Moderator: Pattie Simone
During the first 30 minutes of the Poster Symposium, the authors will each give a 2-minute oral 
presentation at the podium in front of a seated audience. During the remaining time, the audience is 
encouraged to view the individual posters and engage in direct discussion with the authors.
P1.1 Vaccine-Preventable Diseases Among Fatal Cases of Hospitalized Acute Respiratory Infection—
Guatemala, 2000–2013. Sara Tomczyk
P1.2 Mexican-Born Legal Immigrants with Tuberculosis Classifications Using Electronic Disease 
Notification Database, 2009–2012. Jessica Adam
P1.3 Strategies for Maximizing Preventive Treatment of Latent Tuberculosis Infection—Mississippi, 
2008–2012. Erik Reaves
P1.4 Using Electronically Archived Medical Information for Public Health: Analysis of American Indian/
Alaska Native Communicable Disease Diagnoses from the Indian Health Service National Data 
Warehouse—Oregon 2007–2011. Jessica Marcinkevage
P1.5 Tales from the Crypto: Trends in Cryptosporidiosis Surveillance—United States, 1995–2012. Julia 
Painter
P1.6  Epidemiology of Reported Malaria Cases—Maryland, 2007–2012. David Schnabel
P1.7 Investigating the Sensitivity and Specificity of an Alternative Surveillance Case Definition for 
Monkeypox—The Democratic Republic of Congo (DRC), 2010–2013. Lynda Osadebe
P1.8 Human Salmonella Typhimurium Infections Linked with Exposure to Live Poultry from 
Agricultural Feed Stores and Mail-Order Hatcheries—United States, 2013. Tara Anderson
P1.9 Evaluation of a Stillbirth Surveillance Program—Iowa, 2010. Samir Koirala 
P1.10 Two Fish, One Fish: Decreasing Number of Outbreaks Attributed to Fish—United States,  
1998–2011. Jolene Nakao
P1.11 Using Media Reports to Track Deaths, Hurricane Sandy, 2012. Olaniyi Olayinka 
P1.12 Detection of Infectious Disease Outbreaks at an Outdoor Mass Gathering—West Virginia, 2013. 
Erica Thomasson
2:45 BREAK — Sponsored by the EIS Alumni Association
3:00 CONURRENT SESSION C1: Vaccine Preventable Diseases in the United States  ........  Ravinia Ballroom
 Moderator: Jane Seward
3:05 First Use of a Novel Serogroup B Meningococcal Vaccine in the U.S. in Response to a Large 
Outbreak at a University—New Jersey, 2013. Lucy McNamara
3:25 Meningococcal Disease Among Men Who Have Sex With Men—United States, 2012–2013.  
Hajime Kamiya
3:45 Cost of Measles Case Containment in an Ambulatory Pediatric Clinic—King County, Washington, 
2013. Kristen Wendorf
4:05 Effect of Rotavirus Vaccines on Diarrhea-Associated Hospitalizations in U.S. Children <5 Years of 
Age, 2007– 2011. Eyal Leshem
3:00 CONCURRENT SESSION C2: Chronic Disease Prevention  ..........................................  Dunwoody Suite
 Moderator: Peter Briss
3:05 Do Individual-Level and Area-Based Poverty Measure the Same Thing? Association of Poverty 
Measures with Self-Reported Health Outcomes—New York City, 2012. Kari Yacisin
3:25 Smoking Cessation Among Users of Telephone and Web-Based Interventions. Mary Puckett
3:45 Trends in Exposure to Pro-Tobacco Advertisements via the Internet, Newspapers or Magazines, and 
Retail Stores Among U.S. Middle and High School Students, 2000–2012. Israel Agaku
4:05 Active Transportation Surveillance Across Three Systems—United States, 1999–2012. Geoffrey Whitfield
4:30 EIS CONFERENCE SOCIAL (CASH BAR)  
Sponsored by the EIS Alumni Association  ........................................... Ravinia Ballroom Pre-Function Area
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Tuesday, April 29, 2014
8:30 CONCURRENT SESSION D1: Zoonoses  ......................................................................  Ravinia Ballroom
 Moderators: Jennifer McQuiston and David Wong
8:35 Variation in Tularemia Clinical Presentation—Arkansas, 2009–2012. Laura Lester
8:55 Contact Investigation of Melioidosis Cases Reveals Regional Endemicity—Puerto Rico, 2010 and 
2012. Thomas Doker
9:15 Impact of the New National Surveillance Case Definition on Babesiosis Reporting—Connecticut, 
2001–2013. Jocelyn Mullins
9:35 Changing Trends in Backyard Flocks: Review of Outbreaks of Human Salmonellosis Linked to 
Contact with Live Poultry—United States, 1990–2013. Colin Basler
9:55 Raccoon Rabies Virus Variant Transmission Through Solid Organ Transplantation—United States, 
2013. Neil Vora
8:30 CONCURRENT SESSION D2: Tuberculosis  ...................................................................  Dunwoody Suite
 Moderator: Philip LoBue
8:35 Tuberculosis and Excess Alcohol Use in the United States, 1997–2012. Tyson Volkmann
8:55 Characterization of Tuberculosis due to Mycobacterium africanum—United States, 2004–2012. 
Aditya Sharma
9:15 Opportunities for Improved Detection and Treatment of Latent Tuberculosis Infection Among 
Veterans—Western United States, January 2010–July 2013. Tara Perti
9:35 Contact Investigation of Health Care Personnel Exposed to Maternal and Neonatal Tuberculosis—
Clark County, Nevada, 2013. Kaci Hickox
9:55 Childhood Tuberculosis—Botswana, 2008–2011. Negar N. Alami
10:15 BREAK — Sponsored by the EIS Alumni Association
10:45 CONCURRENT SESSION EI: Injury Prevention  ..........................................................  Ravinia Ballroom 
Moderator: Ileana Arias
10:50 Unintentional Injury Child Deaths and the National Child Death Review Case Reporting 
System—13 U.S. States, 2006 and 2009. Melissa Mercado–Crespo
11:10 Global Differences in Burden of Childhood Sexual Violence Against Boys—Haiti, Kenya, and 
Cambodia, 2010–2013. Steven Sumner
11:30 Injuries Among High School Football Players—Nebraska, Fall 2013. Deborah Hastings
11:50 Do Children in Domestic Servitude Experience More Violence?—Results from the Violence Against 
Children Survey, Haiti, 2012. Leah Gilbert
10:45 CONCURRENT SESSION E2: STDs/HIV  .......................................................................  Dunwoody Suite
 Moderators: Gail Bolan and Ken Castro
10:50 Is Vaccine Type Seropositivity a Marker for Human Papillomavirus Vaccination?—Results from the 
National Health and Nutrition Examination Survey, 2003–2010. Emiko Petrosky
11:10 Erectile Dysfunction Medication Use Associated with Sex without a Condom in HIV-Infected Men 
Who Have Sex with Men—Medical Monitoring Project, United States, 2009. Xia Lin
11:30 Syphilis Time-to-Treatment in STD Clinics versus Private Clinics—Arizona, 2009–2012.  
Candice Williams
11:50 Overseas Screening for Syphilis among U.S.-Bound Refugees, 2008–2013. Edith Nyangoma
12:10 LUNCH
12:10–1:30 SPECIAL SESSION: Creative Solutions for Outbreak Data Management and Contact  
Tracing with Epi Info™: Viral Hemorrhagic Fever Outbreaks and Beyond  ..................  Ravinia Ballroom 
 Moderator: Barbara Knust
 Speakers: Ilana Schafer, Erik Knudsen, and Asad Islam
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1:30–2:45 POSTER SYMPOSIUM II  ................................................................................................  Dunwoody Suite
 Moderator: Fred Angulo
During the first 30 minutes of the Poster Symposium, the authors will each give a 2-minute oral presentation 
at the podium in front of a seated audience. During the remaining time, the audience is encouraged to view 
the individual posters and engage in direct discussion with the authors.
P2.1 Fungemia Outbreak Among Injection-Drug Users—Lane County, Oregon, 2012–2013. Kara Levri
P2.2 A Cluster of Cryptococcus neoformans Infections at a Community Hospital—Arkansas, 2013. 
Snigdha Vallabhaneni
P2.3 University-Based Gastrointestinal Illness Outbreak Caused by Dual Pathogens—Tennessee, 2013. 
Joshua Clayton
P2.4 Rapid Identification of Prepackaged, Ready-to-Eat Salads Associated with an Outbreak of 
Escherichia coli O157:H7 Infections—Multiple States, 2013. Patrick Ayscue
P2.5 Acute Gastroenteritis Among Seminar Attendees After a Catered Lunch—Washington, DC, 2013. 
Sasha McGee
P2.6 Gastroenteritis Associated with Rafting the Middle Fork of the Salmon River—Idaho, 2013.  
Mariana Rosenthal
P2.7 Reported Reasons for Testing Among Hepatitis B Virus-Infected Patients—Chronic Hepatitis 
Cohort Study, United States, 2006–2010. Gemechu Gerbi
P2.8 Mortality Risk After Opportunistic Illness Diagnoses Among HIV-infected Persons—San Francisco, 
1980–2012. Kpandja Djawe
P2.9 Delayed Diagnosis of Multidrug-Resistant Tuberculosis and the Resulting Outbreak—Sheboygan, 
Wisconsin, 2012–2013. Abbey Canon
P2.10 Micronutrient Powder Use and Infant and Young Child Feeding Practices—Nepal, 2011.  
Kelsey Mirkovic
P2.11 Adverse Drug Events Associated with an Electronic Music Festival—New York City, 2013.  
Alison Ridpath
P2.12 Sudden Cardiac Death in Patients with Unrecognized Lyme Carditis—United States, 2012–2013. 
Joseph Forrester
2:45 BREAK — Sponsored by the EIS Alumni Association
3:00 CONCURRENT SESSION F1: Foodborne Diseases  ......................................................  Ravinia Ballroom 
Moderators: Ian Williams and Barbara Mahon
3:05 Multistate Outbreak of Listeriosis Linked to Company A Artisanal Cheeses—United States, 2013. 
Mary Choi
3:25 Escherichia coli O157:H7 Outbreak Associated with a Mexican Food Restaurant—Arizona, 2013. 
Laura Adams
3:45 Distinct Epidemiologic Patterns of Foodborne versus Person-to-Person Norovirus Outbreaks in the 
United States, 2009–2012. Kimberly Pringle
4:05 Multistate Outbreak of Multidrug-Resistant Salmonella Heidelberg Infections Linked to Foster 
Farms Brand Chicken—United States, 2013. Jolene Nakao
4:25 Outbreaks of Cyclosporiasis—United States, June–August 2013. R. Reid Harvey
4:45 Human Escherichia coli O121 Infections Linked to Multiple Frozen Snack Foods—United States, 
2013. Tara Anderson
3:00 CONCURRENT SESSION F2: Occupational Safety and Health  .....................................  Dunwoody Suite
 Moderator: RADM Boris Lushniak, Acting Surgeon General of the United States
3:05 Analysis of Injuries and Illnesses Among American Red Cross® Responders—United States,  
2008–2012. Kimberly Brinker
3:25 Occupational Hazardous Substance Exposure Surveillance Using Poison Center Data—Wisconsin, 
2004–2012. Jon Meiman
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3:45 Knowledge, Attitudes, and Practices Regarding Antimalarial Chemoprophylaxis in Peace Corps 
Volunteers—Africa, 2013. Keren Landman
4:05 Bigger Is Better: Abnormal Lung Function and Coal Workers’ Pneumoconiosis by Mine Size Among 
Active Underground Coal Miners—United States, 2005–2012. David Blackley
4:25 Blowing in the Wind: Coccidioidomycosis Among Solar Power Farm Construction Workers—
California, 2011–2013. Jason Wilken
4:45 Is Green Energy Good for Workers? An Evaluation of Exposure and Health at a Windblade 
Manufacturing Facility—North Dakota, 2013. Anna-Binney McCague
6:00 PREDICTION RUN  ................................................................................................ Murphey Candler Park
Sponsored by the EIS Alumni Association 
Self–transport to venue; carpooling is encouraged.
Wednesday, April 30, 2014
8:30 CONCURRENT SESSION G1: Vectorborne and Parasitic Diseases  ............................  Ravinia Ballroom
 Moderators: Mark Eberhard and Kay Tomashek
8:35  First Chikungunya Outbreak in Micronesia—Yap State, Federated States of Micronesia, 2013. Daniel 
Pastula
8:55  Dengue Outbreak—Mombasa, Kenya, 2013. Esther Ellis
9:15  Factors Associated with Dengue Mortality—Puerto Rico, 2010. Dana Thomas
9:35 Atovaquone-Proguanil-Resistant Malaria in Two Travelers Returning from the Same Site— 
Nigeria, 2012–2013. Mateusz Plucinkski
9:55 Prevalence of Strongyloides stercoralis Antibodies Among a Rural Appalachian Population—
Kentucky, 2013. Elizabeth Russell
8:30 CONCURRENT SESSION G2: Child and Adolescent Health .........................................  Dunwoody Suite
 Moderator: Marshalyn Yeargin-Allsopp
8:35 Scabies and Bacterial Superinfection Among Children—American Samoa, 2011. Laura Edison
8:55 Fungal Sensitization Not Associated with Poor Outcomes in Children with Asthma: Data from the 
2005–2006 National Health and Nutrition Examination Survey. Kenneth Quinto
9:15 Prevalence and Correlates of Overweight and Obesity Among 5th Graders—Maine Integrated Youth 
Health Survey, 2009. Leigh Ann Miller
9:35 Willingness to Pay for Micronutrient Powder Supplements for Children—Nepal, 2011. Rajni 
Gunnala
9:55 Adolescent Substance Use and the Association with a School-Based Socioeconomic Measure—
Washington State, 2012. Mandy Stahre
10:15 BREAK — Sponsored by the EIS Alumni Association
10:45 CONCURRENT SESSION H1: Vaccine Preventable Diseases Worldwide  ...................  Ravinia Ballroom
 Moderator: Rebecca Martin
 Presentation of the lain C. Hardy Award
10:50 Measles Post-Campaign Vaccination Coverage—Equateur and Province Orientale, Democratic 
Republic of the Congo, 2013. Jennifer Harris
11:10 Reasons for Low Influenza Vaccination Coverage Among Adults in Puerto Rico, Influenza Season 
2013–14. Carmen Arriola
11:30 Detecting the Reemergence of Wild Poliovirus Type 1 in Syria Through an Early Warning Alert and 
Response Network, July–October 2013. Miriam Shiferaw
11:50 Diphtheria Outbreak in Lao Peoples Democratic Republic (PDR) 2012–2013: A Failure of Routine 
Immunization. Carolyn Sein
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10:45 CONCURRENT SESSION H2: Maternal and Child Health ............................................  Dunwoody Suite
 Moderator: Wanda Barfield
10:50 Mother’s Return to Work and Meeting Her 6-Month Breastfeeding Intention—United States,  
2005–2007. Kelsey Mirkovic
11:10 Trends in Gestational Weight Gain: Results from the Pregnancy Risk Assessment Monitoring 
System—2000–2009. Jonetta Johnson
11:30 Vitamin K Deficiency Bleeding in Infants Not Receiving Vitamin K Prophylaxis—Tennessee, 2013. 
Lauren Marcewicz
11:50 Vitamin K Refusal Rates and Parental Attitudes—Tennessee, 2013. Joshua Clayton
12:10 LUNCH
12:10–1:30 SPECIAL SESSION: EIS—Challenges and Opportunities in Epidemiology Training  ...  Dunwoody Suite
 Moderator: Mary Kamb
 Speakers: David L. Swerdlow, Tim Jones, Laurene Mascola, and Diana Bensyl
1:30  CONCURRENT SESSION I1: Global Health  ................................................................  Ravinia Ballroom 
Moderators: Jordan Tappero and Rob Tauxe 
1:35 Where’s the TB? Understanding Low TB Case Notification Rates—Haiti, 2013. Stephanie Salyer
1:55 Challenges in Detecting Malaria Outbreaks in an Epidemic-Prone Region—Kuando Kubango 
Province, Angola, 2013. Magdalena Paczkowski
2:15 Pathogen-Specific Mortality Among Infants and Young Children with Moderate-to-Severe 
Diarrhea—Western Kenya, 2008–2011. Allison Walker
2:35 Ceramic Water Filters and Reducing the Burden of Diarrheal Disease in Infants—Western Kenya, 
2013. Jamae Morris
2:55 Integrating Water Treatment into Antenatal Care: Impact on Use of Reproductive Health Services 
and Household Water Treatment by Pregnant Women—Uganda, 2013. Almea Matanock
3:15 Use of Capture–Recapture Methodology To Characterize Neonatal Mortality Rates in Farchana 
Refugee Camp—Chad, 2013. Rachel Idowu
1:30 CONCURRENT SESSION I2: Health Care  ......................................................................  Dunwoody Suite
 Moderators: Joseph Perz and Marion Kainer
1:35 Risk Factors for Invasive Methicillin-Resistant Staphylococcus aureus Infection After Discharge from 
Acute-Care Hospitals—United States, 2011–2013. Lauren Epstein
1:55 Peripheral Joint Infections Associated with Contaminated Preservative-Free Methylprednisolone 
Acetate Injections—Michigan, October 2012–October 2013. Mawuli Nyaku
2:15 National Estimates of Insulin-related Hypoglycemia and Errors (IHEs) Leading to Emergency 
Department (ED) Visits and Hospitalizations—United States, 2007–2011. Andrew Geller
2:35 Cluster of Staphylococcus aureus Septic Arthritis Cases After Intra-Articular Injection of Autologous 
Platelet-Rich Plasma—North Carolina, October 2013. Sarah Rhea
2:55 The Effect of Having a Medical Home and Reported Family Financial Burden Among Children with 
Special Health Care Needs—Kansas, 2009–2010. Suparna Bagchi
3:15 Infection Control Practices and Multidrug-Resistant Acinetobacter baumannii Outbreak in a 
Hospital—Puerto Rico, 2013. Nora Chea
3:35 BREAK — Sponsored by the EIS Alumni Association
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3:50 SESSION J: Alexander D. Langmuir Memorial Lecture and Reception  .......................  Ravinia Ballroom
 Moderators: Pattie Simone and Denise Koo 
 Speaker: Martin-J. Sepúlveda, MD, FACP: EIS in an Era of Data, Technology and Urban Transformations  
Presentation of Awards
 • Alexander D. Langmuir Prize Manuscript Award
 • Distinguished Friend of EIS Award
This event is cosponsored by the EIS Alumni Association and the Center for Surveillance, Epidemiology, 
and Laboratory Services. 
5:30 EIS ALUMNI ASSOCIATION MEETING  .......................................................................  Dunwoody Suite
5:30–10:00 SESSION K: International Night  ....................................................................................  Ravinia Ballroom
5:30 Poster Presentations
6:45 Photo Contest
7:30–10:00 Oral Presentations and Awards
See supplement for complete list of presenters and abstracts.
7:45 Reemergence of Rabies on an Island Nation: A Once in a Lifetime Event, or an Indication of 
more to come? Ryan Wallace
International Night is cosponsored by the Center for Global Health (CGH)/Division of Global Health Protection 
(DGHP) and the Training Programs in Epidemiology and Public Health Interventions Network (TEPHINET). 
The posters and presentations featured during International Night are from participants in international 
programs in applied field epidemiology similar to that of EIS. Some of the programs are sponsored by or 
partnered with CDC and some are independent. All conference attendees are invited to these sessions.
Thursday, May 1, 2014
8:30 SESSION L: Donald C. Mackel Memorial Award Finalists ............................................  Ravinia Ballroom
 Moderators: Steve Monroe and Rachel Kaufmann
8:35 Outbreak of New Delhi Metallo-ß-Lactamase–Producing Carbapenem-Resistant Enterobacteriaceae 
at a Hospital—Illinois, 2013. Jennifer Hunter
8:55 Hospital-Associated Outbreak of Middle East Respiratory Syndrome Coronavirus (MERS-CoV)—
Jordan, 2012. Brian Rha
9:15 Pantoea Bloodstream Infection Outbreak at an Oncology Clinic—Illinois, 2012–2013. Brian Yablon
9:35 Novel, Illicit Fentanyl-Analog Causes 14 Overdose Deaths—Rhode Island, 2013. Matthew Lozier
9:55 Two Cattle Herdsmen Infected with a Novel Species of Orthopoxvirus—Georgia (Country), 2013.  
Neil Vora
10:15 BREAK — Sponsored by the EIS Alumni Association
10:45 SESSION M: J. Virgil Peavy Memorial Award Finalists  .................................................  Ravinia Ballroom 
Moderator: Drew Baughman
10:50 Metabolic Score and Cardiovascular Disease Mortality Among U.S. Adults Aged 18 Years or Older: 
A Structural Equation Modeling Approach—National Health and Nutrition Examination Survey III 
Linked Mortality File, United States, 1988–2006. Carla Mercado
11:10 Stevens-Johnson Syndrome Associated with Mycoplasma pneumoniae Infection—Colorado, 2013. 
Louise Francois Watkins
11:30 Prevalence Assessment of Nodding Syndrome—Uganda, 2013. Preetha Iyengar




12:10–1:30 SPECIAL SESSION: Syria Crisis: Epidemiology of Civil War and Refugee Crisis ...........Dunwoody Suite 
 Moderator: Jordan Tappero
 Speakers: Mike Gerber, Muireann Brennan, Alison Ridpath, and Allison Walker
1:30 CONCURRENT SESSION N1: Respiratory Diseases ...................................................... Ravinia Ballroom
 Moderators: Cyndy Whitney and Seema Jain
1:35 Legionnaire’s Disease Outbreak Associated with a Cooling Tower at a Long-Term-Care Facility—
Ohio, 2013. Celia Quinn
1:55 Timing of Highly Pathogenic Avian Influenza A (H5N1) Poultry Outbreaks, Human Influenza A 
(H5N1) Cases, and Seasonal Influenza Epidemics—Worldwide, 2004–2013. Lizette Durand 
2:15 Impact of Changes in Diagnostic Testing on Estimated Influenza-Associated Hospitalization Rates 
in the Influenza Hospitalization Surveillance Network (FluSurv-NET): United States, 2003–2013. 
Alexander Millman
2:35 Rapid Urine Antigen Testing for Streptococcus pneumoniae in Adults with Community-Acquired 
Pneumonia: Clinical Use and Barriers. Aaron Harris
2:55 Assessing the Burden of Pediatric Acute Rheumatic Fever and Rheumatic Heart Disease—American 
Samoa, 2011–2012. Amanda Beaudoin
1:30 CONCURRENT SESSION N2: Hepatitis ...........................................................................Dunwoody Suite
 Moderator: Deborah Holtzman
1:35 Hepatitis A Outbreak Associated with Consumption of Imported Pomegranate Arils—Multiple 
Western U.S. States, 2013. Erin Epson
1:55 Hepatitis B Vaccine Response Among Infants Born to Hepatitis B Surface Antigen-Positive 
Women—United States, 2008–2013. Stephen Ko
2:15 Reactivation and Transmission of Hepatitis B Virus from an HIV-Positive Hemodialysis Patient—
North Carolina, 2013. Sarah Rhea
2:35 Health Care-Associated Hepatitis C Virus Outbreak in a Skilled Care Facility—North Dakota, 2013. 
Dinorah Calles
2:55 Susceptibility to, and Risk Factors for, Hepatitis E Virus Infection Among a Refugee Population—
South Sudan, 2012. Miriam Shiferaw
3:15 BREAK — Sponsored by the EIS Alumni Association
3:30 Presentation of Awards..................................................................................................... Ravinia Ballroom
 Moderator: Diana Bensyl 
 • Donald C. Mackel Memorial Award 
 •  J. Virgil Peavy Memorial Award
 •  Paul C. Schnitker International Health Award
 •  James H. Steele Veterinary Public Health Award
 •  Outstanding Poster Presentation Award
3:45 Session O: Late-Breaking Reports .................................................................................... Ravinia Ballroom
3:45–5:10 See supplement for presenters and abstracts.
 Moderators: Kevin Vagi and Tracie Gardner
5:10 Closing Remarks and Adjournment  ............................................................................... Ravinia Ballroom
 Thomas R. Frieden, Director, Centers for Disease Control and Prevention
 Tracie Gardner, Scientific Program Committee Chair
POSTCONFERENCE ACTIVITY
7:30 EIS Satiric Revue .............................................................................................................. Ravinia Ballroom
 Presentation of Philip S. Brachman Award
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Awards Descriptions and Committee Members
Stephen B. Thacker  
EIS Champion Award
The Stephen B. Thacker EIS Champion Award, established 
in 2013 by the EIS Alumni Association, recognizes an 
individual who is an inspiration to the EIS community 
and exhibits unwavering commitment to the EIS Program, 
officers, and alumni.
2014 Committee Members: Carol Ciesielski (Co-Chair), 
Peter Kerndt (Co-Chair), Diana Bensyl, Alexandre Macedo 
De Oliveira, Alexa Oster, Maria Thacker
Iain C. Hardy Award
The Iain C. Hardy Award, sponsored by the National Center 
for Immunization and Respiratory Diseases, recognizes a 
current EIS officer or alumnus (within 5 years) who has 
made an outstanding contribution to the control of vaccine-
preventable diseases.
2014 Committee Members: David Swerdlow (Chair), 
Melinda Wharton, Cynthia Whitney, John Modlin,  
William Schaffner
Alexander D. Langmuir Prize 
Manuscript Award
The Alexander D. Langmuir Prize, established in 1966 by 
the EIS Alumni Association, recognizes a current EIS officer 
or recent alumnus (1 year) for excellence in a written report 
or an epidemiological investigation or study.
2014 Committee Members: Mary Kamb (Chair),  
Carol Ciesielski, Neil Gupta, Peter Kerndt, Alexa Oster,  
Sarah Patrick
Distinguished Friend of EIS Award
The Distinguished Friend of EIS Award, sponsored by 
the EIS Alumni Association, recognizes an individual for 
contributions to the health, welfare, and happiness of EIS 
officers and the EIS Program.
2014 Committee Members: Peter Kerndt (Chair),  
Rachel Avchen, Carol Ciesielski, Neil Gupta, Alexa Oster 
Donald C. Mackel Memorial Award
The Donald C. Mackel Memorial Award, sponsored by the 
EIS Alumni Association, recognizes a current EIS officer 
for the oral presentation that best exemplifies the effective 
application of a combined epidemiology and laboratory 
approach to an investigation or study.
2014 Committee Members: Dianna Blau (Chair),  
Henraya Davis McGruder, Fred Angulo, Vitaliano Cama, 
Elizabeth Hall, Julu Bhatnagar 
J. Virgil Peavy Memorial Award
The J. Virgil Peavy Memorial Award, established in 2003 by 
the EIS Alumni Association, recognizes a current EIS officer 
for the oral presentation that best exemplifies the effective 
and innovative application of statistics and epidemiologic 
methods in an investigation or study.
2014 Committee Members: Kanta Sircar (Chair),  
Brian Kit, Matt Wise, Drew Baughman, Dana Flanders
Paul C. Schnitker International 
Health Award
Paul C. Schnitker, MD, died in a plane crash in Nigeria in 
1969. He was en route to serve as a public health officer in 
the response to famine and other public health problems 
resulting from the Biafra Civil War in Nigeria. He is the only 
person who has died while serving as an EIS officer.
The Paul C. Schnitker International Health Award, 
sponsored by the Schnitker family, recognizes a current 
EIS officer or alumnus (1 year) who has made a significant 
contribution to international public health.
2014 Committee Members: Douglas Hamilton (Chair), 
Tom Handzel, J. Lyle Conrad, Ezra Barzilay, Asim Jani, 
Donna Jones
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James H. Steele Veterinary Public 
Health Award
The James H. Steele Veterinary Public Health Award, 
sponsored by CDC veterinarians, recognizes a current 
EIS officer or alumnus (within 5 years) who has made 
outstanding contributions in the field of veterinary 
public health through outstanding contributions in the 
investigation, control, or prevention of zoonotic diseases or 
other animal-related human health problems. 
2014 Committee Members: Casey Barton Behravesh 
(Chair), Frederick J. Angulo, Barbara Knust, Jennifer 
McQuiston, Kirk Smith
Outstanding Poster  
Presentation Award
The Outstanding Poster Presentation Award is presented 
by the EIS Scientific Program Committee to a current EIS 
officer for the poster that best exemplifies scientific content, 
including originality, study design, and analysis; public 
health impact; and presentation effectiveness.
2014 Committee Members: Jennifer Verani (Chair),  
Julie Magri, Rachel Avchen, Katherine Mollenkamp
Philip S. Brachman Award
The Philip S. Brachman Award, sponsored by the graduating 
class of EIS officers, recognizes excellence in teaching 
epidemiology to EIS officers. 
2014 Committee Members: 2012 EIS Class
Mitch Singal Excellence in 
Occupational and Environmental 
Health Award
The Mitch Singal Excellence in Occupational Safety 
and Environmental Health Award, co-sponsored by the 
National Institute for Occupational Safety and Health and 
the National Center for Environmental Health/Agency for 
Toxic Substances and Disease Registries, established in 2010 
recognizes a current EIS officer for excellence in an oral 
or poster presentation that best exemplifies the effective 
application of public health in the area of occupational or 
environmental health to an investigation.
2014 Committee Members: Sally Brown, (Chair) 
Diana Bensyl, David Callahan, Renee Funk, Yulia Iossifova, 
Josephine Malilay, Barbara Materna, Cammie Menendez, 
Kanta Sircar
Awards Presented at the 2013 EIS Conference
Stephen B. Thacker EIS Champion Award 
Stephen B. Thacker 
Iain C. Hardy Award 
Jim L. Goodson
Alexander D. Langmuir Prize Manuscript Award 
Robyn N. Fanfair
Distinguished Friend of the EIS Award 
Douglas H. Hamilton
Donald C. Mackel Memorial Award  
Mary J. Choi
J. Virgil Peavy Memorial Award 
Alison Laufer
Paul C. Schnitker International Health Award 
Kevin R. Clarke
James H. Steele Veterinary Public Health Award 
Maho Imanishi and Megin Nichols
Outstanding Poster Presentation  
W. Thane Hancock
Philip S. Brachman Award 
Stephen B. Thacker
Mitch Singal Excellence in Occupational and 
Environmental Health Award 
Duke. J. Ruktanonchai
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Stephen B. Thacker EIS Champion Award, 2013
2013 Stephen B. Thacker
Iain C. Hardy Awards, 1996–2013
1996 Peter Strebel
1997 D. Rebeca Prevots
1998 Beth P. Bell
1999 Chares R. Vitek
2000 Linda Quick and Nancy Rosenstein
2001 Orin S. Levine
2002 Umesh D. Parashar
2003 Karen A. Hennessey





2009 Amanda Cohn and Rosalyn O’Laughlin
2010 Amy A. Park Fiebelkorn
2011 Jacqueline E. Tate
2012 Preeta Kutty
2013 Jim L. Goodson
Alexander D. Langmuir Prize Manuscripts, 1966–2013
1966 Complications of Smallpox Vaccination: I. National 
Survey in the United States, 1963. N Engl J Med 
1967;276:125–32. 
J.M. Neff, J.M. Lane, J.H. Pert, R. Moore, J.D. Millar, 
D.A. Henderson
1967 An Outbreak of Neuromyasthenia in a Kentucky 
Factory—The Possible Role of a Brief Exposure to 
Organic Mercury. Am J Epidemiol 1967;86:756–64. 
G. Miller, R. Chamberlin, W.M. McCormack
1968 Salmonellosis from Chicken Prepared in 
Commercial Rotisseries: Report of an Outbreak. 
Am J Epidemiol 1969;90:429–37. 
S.B. Werner, J. Allard, E.A. Ager
1969 Outbreak of Tick-Borne Relapsing Fever 
in Spokane County, Washington. JAMA 
1969;210:1045–50.  
R.S. Thompson, W. Burgdorfer, R. Russell,  
B.J. Francis
1970 Tularemia Epidemic: Vermont, 1968—Forty-Seven 
Cases Linked to Contact with Muskrats. N Engl J 
Med 1969;280:1253–60. 
L.S. Young, D.S. Bicknell, B.G. Archer, et al.
1971  Tomato Juice-Associated Gastroenteritis, 
Washington and Oregon, 1969. Am J Epidemiol  
1972;96:219–26. W.H. Barker Jr., V. Runte
1972 Salmonella Septicemia from Platelet Transfusions: 
Study of an Outbreak Traced to a Hematogenous 
Carrier of Salmonella cholerae-suis. Ann Intern 
Med 1973;78:633–41.  
F.S. Rhame, R.K. Root, J.D. MacLowry, T.A. 
Dadisman, J.V. Bennett
1973 Outbreak of Typhoid Fever in Trinidad in 1971 
Traced to a Commercial Ice Cream Product. Am J 
Epidemiol 1974;100:150–7. 
A. Taylor Jr., A. Santiago, A.Gonzales-Cortes, E.J. 
Gangarosa
1974 Oyster-Associated Hepatitis: Failure of Shellfish 
Certification Programs To Prevent Outbreaks. 
JAMA 1975;233:1065–8. 
B.L. Portnoy, P.A. Mackowiak, C.T. Caraway, J.A. 
Walker, T.W. McKinley, C.A. Klein Jr.
1975 Staphylococcal Food Poisoning Aboard a 
Commercial Aircraft. Lancet 1975;2:595–9. 
M.S. Eisenberg, K. Gaarslev, W. Brown, M. Horwitz, 
D. Hill
1976 Nursery Outbreak of Peritonitis with 
Pneumoperitoneum Probably Caused by 
Thermometer-Induced Rectal Perforation. Am J 
Epidemiol 1976;104:632–44. 
M.A. Horwitz, J.V. Bennett
1977 Epidemic Yersinia entercolitica Infection due to 
Contaminated Chocolate Milk. N Engl J Med 
1978;298:76–9. 
R.E. Black, R.J. Jackson, T. Tsai, et al.
1978 Measles Vaccine Efficacy in Children Previously 
Vaccinated at 12 Months of Age. Pediatrics 
1978;62:955–60. 
J.S. Marks, T.J. Halpin, W.A. Orenstein
1979 An Outbreak of Legionnaires’ Disease Associated 
with a Contaminated Air-Conditioning Cooling 
Tower. N Engl J Med 1980;302:365–70. 
T.J. Dondero, Jr., R.C. Rendtorff, G.F. Mallison, et al.
 Risk of Vascular Disease in Women: Smoking, Oral 
Contraceptives, Noncontraceptive Estrogens, and 
Other Factors. JAMA 1979;242:1150–4. 
D.B. Petitti, J.Wingerd, J. Pellegrin, et al.
1980 Injuries from the Wichita Falls Tornado: 
Implications for Prevention. Science 1980;207: 
734–8. 
R.I. Glass, R.B. Craven, D.J. Bregman, et al.
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1981 Respiratory Irritation due to Carpet Shampoo: Two 
Outbreaks. Environ Int 1982;8:337–41. 
K. Kreiss, M.G. Gonzalez, K.L. Conright, A.R. 
Scheere
1981 Toxic-Shock Syndrome in Menstruating Women: 
Association with Tampon Use and Staphylococcus 
aureus and Clinical Features in 52 Cases. N Engl J 
Med 1980;303:1436–42. 
K.N. Shands, G.P. Schmid, B.B. Dan, et al.
1982 Risk Factors for Heatstroke: A Case-Control Study. 
JAMA 1982;247:3332–6. 
E.M. Kilbourne, K. Choi, T.S. Jones, S.B. Thacker
1983 Epidemic Listeriosis C—Evidence for Transmission 
by Food. N Engl J Med 1983;308:203–6. 
W.F. Schlech III, P.M. Lavigne, R.A. Bortolussi, et al.
1984 Unexplained Deaths in a Children’s Hospital: 
An Epidemiologic Assessment. N Engl J Med 
1985;313:211–6. 
J.W. Buehler, L.F. Smith, E.M. Wallace, C.W. Heath, 
R. Kusiak, J.L. Herndon 
1984 Medication Errors with Inhalant Epinephrine 
Mimicking an Epidemic of Neonatal Sepsis. N Engl 
J Med 1984;310:166–70. 
S.L. Solomon, E.M. Wallace, E.L. Ford-Jones, et al.
1985 The Use and Efficacy of Child-Restraint Devices: 
The Tennessee Experience, 1982 and 1983. JAMA 
1984;252:2571–5.  
M.D. Decker, M.J. Dewey, R.H. Hutcheson Jr., W.S. 
Schaffner
1986 The Role of Parvovirus B19 in Aplastic Crisis and 
Erythema Infectiosum (Fifth Disease). J Infect Dis 
1986;154:383–93. 
T.L. Chorba, P. Coccia, R.C. Holman, et al.
1987 Oral Contraceptives and Cervical Cancer Risk in 
Costa Rica: Detection Bias or Causal Association? 
JAMA 1988;259:59–64. 
K.L. Irwin, L. Rosero-Bixby, M.W. Oberle, et al.
1988 A Day-Care-Based Case-Control Efficacy Study of 
Haemophilus influenzae B Polysaccharide Vaccine. 
JAMA 1988;260:1413–8. 
L.H. Harrison, C. Broome, A.W. Hightower, et al.
1989 Group A Meningococcal Carriage in Travelers 
Returning from Saudi Arabia. JAMA 
1988;260:2686–9.  
P.S. Moore, L.H. Harrison, E.E. Telzak, G.W. Ajello, 
C.V. Broome
1989 Transmission of Plasmodium vivax Malaria in San 
Diego County, California, 1986. Am J Trop Med 
Hyg 1990;42:3–9. 
Y.A. Maldonado, B.L. Nahlen, R.R. Roberta, et al.
1990 An Outbreak of Surgical Wound Infections due to 
Group A Streptococcus Carried on the Scalp.  
N Engl J Med 1990;323:968–72. 
T.D. Mastro, T.A. Farley, J.A. Elliott, et al.
1991 An Investigation of the Cause of the Eosinophilia-
Myalgia Syndrome Associated with Tryptophan 
Use. N Engl J Med 1990;323:357–65. 
E.A. Belongia, C.W. Hedberg, G.J. Gleich, et al.
1992 An Outbreak of Multidrug-Resistant Tuberculosis 
Among Hospitalized Patients with the Acquired  
Immunodeficiency Syndrome. N Engl J Med 
1992;326:1514–21. 
B.R. Edlin, J.I. Tokars, M.H. Grieco, et al.
1993 Comparison of Prevention Strategies for Neonatal 
Group B Streptococcal Infection: A Population-
Based Economic Analysis. JAMA 1993;270:1442–8. 
J.C. Mohle-Boetani, A. Schuchat, B.D. Plikaytis, J.D. 
Smith, C.V. Broome
1993 Retrospective Study of the Impact of Lead-Based 
Hazard Remediation on Children’s Blood Lead 
Levels in St. Louis, Missouri. Am J Epidemiol 
1994;139:1016–26. 
C. Staes, T. Matte, C.B. Copley, D. Flanders, S. 
Binder
1994 A Massive Outbreak in Milwaukee of 
Crytosporidium Infection Transmitted Through 
the Public Water Supply. N Engl J Med 1994;331: 
161–7. 
W.R. Mac Kenzie, N.J. Hoxie, M.E. Proctor, et al.
1995 A Multistate Outbreak of Escherichia coli 0157:H7-
Associated Bloody Diarrhea and Hemolytic Uremic 
Syndrome from Hamburgers: The Washington 
Experience. JAMA 1994;272:1349–53. 
B.P. Bell, M. Goldoft, P.M. Griffin, et al.
1996 A Multistate Outbreak of Salmonella Enteriditis 
Infections Associated with Consumption of Schwan’s 
Ice Cream. N Engl J Med 1996; 334:1281–6. 
T.W. Hennessy, C.W. Hedberg, L. Slutsker, et al.
1996 Passenger to Passenger Transmission of 
Mycobacterium tuberculosis Aboard Commercial 
Aircraft During Transoceanic Travel. N Engl J Med 
1996;334:993–8. 
T.A. Kenyon, S.E. Valway, W.W. Ihle, I.M. Onorato
1997 Epidemic Meningococcal Disease and Tobacco 
Smoke: A Risk Factor Study in the Pacific 
Northwest. Pediatr Infect Dis J 1997;16:979–83. 
M.A. Fisher, K. Hedberg, P. Cardosi, et al.
1998 Suicide After Natural Disasters. N Engl J Med 
1998;338:373–8. 
E.G. Krug, M. Kresnow, J.P. Peddicord, et al.
2014 EIS Conference 13
1999 Legalized Physician-Assisted Suicide in Oregon—
The First Year’s Experience. N Engl J Med 
1999;340:577–83. 
A.E. Chin, K. Hedberg, G.K. Higginson, D.W. Fleming
2000 Infantile Hypertrophic Pyloric Stenosis After 
Pertussis Prophylaxis with Erythromycin: A Case 
Review and Cohort Study. Lancet 1999;354:2101–5. 
M.A. Honein, L.J. Paulozzi, I.M. Himelright, B. Lee, 
J.D. Cragan, L. Patterson, A. Correa, S. Hall,  
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Alexander D. Langmuir Lectures, 1972–2013
1972 Prevention of Rheumatic Heart Disease—Fact or 
Fancy.  
Charles H. Rammelkamp
1973 Cytomegaloviral Disease in Man: An Ever 
Developing Problem.  
Thomas H. Weller
1974  Hepatitis B Revisited (By the Non-Parenteral Route). 
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1975  Origin, Spread, and Disappearance of Kuru: 
Implications of the Epidemic Behavior of a Disease 
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D. Carleton Gajdusek
1976 The Future of Epidemiology in the Hospital.  
Paul F. Wehrle
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1977 The Historical Evolution of Epidemiology.  
Abraham Lilienfeld
1978 The Biology of Cancer: An Epidemiological 
Perspective.  
Sir Richard Doll
1979 The Epidemiology of Antibiotic Resistance.  
Theodore C. Eickoff
1980 Health and Population Growth.  
Thomas McKeown
1981 The Pathogenesis of Dengue: Molecular 
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Scott B. Halstead
1982 The Epidemiology of Coronary Heart Disease: 
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1983 Sexually Transmitted Diseases—Past, Present, and 
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1984 Poliomyelitis Immunization—Past and Future.  
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1985 An Epidemiologist’s View of Postmenopausal 
Estrogen Use, or What to Tell Your Mother.  
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1988 Lymphotropic Retroviruses in Immunosuppression. 
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Control Success in the Age of Social Networks. 
Robert A. Weinstein
2012 Prevention of Teen Pregnancy: What Do We 
Know? Where Do We Go? 
Robert Blum
2013 The Role of EIS in Communities of Solution: 
Using GIS and Epidemiology to Activate Health 
Partnerships. 
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Distinguished Friend of EIS Awards, 1984–2013




1988 Frances H. Porcher
1989  Not Awarded 
1990 J. Lyle Conrad
1991 Alexander D. Langmuir
1992 Laurence R. Foster
1993 Kenneth L. Herrmann and William Roper
1994 Louise McFarland
1995 Mike Osterholm
1996 Jim Curran and Larry Schonberger
1997 Patsy Bellamy
1998 John Horan
1999 Not Awarded 
2000 James Hadler
2001 Barbara R. Holloway and William R. Jarvis










2012 Jeffrey P. Davis
2013 Douglas H. Hamilton
Donald C. Mackel Memorial Awards, 1987–2013
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1996 Malassezia pachydermatis Fungemia in Neonatal 
Intensive Care Unit Patients: There’s a [New] 
Fungus Among Us! 
Huan Justina Chang
1997 Epidemic of Deaths from Acute Renal Failure 
Among Children in Haiti. 
Katherine L. O’Brien
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2002 Dances with Cows?: A Large Outbreak of E. 
coli O157 Infections at Multi-Use Community 
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2003 Hepatitis C Virus Transmission from an Antibody-
Negative Organ and Tissue Donor. 
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2004 Multiple Hepatitis A Outbreaks Associated with 
Green Onions Among Restaurant Patrons—
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2005 Case-Control Study of an Acute Aflatoxicosis 
Outbreak. 
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2006 Delayed Onset of Pseudomonas fluorescens 
Group Bloodstream Infections After Exposure 
to Contaminated Heparin Flush—Michigan and 
South Dakota. 
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2007 Epidemiologic and Molecular Investigation of 
an Outbreak of Hepatitis C Viral Infection at 
Hemodialysis Unit—Richmond Virginia, 2006. 
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2008 Multistate Measles Outbreak Associated with an 
International Youth Sporting Event—Pennsylvania, 
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2009 Cardiac Events and Deaths in a Dialysis Facility 
Associated with Healthcare Provider—Texas, 2008. 
Melissa K. Schaefer
2010 Fatal Case of Laboratory-Acquired Infection with 
an Attenuated Yersinia pestis Strain of Plague—
Illinois, 2009. 
Andrew Medina-Marino
2011 Outbreak of Nosocomial Listeriosis—Texas, 2010. 
Noha H. Farag
2012 Pyrrolizidine Alkaloid Toxicity as the Cause of 
Unknown Liver Disease—Tigray, Ethiopia,  
2007–2011. 
Danielle E. Buttke
2013 Active Surveillance for Variant Influenza Among 
Swine, the Environment, and Employees at Live 
Animal Markets—Minnesota, 2012. 
Mary J. Choi
J. Virgil Peavy Memorial Awards, 2003–2013
2003  Danice Eaton
2004 Lori A. Pollack
2005 Andrea Sharma
2006  Andrea Sharma
2007 Abhijeet Anand and David Lowrance
2008 Katherine Ellingson
2009 Michael L. Jackson
2010 Erin Murray
2011 Matthew Willis
2012 Noha H. Farag
2013 Alison Laufer
Paul C. Schnitker International Health Award, 1995–2013
1995 Leslie F. Roberts
1996 Peter Kilmarx
1997 Alexander K. Rowe and Eric L. Mouzin
1998 Etienne G. Krug
1999 Kayla F. Laserson
2000 John MacArthur and Peter Salama
2001 Valerie D. Garrett
2002 Robert D. Newman and Lorna E. Thorpe






2008 Sapna Bamrah and David Lowrence
2009 Rinn Song
2010 Andrew Auld
2011 W. Roodly Archer
2012 Sudhir Bunga and Janell A. Routh
2013 Kevin R. Clarke
James H. Steele Veterinary Public Health Award, 1999–2013







2006 Katherine Heldman and James Kile
2007 Jennifer Wright
2008 John R. Dunn




2013 Maho Imanishi and Megin Nichols
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Outstanding Poster Presentation Award, 1986–2013
1986 Gender Gap in the Diaper Set: A Closer Look at 
Differences in Sex-Specific Mortality. 
Ray Yip
1987 Socioeconomic Differences in Smoking Behavior in 
Selected States. 
Thomas E. Novotny
1988 Late-Stage Diagnosis of Breast Cancer Among 
Women in Low Socioeconomic Groups, 
Connecticut, 1984–1985. 
Thomas A. Farley
1989 Malaria Infection in Early Infancy, Malawi. 
Laurence Slutsker
1990 Seroprevalence of Human Immunodeficiency 
Virus Type I Among College Students, United 
States. 
Brian R. Edlin
1991 Diarrheal Outbreak Associated with a 
Cyanobacteria (Blue-Green Algae)-Like Body, 
Chicago. 
Philip P. Huang
1992 Response to One Dose of Inactivated Poliovirus 
Vaccine after Three Doses of Oral Poliovirus 
Vaccine, Abidjan, Cote d’Ivoire. 
Bernard J. Moriniere
1993 Cholera Outbreak in Rumonge, Burundi. 
Maureen E. Birmingham
1994 Salivary Testing as an Epidemiologic Tool 
During an Outbreak of Hepatitis A in an Amish 
Community in Indiana. 
Edmundo Muniz
1995 Longitudinal Predictors of Initiation of Smokeless 
Tobacco Use. 
Scott L. Tomar
1996 Nonvenomous Animal-Related Fatalities in the 
U.S. Workplace, 1992–1994. 
Constance C. Austin
1997 Multidrug-Resistant Pneumococcal Meningitis in a 
Day Care Center—Tennessee. 
Allen Craig
1998 Beliefs About the Tobacco Industry and Opinions 
About Anti-Tobacco Policies: How Tight is the 
Link? 
Arthur E. Chin
1999 Cold Breakfast Cereal: A New Vehicle Implicated 
in a Multistate Outbreak of Salmonella Agona 
Infections. 
Thomas Breuer
2000 Hurricane—Puerto Rico, 1998. 
Dan O’Leary
2001 Counting Crows: Crow Mortality as a Sentinel for 
West Nile Virus Disease in Humans—Northeastern 
United States, 2000. 
Kathleen G. Julian 
2002  Outbreak of Echovirus 18 Meningitis at a Summer 
Camp—Alaska, 2001. 
Joseph B. Mclaughlin
2003 Surveillance for Chlamydia in Women—South 
Carolina, 1998–2001. 
Wayne A. Duffus
2004 Hospitalizations Associated with Rotavirus 
Diarrhea—United States, 1996–2000. 
Myrna Charles
2005 Risk of Secondary Transmission from Imported 
Lassa Fever—New Jersey, 2004. 
Ester Tan
2006 Risk Factors for Helicobacter pylori in a Rural 
Community—Montana, 2005. 
Elizabeth Melius
2007 Outbreak of Escherichia coli 0157 Associated with 
Packaged Spinach—Wisconsin, 2006. 
Authur M. Wendel
2008 The Power of Combining Routine Molecular 
Subtyping and Specific Food Exposure Interviews 
During Escherichia coli O157:H7 Outbreak—
Minnesota, 2007. 
S. M. Holzbauer
2009 Seroprevalence of Herpes Simplex 2—National 
Health and Nutritional Examination Surveys, 
United State, 2005–2006. 
Sara E. Forhan
2010  Travelers’ Impressions of 2009 H1N1 Influenza 
National Health Messaging Campaign. 
Emily Jentes
2011  Vibrio mimicus Infection After Consumption of 
Crayfish—Spokane, Washington, 2010. 
Meagan K. Kay
2012 Associations Between Salmonella Serotypes and 
Particular Food Commodities—United States, 
1998-2008. 
Brendan R. Jackson
2013 A Spicy Catch: Salmonella Bareilly and Nchanga 
Infections Associated with Raw Scraped Tuna 
Product—United States, 2012. 
W. Thane Hancock
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Philip S. Brachman Awards, 1983–2013
1983 Philip S. Brachman
1984 Michael Gregg
1985 Howard Ory
1986 J. Lyle Conrad
1987 Andrew G. Dean
1988 Richard C. Dicker
1989 Carl W. Tyler, Jr.
1990 Richard C. Dicker
1991 Richard C. Dicker
1992 Jeffrey J. Sacks
1993 J. Lyle Conrad and Michael Toole
1994 Willard (Ward) Cates and Robert Breiman
1995 John Horan
1996 Polly Marchbanks
1997 William Mac Kenzie
1998 Laura A. Coker
1999 Christine Zahniser
2000 Jeffrey J. Sacks
2001 Douglas H. Hamilton
2002 Marcelle Layton, Steve Weirsma, James L. Hadler, 
Eddy Bresnitz, Elizabeth Barrett, Robert B. Stroube, 
Ross J. Brechner, David S.B. Blythe, Larry Siegel, 
Karyn Berry, Sherri Adams, John Eisold, and Greg 
Martin




2007 Joshua Mott and Peter Cegielski
2008 Lisa Pealer
2009 C. Kay Smith and Julie Magri
2010  Betsy Gunnels
2011 William Schaffner
2012 Rachel N. Avchen
2013 Stephen B. Thacker
Mitch Singal Excellence in Occupational and Environmental Health 
Award, 2010–2013
2010 Surveillance and Prevention of Occupational Injury 
Deaths—Wyoming, 2003–2007. 
Paul Anderson
2011 Unprecedented Outbreak of Acute Childhood Lead 
Poisoning—Zamfara State, Nigeria, 2010. 
Carrie A. Dooyema
2012 Pyrrolizidine Alkaloid Toxicity as the Cause of 
Unknown Liver Disease—Tigray, Ethiopia  
(2007–2011). 
Danielle E. Buttke
2013 Impact of Aerial Insecticide Spraying on West Nile 
Virus Disease—North Texas, 2012. 
Duke J. Ruktanonchai
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SeSSION a: StepheN B. thacker OpeNINg SeSSION
8:30–10:15am
Ravinia Ballroom
Moderators: Michael Iademarco and Diana Bensyl 
8:35 FeBrIle IllNeSS at a State cOrrectIONal FacIlIty — IllINOIS, 2013
Authors: M. Allison Arwady, S. Vallabhaneni, V. Tsai,  
R. Smith, B. Park, C. Conover
Background: On August 29, health authorities were 
notified that 42 state prison inmates had become ill 
during the preceding 48 hours, with fever, headache, 
cough, and dyspnea. A respiratory virus was suspected, 
and the prison was placed on lockdown. During the 
following week, 50 additional inmates became ill. We 
aimed to identify a source and prevent further infections.
Methods: We recommended laboratory testing for 
viruses, bacteria, and fungi; abstracted medical charts; 
interviewed inmates and staff; and conducted an 
environmental assessment. Cases were defined as illness 
in an inmate, including >2 of the following: temperature 
>100ºF, chills, headache, chest pain, shortness of breath, 
cough, myalgia, or fatigue with onset after August 12.
Results: Eighty-five inmates met the case definition, 3 of 
whom required hospitalization. Testing for 21 viral and 
bacterial respiratory pathogens was negative. Of the 82 
symptomatic inmates who submitted blood or urine, 78 
(95%) tested positive for acute histoplasmosis (64 had 
positive antigen; 69 had positive antibody). Seventy-one 
of the 78 (91%) were housed in Cellblock X. Two weeks 
prior to the outbreak, 2 trees and their root systems 
directly outside Cellblock X had been removed for 
security reasons. These trees were roosting sites for some 
of the thousands of European starlings found nightly 
within prison grounds.
Conclusions: Acute histoplasmosis can mimic a 
respiratory virus outbreak and should be considered in 
endemic areas. Disturbance of soil contaminated with 
the fungus Histoplasma capsulatum, which thrives in soil 
contaminated with bird droppings, likely aerosolized 
fungal spores and caused this large outbreak. To decrease 
the risk for future histoplasmosis cases, the prison should 
limit starling roosting sites by removing other facility 








8:55 WOrkplace SecONDhaND SmOke expOSure amONg NONSmOkINg WOmeN OF  
reprODuctIve age — uNIteD StateS, 2010
Authors: Candice Y. Johnson, S. Luckhaupt, C. Lawson
Background: One in 10 nonsmoking American workers 
is exposed to secondhand smoke (SHS) at work. SHS 
exposure during pregnancy is associated with adverse 
pregnancy outcomes, notably low birth weight. Our aim 
was to characterize workplace SHS exposure among 
nonsmoking women of reproductive age as a proxy for 
workplace SHS exposure during the periconceptional 
period and early pregnancy.
Methods: We used data from the 2010 National Health 
Interview Survey Occupational Health Supplement, 
reweighting the data to be representative of the age 
distribution of pregnant women instead of the general 
population. We included employed nonsmoking women 
aged 18–44 years (unweighted N = 3,278), and used 
logistic regression (SAS v9.3) to estimate odds ratios 
(OR) and 95% confidence intervals (CI) for associations 
between sociodemographic and workplace characteristics 
and self-reported workplace SHS exposure. 
Results: Eight percent of the study population reported 
workplace SHS exposure. Prevalence of exposure 
decreased with increasing age, education, and earnings. 
Workplace SHS exposure was associated with working 
non-day shifts (OR: 4.0, CI: 2.0–8.1 for evening vs. day); 
food preparation and serving occupations (OR: 3.4, 
CI: 1.9–6.0 vs. all other occupations); worrying about 
unemployment (OR: 3.4, CI: 1.8–6.4 for most vs. least 
worry); exposure to chemicals (OR: 3.3, 95% CI: 2.2–5.1) 
or vapors, gas, dust, or fumes (OR: 2.9, CI: 2.0–4.2) at 
work; and being threatened, bullied, or harassed at work 
(OR: 2.9, CI: 1.8–4.7).
Conclusions: Disparities exist in workplace SHS exposure 
among nonsmoking women of reproductive age, with 
strong associations between sociodemographic and work 
characteristics and SHS. Comprehensive smoke-free laws 
covering all workers could help to eliminate workplace 
SHS disparities in the periconceptional period and 
during pregnancy.
9:15 the FIrSt u.S. cryptOSpOrIDIOSIS OutBreak aSSOcIateD WIth a SurFace Water-SupplIeD 
muNIcIpal Water SyStem IN 20 yearS — Baker cIty, OregON 2013
Authors: Malini B. DeSilva, S. Schafer, B. Robinson,  
G. Buser, M. Kendall, E. DeBess, A. Hills, L. Xiao, V. Hill, 
D. Roellig, M. Gronostaj, K. Hedberg
Background: Cryptosporidium, a chlorine-tolerant 
parasite, causes gastrointestinal illness affecting 
approximately 748,000 U.S. residents annually and 
has caused massive, communitywide waterborne 
outbreaks. Laboratory-based surveillance detected a 
cryptosporidiosis outbreak in Baker City, Oregon in July 
2013, anecdotally linked to municipal drinking water. We 
investigated to confirm the outbreak source, assess attack 
rate, and evaluate detection timeliness.
Methods: We tested raw and treated city water 
and assessed potential environmental sources of 
contamination. Trained interviewers administered 
a standardized survey to 380 randomly sampled 
households. To determine attack rate, survey cases were 
defined as Baker City residents with onset after July 1 of 
acute diarrhea lasting ≥3 days. Data were weighted to 
reflect the sampling design. We compared survey case 
symptom onset with report dates of laboratory-confirmed 
cases detected by passive surveillance to determine 
outbreak detection timeliness.
Results: Cattle grazing encircles the watershed; cattle 
feces were observed within watershed barriers. City water 
tested positive for Cryptosporidium; one watershed 
sample had 913 oocysts. The attack rate was 28.3% (95% 
confidence interval: 22.1%–33.6%), indicating 2,780 
residents became ill. The first survey case onset was July 
1; first laboratory-confirmed case was reported July 29. A 
3-week boil water advisory began July 31; the implicated 
reservoir was taken offline and no subsequent cases 
occurred. Cryptosporidium parvum subtype IIaA15G2R1, 
a common parasite of U.S. dairy calves, was found in 
stool specimens from nine patients.
Conclusions: This community-wide outbreak highlights 
the importance of regulations requiring source water 
protection and treatment to control Cryptosporidium. 
Watershed contamination by cattle likely caused 
this outbreak, which was undetected by traditional 
surveillance for four weeks. Prevention and control of 
cryptosporidiosis outbreaks requires improvements in 
drinking water treatment and enhanced surveillance.







9:35 herOIN-relateD OverDOSeS aND DeathS — WIScONSIN, 2003–2012
Authors: Jon G. Meiman, K. Bisgard, C. Tomasallo
Background: In the United States during 2003–2012, 
heroin use increased >2-fold to ~669,000 persons; during 
2011, ~258,000 heroin-related emergency department 
(ED) visits occurred. We examined Wisconsin data to 
characterize trends in heroin overdose and fatalities 
as a surrogate for heroin use to support intervention 
strategies.
Methods: A nonfatal case was defined as an ED visit 
or hospitalization with a principal diagnosis of heroin 
overdose; two statewide discharge databases included 
data for 2003–2012. A heroin-related fatality included 
drug overdose as the underlying cause and heroin 
poisoning as any contributing cause; death certificate 
data were available for 2003–2011. Rural areas were 
defined using the Rural-Urban Commuting Area Codes 
and accounted for 1.7 million (30%) of Wisconsin’s 
population (5.7 million). We computed annual age-
adjusted rates; we used chi-square tests to assess 
demographic characteristics.
Results: During 2003–2012, a total of 1,429 ED patients 
were treated and released (patients’ median age: 25 
years) (74% male) and 809 were hospitalized (patients’ 
median age: 28 years) (71% male) due to heroin 
overdose. Age-adjusted ED visit rates increased from 
0.9/100,000 persons in 2003 to 7.2/100,000 in 2012; 
overdose hospitalizations increased during the same 
period (0.7/100,000 to 3.2/100,000). Non-Hispanic whites 
accounted for a higher proportion of hospitalizations 
during 2008–2012 (87%), compared with 2003–2007 
(76%; P ≤0.01). Five hundred five heroin-related fatalities 
(patients’ median age: 33 years) (84% male) occurred 
during 2003–2011. Statewide, fatalities increased from 
0.5/100,000 in 2003 to 2.4/100,000 in 2011; in rural areas, 
fatalities increased from 0 in 2003 to 22 in 2011.
Conclusions: Since 2003, Wisconsin has had a substantial 
increase in heroin overdoses; strengthened prevention 
and treatment initiatives are needed throughout the state.
9:55 rISk FactOrS FOr INFlueNza a(h7N9) DISeaSe — chINa, 2013
Authors: Fiona P. Havers, B. Liu, E. Chen, Z. Yuan,  
H. Yuan, J. Ou, M. Shang, K. Kang, K. Liao, F. Liu, D. Li, 
H. Ding, L. Zhou, W. Zhu, F. Ding, P. Zhang, X. Wang,  
J. Yao, N. Xiang, S. Zhou, X. Liu, Y. Song, H. Su, R. Wang, 
J. Cai, Y. Cao, X. Wang, T. Bai, J. Wang, Z. Feng, Y. Zhang, 
Q. Li, M.A. Widdowson
Background: A novel avian influenza A(H7N9) caused 
147 human infections, including 48 deaths, in China 
between March and December 2013. The majority of 
case-patients reported poultry exposure. Specific host 
and exposure risk factors for disease are unknown, yet 
critical to design prevention measures.
Methods: In March–April 2013, we conducted a case-
control study in eight Chinese provinces. Laboratory-
confirmed A(H7N9) case-patients were matched 1:4 
for age, sex, and neighborhood to controls. Subjects 
completed a questionnaire on medical history and 
potential exposures, including poultry markets and other 
types of poultry exposure. We used conditional logistic 
regression to calculate matched odds ratios (mORs) for 
the association of A(H7N9) virus disease with potential 
risk factors. 
Results: We studied 89 A(H7N9) cases with 340 matched 
controls. Obesity (mOR: 4.7; confidence interval [CI]: 
1.8–12.5), chronic obstructive pulmonary disease 
(mOR: 2.71; CI: 1.1–6.9), and use of immunosuppressive 
medications (mOR: 9.0; CI: 1.7–47.2) were associated 
with A(H7N9) disease. 55% of cases compared with 31% 
of controls reported any contact with poultry (mOR: 
8.0; CI: 3.3–19.2). 67% of case-patients compared with 
34% of controls visited a live poultry market (mOR: 
2.4; CI: 1.1–5.6); visiting live poultry markets increased 
risk of infection even after adjusting for poultry contact 
and other confounders (adjusted OR: 3.5; CI: 1.8–6.8). 
Domestically raised poultry were not associated with 
increased risk; 12 (14%) of case-patients did not report 
any poultry exposure or market visit. 
Conclusions: Exposure to poultry in markets was 
associated with A(H7N9) virus infection, even without 
direct or indirect poultry contact. China should 
consider permanently closing live poultry markets and 
aggressively pursuing control measures to prevent spread 












10:50 evaluatION OF aNtIBIOtIcS aDmINIStereD FOr acute upper reSpIratOry tract INFectIONS 
—  OregON, 2011
Authors: Kara M. Levri, A. Thomas, B. Robinson
Background: Incorrect antibiotic use increases the risk 
for antibiotic-resistant bacteria emergence, and infections 
caused by antibiotic-resistant bacteria are associated 
with morbidity, mortality, and substantial economic 
burden. We report a statewide evaluation of antibiotic 
administration for acute upper respiratory infections 
(URTIs) among outpatients.
Methods: All-payer claims data were reviewed for 
outpatient visits for acute URTIs (otitis media, sinusitis, 
pharyngitis, bronchitis, and upper respiratory infections 
[URIs] having International Classification of Diseases, 
Ninth Revision codes) and excluded visits for patients 
with other provider-diagnosed infectious diseases 
or underlying pulmonary conditions. As a proxy for 
prescribing practices, we assessed whether antibiotics 
had been obtained within 3 days of the outpatient visit 
by using pharmacy claims. Outpatient visit claims were 
linked with pharmacy claims for antibiotic prescriptions, 
then duplicates removed to represent each patient at 
first diagnosis. We calculated the proportion of patients 
with an obtained antibiotic by URTI, antibiotic category 
(narrow or broad-spectrum), and selected antibiotics.
Results: Among all URTI outpatients (n = 621,764), 40% 
received antibiotics (n = 246,026) during 2011. Children 
were more likely to obtain antibiotics than adults for all 
URTI visits except URIs; the proportion receiving broad-
spectrum antibiotics increased with age. For bronchitis 
and URI, diagnoses rarely requiring antibiotics, 50% and 
12% obtained antibiotics, respectively. Of those, 90% 
and 66%, respectively, were broad-spectrum antibiotics. 
Azithromycin, a broad-spectrum antibiotic, was obtained 
for 36% of bronchitis and 6% of URI diagnoses.
Conclusions: In Oregon, broad-spectrum antibiotics, 
particularly azithromycin, are being overly prescribed 
for bronchitis and URIs, diagnoses that rarely require 
antibiotics. Use of payer and claims data is a helpful tool 
for program evaluation and the development of targeted 
messages to improve antibiotic prescribing.
11:10 OutpatIeNt aNtIBIOtIc preScrIBINg FOr chIlDreN — uNIteD StateS, 2011
Authors: Alicia Demirjian, R. Roberts, M. Bartoces,  
T. Taylor, L. Hicks
Background: In the United States, at least two million 
people develop severe infections caused by antimicrobial-
resistant pathogens every year, and more than 23,000 die 
as a direct result. The inappropriate use of antibiotics is 
the largest modifiable contributor to antibiotic resistance. 
We sought to describe the use of antibiotics in children 
according to provider specialty and geography.
Methods: The number of oral antibiotic prescriptions 
dispensed to persons < 20 years of age was extracted from 
2011 IMS Health© Xponent® data, which represent all 
outpatient antibiotics prescribed in the U.S. Prescribing 
rates were calculated using census data for denominators.
Results: In 2011, 73.7 million courses of antibiotics, or 
885 prescriptions per 1,000 persons < 20 years of age, 
were dispensed; the prescribing rate was highest for 
patients 0–2 years (1,267 per 1,000 persons). The most 
common categories prescribed were penicillins and 
macrolides; amoxicillin was the most common individual 
antibiotic (33.7% of total), followed by azithromycin 
(20.6%). Azithromycin accounted for 28.3% of 
prescriptions written by family practitioners, compared 
to only 20.0% of prescriptions written by pediatricians. 
Pediatricians prescribed 362 courses per 1,000 persons 
and family practitioners prescribed 154 per 1,000 
persons, accounting for 58.3% of pediatric antibiotic 
prescriptions. Prescription rates varied by census region 
(lowest, 638 vs. highest, 1,027 per 1,000 persons in the 
West and South, respectively) and state (lowest, 339 vs. 
highest, 1,482 per 1,000 persons in Alaska and Kentucky, 
respectively).
Conclusions: Antibiotic prescribing practices vary 
markedly according to provider specialty and geography, 
suggesting an opportunity for targeted interventions to 
reduce use. The common use of azithromycin among 
family practitioners and overall high prescription rates in 
the South are potential areas for improvement.







11:30 vaccINeS FOr a “pIèce De réSIStaNce”: preveNtION OF aNtImIcrOBIal reSIStaNce amONg 
chIlDreN ageD <5 yearS WIth the 13-valeNt pNeumOcOccal cONjugate vaccINe — 
SelecteD u.S. areaS, 2004–2012
Authors: Sara Tomczyk, J. Jorgensen, R. Lynfield,  
W. Schaffner, D. Aragon, L. Harrison, M. Nicholas,  
S. Petit, A. Thomas, A. Reingold, M. Farley, S. Zansky,  
B. Beall, L. McGee, L. Kim
Background: Antimicrobial resistant Streptococcus 
pneumoniae (pneumococcus) causes 1.2 million U.S. 
infections annually among all ages. Antimicrobial 
resistant invasive pneumococcal disease (IPD) 
decreased after 7-valent pneumococcal conjugate 
vaccine introduction in 2000. A Healthy People 2020 
(HP2020) goal is to reduce IPD not susceptible (NS) 
to >1 antimicrobials among children aged <5 years old 
from 8.3 (2008) to 6 cases per 100,000 children. We 
evaluated progress towards this goal following the 2010 
introduction of 13-valent pneumococcal conjugate 
vaccine (PCV13).
Methods: We defined IPD as isolation of pneumococcus 
from normally sterile sites among residents aged <5 
years from ten Active Bacterial Core surveillance areas 
during 2004–2012. Isolates were serotyped and tested for 
antimicrobial susceptibility (using Clinical Laboratory 
Standards Institute breakpoints). NS-IPD cases were 
NS to >1 of the following antimicrobials: penicillin, 
amoxicillin, erythromycin, cefotaxime, ceftriaxone, 
cefuroxime, tetracycline, vancomycin, and levofloxacin. 
We compared rates of NS-IPD observed in 2012 (after 
PCV13 introduction) to rates expected in the absence of 
PCV13, using chi-squared analyses.
Results: We identified 3,194 pediatric IPD cases during 
2004–2012. In 2012, the observed rate (cases per 100,000 
children) of NS-IPD was 3.5 (below HP2020 goal) 
compared to the expected rate of 12 in the absence of 
PCV13 (69% decline; P<.0001). Observed antimicrobial-
specific NS-IPD rates were significantly lower in 2012 for 
penicillin (0.5; 93% decline; P<.0001), amoxicillin (0.8; 
89% decline; P<.0001), erythromycin (3.2; 72% decline; 
P<.0001), cefotaxime (0.4; 94% decline; P<.0001), 
ceftriaxone (0.4; 93% decline; P<.0001), cefuroxime (1.5; 
81% decline; P<.0001), and tetracycline (1.1; 86% decline; 
P<.0001).
Conclusions: PCV13 use among children has allowed 
the U.S. to achieve a key HP2020 objective 8 years in 
advance. Continued surveillance is needed to ensure that 
reductions persist.
11:50 vaNcOmycIN-reSIStaNt EntErococcus faEcium IN a NeONatal INteNSIve care uNIt —  
utah, 2013
Authors: Joanna R. Watson, R. Abouzelof, J. Cline,  
A. Oswald, K. Friddle, Y. Kohring, R. Bierer, C. Davis,  
A. Nuibe, S. Patel, E. Thorell, M. Dickey, A. Phillips,  
R. Daley, B. Robinson, S. Varley, A. Nakashima, A. Pavia
Background: Colonization and subsequent infection 
with vancomycin-resistant Enterococcus faecium (VRE) 
is associated with increased morbidity, mortality, and 
health care costs. In January 2013, Hospital A was 
notified that a patient transferred from their neonatal 
intensive care unit (NICU) had tested positive for VRE 
colonization. Hospital A implemented multiple rounds 
of active surveillance of NICU patients, the first of 
which identified 4 additional VRE-colonized infants. 
Control measures, including active surveillance, contact 
precautions, and enhanced environmental cleaning, 
were progressively implemented. We investigated to 
characterize the outbreak and assess control measure 
effectiveness.
Methods: A case was defined as ≥1 clinical or 
surveillance culture-positive result for VRE in a NICU 
patient during January–November 2013. Environmental 
samples were tested in February, March, April, and July. 
Case-patients’ medical records were reviewed, and VRE 
isolates were evaluated by pulsed-field gel electrophoresis 
(PFGE).
Results: We identified 47 cases (45 colonizations, 2 
infections). Median patient age was 48 (range: 13–400) 
days. Peak incidence occurred in March (11 cases). 
No cases were identified after August. Median time 
from NICU admission to positive VRE culture was 30 
(range 0–263) days. Only 1/15 case-patients cultured at 
admission to the unit was positive for VRE. Of 29 patient 
isolates typed by PFGE, 7 belonged to pattern one and 
21 to pattern two. During February–April, 21/125 (17%) 
environmental cultures were VRE-positive, compared 
with 2/44 (5%) in July. All environmental isolates typed 
by PFGE matched patient isolate patterns one (3 isolates) 
or two (5 isolates).
Conclusions: An outbreak with 2 VRE clones occurred in 
a NICU. Implementation of control measures was able to 
reduce environmental contamination, halt transmission, 
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10:50 trOuBle ON the trackS: chemIcal expOSure, health eFFectS, aND cOmmuNIcatION aFter 
a traIN DeraIlmeNt — NeW jerSey, 2012
Authors: Alice M. Shumate, M. Duncan, J. Taylor,  
L. Graziano, C. Hunter, E. Vaouli, J. Devlin, J. Wilken,  
K. Brinker, P. Ruckart, J. Eldridge, C. Tan, M. Orr,  
J. Fagliano
Background: On November 30, 2012, a train derailment 
released vinyl chloride (VC) into a town with ~6,100 
residents. Because acute, high-level VC exposure can 
cause serious health effects, including death, the adjacent 
area was evacuated. Shelter-in-place orders were issued 
and lifted repeatedly for 4 days as airborne VC levels 
fluctuated and the evacuation area was expanded. 
We used in-person surveys to describe exposure and 
health effects experienced by the community and the 
effectiveness of risk communication to the public.
Methods: A 2-stage sampling plan selected census blocks 
and households for interview in the initial evacuation 
zone (Area A), expanded evacuation zone (B), adjacent 
area to evacuation zone (C), and the rest of town (D). 
Associations between risk factors and symptoms and 
symptom prevalence across areas were evaluated by using 
chi-square tests.
Results: During December 14–20, 2012, a total of 459 
persons were interviewed; 256 (56%) reported health 
effects, typically headache, upper-respiratory symptoms, 
coughing, and dizziness. Symptom prevalence was lower 
among residents of Area D (43.9%) than A (53.6%), 
B (61.4%), and C (62.7%; P = 0.02). Persons smelling 
unusual odors were more likely to experience symptoms 
(odds ratio [OR]: 7.34; 95% confidence interval [CI]: 
4.43–12.16), as were smokers (OR: 2.03; 95% CI: 
1.22–3.38) and persons with asthma (OR: 2.2; 95% CI: 
1.30–3.72). Sixty-five percent of respondents (213/328) 
reported being told to shelter-in-place, but only 42% 
(103/246) reported receiving instructions.
Conclusions: Community impact of the VC release 
was widespread, with symptoms prevalent in all areas 
and higher among populations with risk factors for 
respiratory symptoms. Effective risk communication 
messaging is a crucial public health priority during 
chemical releases and might decrease morbidity.







11:10 FOrmalDehyDe levelS aND reSpIratOry allergIeS amONg urBaN, lOW-INcOme chIlDreN 
— uNIteD StateS, 2011–2012
Authors: Joy Hsu, M. Colton, F. Yip, K. Sircar, K. Alwis,  
B. Blount, T. Reponen, G. Adamkiewicz, P. Ryan, G. Chew
Background: Low-income children have 
disproportionately high morbidity from respiratory 
allergies, including asthma and cockroach allergy. 
Health-related hazards are disproportionately found 
in low-income housing. Despite epidemiologic and 
in vitro research linking formaldehyde (an indoor air 
pollutant) to allergic diseases, no home standards for 
formaldehyde exist. We examined associations between 
home formaldehyde and respiratory allergies among U.S. 
low-income children with asthma. 
Methods: Ninety-four urban, low-income children 
with asthma (aged 7–12 years) were recruited from two 
U.S. metropolises during 2011–2012. We performed 
home formaldehyde sampling, allergy testing, and 
questionnaire (demographics, environment, and health) 
assessments. We defined high formaldehyde levels as 
those above the National Institute for Occupational Safety 
and Health 8-hour time-weighted average recommended 
exposure limit (0.016 parts per million). We analyzed 
baseline data using chi-square tests (α = .05). 
Results: Two-thirds of children (56% male; 51% Black, 
29% Asian, 16% Latino, 4% White; 75% with ≥1 positive 
allergy test) had high-formaldehyde homes. High 
formaldehyde was positively associated with allergy to 
dust mites (P = .01), dogs (P = .001), cats, ragweed, and 
cockroaches (all P = .04). High formaldehyde was not 
associated with age, sex, season, or furniture changes 
(all P >.20), nor study site, secondhand smoke, or 
particulate matter <2.5μm (P >.10), but was associated 
with Latino ethnicity. Among non-Latino children, high 
formaldehyde levels remained significantly associated 
with allergy to dust mites and dogs. 
Conclusions: Formaldehyde levels above 
recommendations for adult workers were found in many 
homes of urban, low-income children with asthma, 
especially Latinos. High formaldehyde levels were 
associated with respiratory allergies; Latino ethnicity 
modified some associations. Reducing formaldehyde 
exposure in low-income homes might reduce morbidity 
disparities in respiratory allergies among low-income 
children. 
11:30 IllNeSS aSSOcIateD WIth DIetary SupplemeNtS — NeW yOrk, 2013
Authors: Nina Ahmad, E. Taylor, C. Martin, B. Robinson, 
K. Aldous, E. Yard, K. Chatham-Stephens, M. Boyd,  
D. Spink, B. Tran, P. Parsons, D. Flanders, A. Chang,  
M. Palo, K. Spaeth, G. Birkhead, D. Blog, K. Gelberg,  
N. Graber, A.K. Gleason, A. Newman, L. Lewis
Background: Dietary supplements represented 51% of 
Food and Drug Administration (FDA) Class 1 recalls 
during 2004–2012. In March 2013, physicians notified 
New York State Department of Health (NYSDOH) 
of 18 patients experiencing adverse health effects 
(liver injury, impotence, virilization) consistent with 
anabolic androgenic steroid (AAS) exposure after taking 
supplements recommended by a single nutritionist. 
NYSDOH collaborated with FDA and CDC to 
investigate.
Methods: NYSDOH tested patient supplements by liquid 
and gas chromatography with mass spectrometry. In a 
retrospective cohort study of NY residents counseled 
by the nutritionist during September 1, 2012–July 31, 
2013, we abstracted medical records and interviewed 
patients. Exposed persons had taken Purity First (PF) 
“Vitamin B50” or “Multiminerals” (MM), and unexposed 
persons had taken non-PF supplement(s), for ≥3 days 
during the study period; persons fitting neither category 
were excluded. Cases represented any of 27 otherwise 
unexplainable, AAS-consistent adverse outcomes after 
taking supplements. We used chi-square and Fisher’s 
exact tests to calculate risk ratios (RRs) and 95% 
confidence intervals (CIs). 
Results: Laboratory analysis identified AAS in 
PF B50 (methasterone, dimethazine) and MM 
(methylstenbolone). Of 716 cohort members, 237 (33%) 
participated; 199 (28%) were included. We identified 137 
cases (median patient age 50 [range: 11–79] years, 72% 
female). Exposure was significantly associated with 16 
outcomes (RR: 1.4–undefined), including liver injury 
(RR: 7.7; CI: 1.1–55.7), hair loss (RR: 12.2; CI: 1.7–87.0), 
and hot flashes (RR: 4.2; CI: 1.4–13.1).
Conclusions: Collaborative epidemiologic and laboratory 
investigation determined that adulterated B50 and MM 
caused this outbreak. Consequently, PF recalled these 
supplements nationally on July 31, 2013 and ceased 
operation. These findings could help inform future 








11:50 acute hepatItIS aND lIver FaIlure OF uNkNOWN etIOlOgy — uNIteD StateS, 2013
Authors: Kevin M. Chatham-Stephens, D. Johnston,  
E. Taylor, M. Viray, A. Chang, S.Y. Park, J. Daniel, R. Noe, 
J. Schier, D. Flanders, C. Martin, L. Lewis
Background: Approximately 38 million U.S. adults 
use herbs or dietary supplements, some of which have 
been associated with liver injury. On September 9, 
2013, the Hawaii Department of Health (HDOH) was 
notified of seven patients who had developed acute 
hepatitis and liver failure of unknown etiology. All had 
used OxyELITE ProTM (OEP), a dietary supplement 
marketed for weight-loss and muscle gain that was 
recently reformulated. HDOH, CDC, Food and Drug 
Administration (FDA), and Department of Defense 
(DoD) collaborated to identify and describe illnesses 
among cases nationwide.
Methods: We defined cases as acute hepatitis of 
unknown etiology that occurred on or after April 1, 2013, 
following exposure to a weight-loss or muscle-building 
dietary supplement. We conducted case-finding through 
active screening of DoD records and passive reporting 
from clinicians, poison control centers, and FDA 
MedWatch. For reported cases we performed medical 
chart abstractions and patient interviews. We then 
performed descriptive analyses. 
Results: We identified 62 patients in 15 states with acute 
hepatitis of unknown etiology. The median age was 35 
years (range: 16–67), and 28 (45%) were male. Fifty-one 
(82%) patients reported consuming OEP. Commonly 
reported symptoms included dark urine, jaundice, and 
light-colored stools. Twenty-five (40%) patients were 
hospitalized, 2 (3%) received liver transplants, and 1 (2%) 
died. Product trace back did not implicate a single OEP 
lot, and initial testing identified no contaminants.
Conclusions: At least 62 patients developed acute 
hepatitis after consuming a dietary supplement; most 
patients consumed OEP. We did not identify any 
common exposure among the patients except for OEP. 
This investigation led to a national recall of OEP on 
November 9, 2013 and international case-finding efforts 
by international health authorities. 
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SPONSORS: National Center for Immunization and Respiratory Diseases (NCIRD)
The focus of this session will be to provide an overview for EIS officers, state participants, and other attendees about 
some of the most important pandemic threats facing the world today. Understanding these threats is important since 
many EIS officers and others will participate in epidemiologic investigations and emergency responses if a pandemic 
emerged. The session will also demonstrate how CDC emergency responses are structured and how EIS officers can 
participate. 
The session will provide an update for EIS officers and other attendees, including an overview of the epidemiology, 
a review of the applicable surveillance guidance, including who should be tested and laboratory protocols, and what 
guidance is available for travelers and health care providers. 
Speakers: 
 • Novel Influenza A Viruses with Pandemic Potential: H3N3v, H7N9 and H5N1. Dan Jernigan
 • Of Camels and Men—MERS Coronavirus: The Second Year. Sue Gerber
 • CDC Emergency Responses and How EIS Officers Can Participate: The MERS Example. David L. Swerdlow










Moderator: Pattie Simone 
During the first 30 minutes of the Poster Symposium, the authors will each give a 2-minute oral presentation at the 
podium in front of a seated audience. During the remaining time, the audience is encouraged to view the individual 
posters and engage in direct discussion with the authors.
P1.1 vaccINe-preveNtaBle DISeaSeS amONg Fatal caSeS OF hOSpItalIzeD acute reSpIratOry 
INFectION — guatemala, 2000–2013
Authors: Sara Tomczyk, J. McCracken, C.L. Contreras, 
MR. Lopez, C. Bernart, J. Moir, K. Escobar, L. Reyes,  
W. Arvelo, K. Lindblade, J. Bryan, L. Peruski, J.R. Verani
Background: Acute respiratory infection (ARI) is a 
leading cause of illness and death worldwide, and several 
ARI etiologies are vaccine-preventable. In Guatemala, 
influenza vaccination is recommended for adults aged 
≥60 years but coverage is low. Pneumococcal conjugate 
vaccine was recently introduced for infants. We examined 
characteristics of fatal ARI cases in Guatemala to inform 
efforts to reduce ARI-associated mortality. 
Methods: We analyzed data from the Guatemala 
International Emerging Infections Program. Patients 
admitted to surveillance hospitals in Santa Rosa or 
Quetzaltenango with ARI (≥1 sign of acute infection and 
≥1 sign/symptom of respiratory illness) were enrolled. 
Nasopharyngeal/oropharyngeal swabs from case-patients 
were tested by polymerase chain reaction for respiratory 
syncytial virus (RSV), human metapneumovirus, 
influenza A/B, parainfluenza virus 1/2/3, and adenovirus. 
Urine was tested for pneumococcal antigen among those 
aged ≥11 years. We described in-hospital deaths among 
ARI case-patients and results of diagnostic testing.
Results: From September 2007 to December 2013, 350 
of 7911 ARI case-patients died in-hospital, including 
166/5323 (3.1%) aged <5 years, 106/1654 (6.4%) aged 
5–59 years, and 78/934 (8.4%) aged ≥60 years. Among 
338 fatal cases with viral testing, the most commonly 
detected were RSV (n=57; 16.3%), adenovirus (n=37; 
10.6%), and influenza A (n=29; 8.3%); 42 (73.7%) RSV-
associated deaths and 15 (51.7%) influenza A-associated 
deaths were in children <5 years. Among 119 fatal cases 
among adults with urine tested for pneumococcus, 11 
(9.2%) were positive. 
Conclusions: Vaccine-preventable respiratory diseases 
contribute to ARI deaths in Guatemala, although 
pneumococcal burden was underestimated due to lack 
of testing in young children. Maximizing coverage 
with currently used vaccines and vaccinating children 
against influenza could reduce ARI deaths. RSV vaccines 









P1.2 mexIcaN-BOrN legal ImmIgraNtS WIth tuBerculOSIS claSSIFIcatIONS uSINg electrONIc 
DISeaSe NOtIFIcatION DataBaSe, 2009–2012
Authors: Jessica Adam, Z. Wang, R. Philen, S. Benoit,  
J. Painter, S. Waterman
Background: Foreign-born persons contribute an 
increasing proportion of U.S. tuberculosis (TB) cases 
(63% in 2012); therefore, focusing on this population 
is key to TB elimination. Mexicans accounted for 21% 
of foreign-born persons with TB in 2012. We described 
results of TB screening in Mexico for Mexicans applying 
for U.S. legal permanent resident status. 
Methods: CDC’s Electronic Disease Notification 
database (EDN) alerts receiving health departments 
(HD) of arriving immigrants with notifiable conditions. 
We analyzed EDN data for Mexican immigrants who 
arrived in the United States during 2009–2012 by TB 
classification. Immigrants with medical evaluations 
suggestive of TB and negative diagnostic tests, or who 
have recently completed TB treatment are designated 
Class B1. Persons with latent TB infection (LTBI) are 
Class B2. 
Results: During 2009–2012, approximately 286,762 
Mexicans immigrated to the United States. Of those, 
physicians designated 10,732 (4%) TB Class B1 or B2. 
Active TB was diagnosed among 214 (<1%); 17% were 
smear-negative/culture-positive, which would have gone 
undetected before 2007 CDC guidelines mandating 
cultures for all suspected TB cases. Upon arrival, 
California was the most common destination state (44%) 
followed by Texas (21%) and Illinois (5%). Postarrival 
evaluation by receiving HD was complete in 60% and 
49% of B1 and B2 cases respectively; 23% lacked follow-
up data. B1-classified arrivals had a median time to 
follow-up of 48.5 days; only 23 (0.2%) had active TB. 
Conclusions: Screening among legal Mexican 
immigrants identifies a substantial burden of active and 
latent TB requiring follow-up by state TB programs; 
however, follow-up data are incomplete. Increased 
coordination between CDC and state TB programs could 
better monitor progress in TB elimination efforts among 
this immigrant population. 
P1.3 StrategIeS FOr maxImIzINg preveNtIve treatmeNt OF lateNt tuBerculOSIS INFectION  — 
mISSISSIppI, 2008–2012
Authors: Erik J. Reaves, A. France, M. Holcombe,  
S. Quilter, J. Ellis, T. Navin, S. Morris
Background: An estimated 10–15 million persons in 
the United States have latent tuberculosis infection 
(LTBI). Strategies to eliminate tuberculosis (TB) include 
preventive treatment of LTBI, which lowers the likelihood 
of progression to TB disease. Completion of preventive 
treatment (average: 40%–60%) is lower among groups at 
high risk for TB. To monitor the management of LTBI, 
the Mississippi State Department of Health implemented 
mandatory reporting of LTBI and an electronic reporting 
system (ERS). 
Methods: Using data from the ERS, we assessed 
preventive treatment among persons with LTBI. A case 
of LTBI was defined as infection with Mycobacterium 
tuberculosis diagnosed by Mantoux tuberculin skin test or 
interferon-gamma release assay without evidence of TB 
disease and residence in Mississippi at diagnosis. Groups 
at high-risk were defined as persons with HIV infection, 
contacts of infectious persons, residents of correctional 
facilities, homeless persons, and foreign-born persons. 
Results: During 2008–2012, LTBI cases totaled 13,287. 
Preventive treatment was started for 9,256 (70%) 
persons; of those, 6,936 (75%) completed treatment. 
The proportions of groups at high risk that completed 
preventive treatment were: persons with HIV infection: 
82% (287/348); contacts of infectious persons: 80% 
(679/854); residents of correctional facilities: 79% 
(1795/2280); homeless persons: 74% (265/358); 
and foreign-born persons: 72% (592/825). Monthly 
preventive treatment completion reports from the ERS 
guided follow-up on persons that initiated treatment.
Conclusions: During 2008–2012, a high proportion of 
persons with LTBI started and completed preventive 
treatment in Mississippi, especially among populations 
at highest risk of progressing to TB disease. The statutory 
reporting requirement and ERS components of the LTBI 
surveillance system in Mississippi serve as a model to 
document the burden of LTBI and facilitate treatment.







P1.4 uSINg electrONIcally archIveD meDIcal INFOrmatION FOr puBlIc health: aNalySIS OF 
amerIcaN INDIaN/alaSka NatIve cOmmuNIcaBle DISeaSe DIagNOSeS FrOm the INDIaN 
health ServIce NatIONal Data WarehOuSe — OregON 2007–2011
Authors: Jessica A. Marcinkevage, R. Leman,  
V. Warren-Mears, T. Weiser
Background: American Indian/Alaska Native (AI/
AN) communities experience disproportionate disease 
burdens. No system provides aggregate health or disease 
surveillance data of Oregon AI/AN communities to 
tribal public health authorities; state health department 
data are inaccessible to these organizations, and national 
surveys are not representative of AI/AN populations. 
We evaluated performance of the Indian Health 
Service (IHS) National Data Warehouse (NDW), an 
electronic repository of clinical data from IHS, tribal, 
and urban Indian (I/T/U) clinics, for surveillance of 6 
communicable diseases: hepatitis A, B, and C; gonorrhea; 
chlamydia; and pertussis.
Methods: We determined the number of Oregon AI/
AN persons in the NDW having a diagnosis of each 
condition during 2007–2011, according to International 
Classification of Diseases, 9th Rev., (ICD-9) codes. To 
validate results, we compared these diagnoses with 
laboratory-confirmed cases identified through medical 
records review of the 2 largest IHS/Tribal clinics in 
Oregon, calculating NDW sensitivity and predictive value 
positive (PVP). We also compared NDW case counts 
with counts of AI/AN persons in the Oregon notifiable 
diseases system (NDS) for each condition.
Results: Eleven Oregon I/T/U clinics reported to the 
NDW at least once during 2007–2011. Of 621 diagnoses 
identified at the 2 clinics, 3 (0.5%) were absent from the 
NDW. Sensitivity was higher for sexually transmitted 
infections than other conditions (e.g., chlamydia: 67%; 
hepatitis B: 12%); the opposite was observed for PVP 
(hepatitis B: 50%; chlamydia: 17%). Compared with 
Oregon NDS, diagnoses missed by the NDW were 
among younger AI/AN persons and those living in urban 
counties.
Conclusions: The NDW can be useful for AI/AN-
specific public health surveillance for detecting trends in 
reportable communicable diseases, guiding development 
of future AI/AN-specific public health surveillance 
systems.
P1.5 taleS FrOm the cryptO: treNDS IN cryptOSpOrIDIOSIS SurveIllaNce — uNIteD StateS, 
1995–2012
Authors: Julia E. Painter, M. Hlavsa, J. Yoder, J. Gargano
Background: Cryptosporidiosis is a gastrointestinal 
illness caused by the parasite Cryptosporidium, the 
leading etiology of waterborne disease outbreaks in the 
United States (2001–2010). Historically, cryptosporidiosis 
disproportionately affected children aged 1–4 years. We 
evaluated recent trends in cryptosporidiosis reporting. 
Methods: We analyzed data on all cryptosporidiosis 
cases reported to CDC (N=102,835) from 1995–2012. 
We assessed trends in case type (confirmed versus non-
confirmed) using the Cochrane-Armitage test. We used 
negative binomial regression to estimate incidence rate 
ratios (IRR) and 95% confidence intervals (CI), and test 
interactions across three time periods (1995–2004, 2005–
2008, and 2009–2012) and four age groups (0–14, 15–44, 
45–64, 65+ years).
Results: Annual incidence rates per 100,000 person-
years ranged from 0.9 (1997) to 3.9 (2007). Confirmed 
cases decreased from 88% (1995) to 66% (2012) (P-trend 
<0.0001). Compared with 1994–2004, overall rates were 
higher in 2005–2008 (IRR: 2.69; CI: 2.65–2.73) and 2009-
2012 (IRR: 2.39 CI: 2.36–2.45). Rate changes from 2005–
2008 to 2009–2012 varied by age group (P-interaction 
<0.0001): 0–14 years (IRR: 0.55; CI: 0.54–0.56), 14–44 
years (IRR: 0.99; CI: 0.97–1.01), 45–64 years (IRR: 1.47; 
CI: 1.41–1.52) and 65+ years (IRR: 2.17; CI: 2.06–2.29). 
Analyses restricted to confirmed and non-outbreak cases 
revealed similar patterns.
Conclusions: Increasing cryptosporidiosis reporting 
has been accompanied by an evolving epidemiology, 
particularly in confirmed cases and older adults. 
Potential reasons for these changes include FDA’s 2005 
approval of a treatment for cryptosporidiosis in adults, 
decreasing magnitude of recreational water–associated 
cryptosporidiosis outbreaks, and recent case definition 
revisions. Findings can be used to develop interventions 








P1.6  epIDemIOlOgy OF repOrteD malarIa caSeS — marylaND, 2007–2012
Authors: David C. Schnabel, K. Feldman, D. Rohn,  
S. Stanley, S. Wee, J. Braggio, D. Blythe
Background: Malaria, although eliminated from the 
United States, can be acquired during travel to malaria-
endemic countries and prevented by mosquito avoidance 
and taking chemoprophylaxis. During 2011, Maryland 
had the highest state incidence rate for malaria. We 
characterized Maryland malaria cases to help shape 
prevention strategies.
Methods: Malaria cases reported through Maryland’s 
notifiable disease surveillance system during 2007–2012 
were described. We compared imported, confirmed, 
2009–2011 Maryland cases with the remainder of 
imported, confirmed 2009–2011 U.S. cases reported to 
CDC to assess chemoprophylaxis use and reason for 
travel (U.S. civilians only) and travel destination (all 
cases).
Results: Of 575 Maryland malaria cases during 2007–
2012, one was laboratory-acquired; 574 were imported. 
Median patient age was 33 (range: 1–83) years; 63% were 
male and 81% were black. Of 508 patients with reported 
country of acquisition, 93% had acquired malaria in 
Africa. Of 422 patients with known reason for travel, 
75% had visited friends and relatives (VFR). Of 430 
patients with chemoprophylaxis information, 107 (25%) 
reported its use. During 2009–2011, compared with 
malaria patients from all other states, Maryland patients 
were more likely to be VFR (risk ratio [RR]: 1.18; 95% 
confidence interval [CI]: 1.09–1.28) and to have acquired 
malaria in Africa (RR: 1.40; 95% CI: 1.35–1.46) and less 
likely to have used chemoprophylaxis (RR: 0.80; 95% CI: 
0.61–1.06).
Conclusions: Maryland malaria cases differed from 
other states’ cases, with a greater proportion traveling 
to Africa, being VFR, and chemoprophylaxis nonuse. 
A survey to understand barriers to recommended use 
of chemoprophylaxis and other preventive measures is 
planned to shape efforts to decrease incidence of malaria 
among Maryland’s VFR travelers to Africa.
P1.7 INveStIgatINg the SeNSItIvIty aND SpecIFIcIty OF aN alterNatIve SurveIllaNce caSe 
DeFINItION FOr mONkeypOx — the DemOcratIc repuBlIc OF cONgO (Drc), 2010–2013
Authors: Lynda U. Osadebe, A. McCollum, R. Lushima, 
E. Pukuta, S. Karhemere, M. Balilo, J. Kabamba,  
J. Malekani, B. Nguete, E. Okitolonda, I. Damon,  
J. Muyembe, M. Reynolds.
Background: Monkeypox is a zoonosis endemic in DRC 
with an annual incidence of 5.53/10,000 and case-fatality 
of 3.7%. Monkeypox is often confused with varicella 
and in the absence of laboratory testing, which requires 
extensive resources, it is difficult to know the true burden 
of monkeypox, signaling the need for a more specific 
monkeypox surveillance case definition. The national 
surveillance case definition defines suspect cases as 
persons having a febrile prodome with a rash, while an 
alternative definition specifies a ‘characteristic rash’, plus 
febrile prodrome, and either pustules on palms and soles, 
or lymphadenopathy. This study examines the accuracy 
of the both definitions.
Methods: To determine conformity to either or both 
surveillance definitions we reviewed case-report forms 
and recorded the clinical characteristics of 817 suspected 
monkeypox cases that were investigated from September 
2010–June 2013. Of these, 293 (35.8%) had been 
confirmed by laboratory testing.
Results: Among the 817 suspected cases, 558 (68.3%) 
met the national definition, 219 (39.2%) of these were 
confirmed, while 627 (76.7%) suspected cases met 
the alternative definition, 248 (39.6%) of which were 
confirmed. Of the 293 confirmed cases, 206 (70.3%) met 
both definitions and 32 (10.9%) were excluded (false 
negatives). Only 3 (9.4%) false negatives had febrile 
prodome and none had the ‘characteristic rash’. Of 
the non-cases, 276 (52.7%) met both definitions (false 
positives); all had fever prodome and ‘characteristic rash’. 
Notably, 215 (77.9%) of these were confirmed varicella 
cases. 
Conclusions: These finding suggest that an alternative 
surveillance definition for monkeypox has greater 
sensitivity but equivalent specificity to the current case 
definition. This finding highlights the difficulty in clinical 
identification of monkeypox disease and supports the 
continuing need for laboratory testing.







P1.8 humaN salmonElla typhImurIum INFectIONS lINkeD WIth expOSure tO lIve pOultry FrOm 
agrIcultural FeeD StOreS aND maIl-OrDer hatcherIeS — uNIteD StateS, 2013
Authors: Tara C. Anderson, T. Nguyen, J. Kincaid 
Adams, N. Garrett, C. Bopp, J. Baker, C. McNeil,  
P. Torres, P. Ettestad, M. Erdman, D. Brinson, T. Gomez,  
C. Barton Behravesh
Background: From 1990–2012, 45 outbreaks of human 
salmonellosis linked to live poultry contact have been 
reported resulting in 1,581 illnesses, 221 hospitalizations, 
and five deaths. In March 2013, PulseNet, the national 
bacterial subtyping network for foodborne disease 
surveillance, identified a cluster of human Salmonella 
serotype Typhimurium infections, which we investigated.
Methods: A case was defined as illness in a person 
infected with the outbreak strain of Salmonella 
Typhimurium with illness onset between 03/01/13–
10/22/13. Human and animal health officials collaborated 
to conduct epidemiologic, traceback, and environmental 
investigations. 
Results: We identified 356 cases in 39 states. Illness 
onset dates ranged from 3/4/13–10/12/13. The median 
patient age was seven years (range: <1–87 years); 
57% of ill persons were children ≤10 years; 51% were 
female. Twenty-six percent (62/240) of case-patients 
were hospitalized. Seventy-six percent (189/250) 
of case-patients reported contact with live poultry 
(83% chicks/chickens; 44% ducklings/ducks) in the 
week before illness. Ninety-five percent (149/157) 
reported purchasing live poultry from 116 locations 
of 33 agricultural feed store companies. Traceback 
investigations identified 18 mail-order hatcheries 
that supplied poultry to these stores. The outbreak 
strain was isolated from poultry and environmental 
samples collected from patients’ homes in three states. 
Environmental investigations were conducted at two 
mail-order hatcheries; One of 40 (2.5%) duplicate drag 
swab samples collected at one hatchery yielded the 
outbreak strain. 
Conclusions: Live poultry remain an important source 
of human salmonellosis, particularly among children, 
highlighting the need for educational campaigns and 
comprehensive interventions at the mail-order hatchery 
and feed store levels. Prevention and control efforts 
depend on a One Health approach, involving cooperation 
between public and animal health officials, industry, 
consumers, and human/animal health professionals. 
P1.9 evaluatION OF a StIllBIrth SurveIllaNce prOgram — IOWa, 2010
Authors: Samir Koirala, D.J. Kane
Background: Stillbirth is a major public health issue 
contributing to over half of all perinatal mortality. It is 
understudied compared with other adverse outcomes 
such as prematurity and infant death. The Iowa Stillbirth 
Surveillance Program (ISSP) was established in 2005 to 
enhance Iowa’s capacity to ascertain reportable stillbirths.
Methods: ISSP defines stillbirth as the delivery of a fetus 
weighing >350g or ≥20 weeks gestation. We compared 
2010 Iowa fetal death certificate (I-FDC) and ISSP data to 
assess ISSP’s ability to enhance reportable stillbirths and 
identify discrepancies. ISSP staff reviewed Iowa hospitals’ 
medical records of all fetal deaths regardless of gestational 
age or fetal weight. They used relevant ICD-9 codes for 
stillbirth case finding. Subject-matter experts reviewed 
and validated the data based on the ISSP stillbirth case 
definition.
Results: During 2010, 182 stillbirths were reported per 
I-FDC. Of these, 132 (72%) I-FDC stillbirths met the 
ISSP case definition. Out of the 33 (18%) stillbirths 
that did not meet the case definition, 17 were elective 
terminations of pregnancy, 14 were spontaneous 
abortions and 2 live births. ISSP identified 28 stillbirths 
that had not been reported on I-FDC. Of these, 10 were 
delivered out-of-state and 18 were delivered at Iowa 
hospitals but could not be linked to I-FDC.
Conclusions: The discrepancies between I-FDC and ISSP 
data were primarily due to I-FDC misclassification of 
elective terminations as stillbirths. ISSP also identified 
stillbirths that did not link to I-FDC or were delivered 
out-of-state. Training of hospital staff on proper 
completion of vital records and which forms to use may 
reduce stillbirth reporting discrepancies. IDPH may also 









1.10 tWO FISh, ONe FISh: DecreaSINg NumBer OF OutBreakS attrIButeD tO FISh —  uNIteD 
StateS, 1998–2011
Authors: Jolene H. Nakao, K. Walsh, L. Gould
Background: Foodborne diseases cause 48 million 
illnesses in the U.S. each year. Fish is the second most 
commonly implicated commodity after poultry. We 
present the epidemiology of fish-attributed outbreaks in 
the U.S. during 1998–2011.
Methods: We reviewed CDC’s Foodborne Disease 
Outbreak Surveillance System for outbreaks (≥2 cases 
of a similar illness) attributed to fish; outbreaks caused 
by shellfish were not included. Analyses examined the 
number of outbreaks, illnesses, hospitalizations, state, 
etiologic agent, implicated fish type, and preparation 
setting and method. 
Results: From 1998‒2011, 679 outbreaks were reported, 
resulting in 3,660 illnesses, 229 hospitalizations, and 2 
deaths. The number of fish-associated outbreaks declined 
from an average of 66 per year in 1998–2003 to 35 in 
2004–2011. Hawaii (213 outbreaks; 31%) and Florida 
(158; 23%) reported the most. Fish types implicated most 
often were tuna (35%), mahi mahi (12%), and grouper 
(10%). Among 611 outbreaks with a known single 
etiology, scombroid toxin (338; 55%) and ciguatoxin 
(199; 33%) were most common. The etiology-fish pairs 
responsible for the most outbreaks were scombroid 
toxin in tuna (200 outbreaks), scombroid toxin in mahi 
mahi (73), and ciguatoxin in grouper (60). Of the 618 
outbreaks with a single preparation setting, 57% were 
attributed to fish prepared in a restaurant and 35% to fish 
prepared in a private home. Raw or lightly cooked fish 
was implicated in only 42 (9%) of 458 outbreaks with a 
known preparation method. 
Conclusions: The number of outbreaks attributed to 
fish declined; reasons are unknown. Control measures 
targeted to the most common etiologies implicated in 
outbreaks, including proper fish storage and selection 
of appropriate harvest locations, could further reduce 
outbreaks caused by fish.
P1.11 uSINg meDIa repOrtS tO track DeathS, hurrIcaNe SaNDy, 2012
Authors: Olaniyi O. Olayinka, T. Bayleyegn, S. Burrer,  
A. Wolkin, R. Noe, L. Lewis, A. Madsen, V. Arrisi,  
K. Jones-Vessey, J. Purtill, J. Rainey
Background: Accurate and timely reporting of mortality 
during disasters is useful and critical; however, timely 
national mortality surveillance does not exist. During 
Hurricane Sandy, CDC/Health Studies Branch (HSB) 
piloted an approach for tracking disaster-related deaths 
reported by the media for situational awareness. Our 
objective was to determine the accuracy and timeliness of 
this data.
Methods: From October 29–November 5, 2012, HSB 
tracked hurricane-related, media-reported deaths on the 
internet using a keyword search to capture demographics 
and circumstance of death. From May–October, 2013, 
we requested death records from states affected by Sandy 
to evaluate the media data. Frequencies, sensitivity, and 
positive predictive value (PPV) were calculated. 
Results: We found 76 hurricane-related, media-reported 
deaths from New Jersey, Connecticut, North Carolina, 
Virginia, and New York City (NYC). Of these deaths, 
67 (88 %) were found in vital statistics records. NYC 
identified hurricane-related deaths from vital statistics 
using keyword search; sensitivity and PPV of the media 
to detect deaths in NYC were 77% and 83%, respectively. 
The other four states provided vital statistics records 
based on our media-based list. Percent agreement varied: 
demographics (86%), location (86%), circumstance 
(74%), date (62%), and cause of death (56%). CDC/
HSB and NYC reported deaths for situational awareness 
within 24 hours while none of the other four states 
conducted active disaster-mortality surveillance during 
this event. 
Conclusions: Media-reported deaths captured by HSB 
during Hurricane Sandy were moderately sensitive and 
more timely compared to vital statistics. Tracking media-
reported, disaster-related deaths can provide situational 
awareness and support immediate public health decision-








P1.12 DetectION OF INFectIOuS DISeaSe OutBreakS at aN OutDOOr maSS gatherINg — WeSt 
vIrgINIa, 2013
Authors: Erica D. Thomasson, S. McBee, S. File, D. Bixler
Background: Mass gatherings can be associated with 
infectious disease health risks; therefore, surveillance 
might help early detection and prevention of outbreaks. 
In 2013, West Virginia hosted for the first time a 10-
day camping event that is held by a national youth 
organization every 4 years. A new mass gathering 
surveillance system was implemented to detect and 
prevent outbreaks among the 41,806 attendees. Active 
surveillance was conducted by a team who performed 
attendee health screening upon arrival at the site, daily 
interviews of medical personnel by using standardized 
questionnaires, and follow-up of disease and outbreak 
reports. In this study, we assessed the usefulness of the 
active surveillance system for rapidly detecting outbreaks.
Methods: We reviewed surveillance data for 
completeness and timeliness. We assessed the number 
of outbreaks detected and calculated attack rates within 
camper groups, which comprised 40 campers each. We 
administered an Internet-based survey to all medical staff 
to evaluate their perceptions of active surveillance.
Results: Active surveillance data from medical staff 
interviews were 100% complete and available for review 
daily. An outbreak of influenza A was detected among 
8 campers in a single group (20% attack rate) and 3 
campers from 4 other groups. Gastrointestinal illness 
was detected among 15 campers in a single group (38% 
attack rate) and 12 campers from 7 other groups. Of 
562 medical staff surveyed, 252 (42%) responded. The 
majority of respondents reporting interaction with the 
surveillance team (n = 108) considered information 
or assistance provided by the team useful (73.1%) and 
timely (80.8%).
Conclusions: Active surveillance was useful, enabling 
detection of 2 outbreaks. Active surveillance should be 
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3:05 FIrSt uSe OF a NOvel SerOgrOup B meNINgOcOccal vaccINe IN the u.S. IN reSpONSe tO 
a large OutBreak at a uNIverSIty — NeW jerSey, 2013
Authors: Lucy A. McNamara, A. Shumate, P. Johnsen,  
J. MacNeil, T. Bhavsar, A. Cohn, J. Dinitz-Sklar, J. Duffy,  
J. Finnie, D. Garon, R. Hary, F. Hu, S. Ingraffia, H. Kamiya, 
N. Kratz, S. Meyer, J. Neglia, J. Wagner, K. Wagner,  
X. Wang, Y. Yu, B. Montana, T. Clark, R. Izzo, C. Tan,  
M. Patel
Background: Meningococcal disease is a severe, 
outbreak-prone infection with a 10–15% case-fatality 
ratio. Although a novel meningococcal serogroup B 
(MenB) vaccine is approved elsewhere, it is not licensed 
in the U.S.. To control a MenB outbreak at a New Jersey 
university, the Food and Drug Administration authorized 
the use of investigational MenB vaccine in this setting.
Methods: We conducted case investigations and 
performed molecular typing of MenB isolates to 
characterize the outbreak, define the population at risk, 
and calculate the attack rate. The first dose of MenB 
vaccine was administered December 9–12, 2013; the 
second dose will be administered February 17–20, 2014. 
Vaccination coverage was calculated; surveillance for 
adverse events and new MenB cases is ongoing. 
Results: Between March 22nd and November 20th, 
2013, 7 cases of MenB occurred in undergraduate 
students at the university. Molecular typing confirmed 
circulation of one strain and predicted effectiveness 
of the MenB vaccine. The population at risk included 
5,222 undergraduate students with an attack rate of 
134 per 100,000 persons (>1400 times higher than the 
national incidence in 17–22 year-olds). The first-dose 
vaccination campaign achieved 93% coverage among 
undergraduates. Eighteen syncopal or presyncopal 
episodes (3.4/1000 vaccinees), but no anaphylactic 
reactions, occurred following dose 1. Through January 3, 
2014, two hospitalizations occurred in vaccinees but were 
not considered causally related to the vaccine. Through 
January 3, 2014, no additional MenB cases occurred at 
the university.
Conclusions: A high attack rate and sustained 
transmission of MenB prompted vaccination with an 
unlicensed product to control the outbreak. Multi-agency 
coordination resulted in a vaccination campaign that 
achieved high vaccination coverage. To date, no vaccine 
safety concerns have been identified.







3:25 meNINgOcOccal DISeaSe amONg meN WhO have Sex WIth meN — uNIteD StateS,  
2012–2013
Authors: Hajime Kamiya, J. MacNeil, A. Blain, A. Cohn, 
M. Whaley, F. Hu, X. Wang, L. Mayer, D. Weiss, S. Ngai,  
I. Ezeoke, K. Harriman, K. Winter, L. Mascola, R. Civen, 
L. Misegades
Background: In 2012–2013, New York City (NYC) 
reported an outbreak of meningococcal disease 
(MD) among men who have sex with men (MSM). 
Additionally, Los Angeles County (LAC) reported 4 
cases among MSM within a 5 month time period during 
2012–2013. MSM have not previously been considered at 
increased risk for MD. 
Methods: Health departments reviewed MD cases 
among males aged 18–64 years occurring from January 
2012–May 2013. Demographic, clinical, and risk factor 
information were abstracted for known MSM case-
patients. Rates of MD among MSM were calculated 
using national surveillance data, 2012 census data, and 
estimates of the proportion of MSM in the U.S. 
Results: Thirty-two (13.6%) of 235 male cases were 
reported as MSM, including 17 NYC, 4 LAC, and 11 
sporadic MD cases. HIV prevalence was higher among 
NYC MSM and MSM-sporadic cases compared to cases 
among other men (50.0%, 42.9%, and 6.3% among those 
with known HIV status, respectively); no LAC case-
patients were HIV-positive. The MD rate for MSM in 
NYC was 11.6/100,000 person-years (rate ratio [RR]: 
59.8, 95% confidence interval [CI]: 52.8–67.0, compared 
to other men) and in LAC was 2.3/100,000 person-years 
(RR: 14.1, CI: 12.4–15.8, compared to other men). The 
rate for MSM-sporadic cases was 0.22/100,000 person-
years (RR: 1.4, CI: 1.3–1.6, compared to other men). 
Serogroup C accounted for all NYC and LAC MSM cases 
and 72.7% of MSM-sporadic cases. 
Conclusions: The NYC MSM rate surpasses the MD 
outbreak threshold (≥10/100,000 population). The 
LAC MSM and MSM-sporadic rates, while elevated, 
are lower than rates observed among high-risk groups 
routinely recommended for meningococcal vaccination. 
Epidemiologic data should continue to be used to identify 
high-risk groups recommended for vaccination routinely 
or during outbreaks.
3:45 cOSt OF meaSleS caSe cONtaINmeNt IN aN amBulatOry peDIatrIc clINIc — kINg 
cOuNty, WaShINgtON, 2013
Authors: Kristen A. Wendorf, M. Kay, I. Ortega-Sanchez, 
J. Duchin
Background: Measles is highly infectious. Prompt 
containment of measles cases, including management of 
exposed persons, is necessary to prevent spread in health 
care settings. Containment costs to ambulatory care 
providers are unknown. In August 2013, a 13-year-old 
male with undiagnosed measles presented to a pediatric 
clinic, exposing patients and employees. We studied 
the containment costs to the clinic to identify future 
avoidable costs.
Methods: Measles exposure was defined as in-person 
contact with, or presence in the same room within two 
hours of, the measles patient. Costs were calculated 
retrospectively using published costs of measles-
mumps-rubella (MMR) vaccine, cost-to-charge ratios 
for inpatient care in urban Washington State, and 
information provided by an emergency department 
where immunoglobulin (IG) was administered. Personnel 
costs were calculated by multiplying gross wages by 
time for the 6 employees who worked on the response; 
overhead was excluded. 
Results: Fifty-two patients and 10 employees were 
exposed at the clinic. Personnel time for the response 
cost approximately $1,960.80. Exposed patients had a 
mean age of 9.6 years (range: 2 months–19 years); 34 
(65%) were fully vaccinated, 18 (35%) were aged <12 
months and too young to be vaccinated. Five patients 
(1%) were aged <6 months and required IG; 13 infants 
(25%) aged 6–12 months required MMR vaccination. 
One employee had documented immunity; nine required 
measles antibody testing or vaccination. Management 
of exposed persons cost $3,694.40; therefore, total costs 
were $5655.20. 
Conclusions: Responding to one measles case cost the 
pediatric clinic >$5,000, despite isolating the patient after 
examination. Minimizing measles exposures through 
prompt identification and triage with immediate isolation 
and improved documentation of health care worker 








4:05 eFFect OF rOtavIruS vaccINeS ON DIarrhea-aSSOcIateD hOSpItalIzatIONS IN u.S. chIlDreN 
<5 yearS OF age, 2007–2011
Authors: Eyal Leshem, R.E. Moritz, A. Curns, F. Zhou,  
J.E. Tate, B.A. Lopman, U.D. Parashar
Background: Prior to vaccine introduction in 2006, 
rotavirus accounted for ~40% of diarrhea-associated 
hospitalizations in children in the United States (U.S.). 
Our objectives were to examine reductions in diarrhea-
associated hospitalizations following rotavirus vaccine 
introduction and to assess the direct effectiveness of 
vaccination.
Methods: We conducted a retrospective cohort analysis 
of claims data of commercially insured U.S. children 
aged <5. Annual pentavalent (RV5) and monovalent 
(RV1) rotavirus vaccine coverage were examined. We 
compared rates of diarrhea-associated hospitalizations 
in pre-vaccine (2001–2006) versus post-vaccine 
introduction (2007–2011) years, and compared rates of 
diarrhea-associated hospitalizations in vaccinated versus 
unvaccinated children during 2010–2011. 
Results: Among children <5 years of age, RV5 and RV1 
coverage rates reached 58% and 5%, respectively, by 
December 31, 2010. Compared with the average rate of 
rotavirus-coded hospitalizations in 2001–2006, rates were 
reduced by 75% (95% confidence interval [CI], 72–77) 
in 2007–2008, 60% (95% CI, 58–63) in 2008–2009, 94% 
(95% CI, 93–95) in 2009–2010, and 80% (95% CI, 78–81) 
in 2010–2011. Compared with the average rate of all-
cause diarrhea-associated hospitalization in 2001–2006, 
rates were reduced by 33% (95% CI, 31–35) in 2007–
2008, 25% (95% CI, 23–27) in 2008–2009, 54% (95% CI, 
52–55) in 2009–2010, and 47% (95% CI, 46–49) in 2010–
2011. Compared with unvaccinated children, in 2010–
2011, the rate of rotavirus-coded hospitalizations was 
reduced by 92% (95% CI, 87–96) among RV5 recipients 
and 96% (95% CI, 74–100) among RV1 recipients. 
Conclusions: Implementation of rotavirus vaccines 
has substantially reduced diarrhea hospitalization rates 
among U.S. children. Both rotavirus vaccines conferred 
high protection against rotavirus hospitalizations.











3:05 DO INDIvIDual-level aND area-BaSeD pOverty meaSure the Same thINg? aSSOcIatION OF 
pOverty meaSureS WIth SelF-repOrteD health OutcOmeS — NeW yOrk cIty, 2012
Authors: Kari A. Yacisin, K. Konty, L. Gupta, T.G. Harris,  
J. Hadler
Background: Poverty is associated with adverse health 
outcomes, but individual-level poverty (ILP) is often 
difficult to measure because data are unavailable or 
inaccurate. Consequently, the New York City (NYC) 
Health Department adopted area-based poverty (ABP) 
measures for routine analysis. Whether these measures 
are interchangeable is unknown. To determine if ILP and 
ABP have similar associations with health outcomes, we 
analyzed NYC’s 2012 Community Health Survey (CHS) (a 
random-digit-dial survey of 8,797 adults), which contains 
both measures.
Methods: ILP was categorized into 4 groups (household 
income ≥400% [lowest poverty], 200%–<400%, 100%–
<200%, <100%, of federal poverty level [FPL]). ABP was 
categorized into 4 groups (<10% [lowest], 10%–19%, 
20%–29%, ≥30% residents with household income below 
FPL in respondent’s zip code). Respondents with missing 
ILP or ABP were excluded (19.6%). Using SAS®-callable 
SUDAAN®, we calculated weighted prevalences of self-
reported asthma, obesity, and hypertension by poverty 
level and tested associations of these outcomes with 
increasing ILP, controlling for ABP, and vice-versa with 
logistic regression.
Results: Among persons with lowest versus highest ILP, 
asthma prevalence was 13.2% versus 16.6%, obesity 
24.8% versus 38.1%, and hypertension 21.6% versus 
31.2%. Among persons with lowest versus highest ABP, 
asthma prevalence was 9.9% versus 15.5%, obesity 20.1% 
versus 29.8%, and hypertension 25.5% versus 30.7%. 
ABP was independently associated with asthma (P=.03) 
and obesity (P=.002) but not hypertension (P=.82). ILP 
was independently associated with obesity (P=.005) and 
hypertension (P <.001) but not asthma (P=.42).
Conclusions: ILP and ABP might measure different 
health effects of poverty. For certain health outcomes, 
one measure might be more important than the other. In 
NYC, CHS data should be routinely analyzed by both.
3:25 SmOkINg ceSSatION amONg uSerS OF telephONe aND WeB-BaSeD INterveNtIONS
Authors: Mary C. Puckett, A. Neri, J. Underwood,  
B. Momin, L. Zhang, J. Kahende, S.L. Stewart
Background: Smoking causes 443,000 deaths a year in 
the United States. Among smokers who attempt quitting, 
successful cessation rates are 3%–5% per year. Quitlines 
serve as effective interventions, but state quitlines only 
reach approximately 1% of smokers due to limited 
funding. Studies report mixed results whether combined 
telephone and Web-based interventions improve long-
term cessation over quitlines alone. We report the findings 
of one of the largest studies to date comparing users of 
Web and phone-based cessation interventions to users of 
single interventions.
Methods: 16,332 participants were enrolled from four 
states: Alaska, Arizona, Florida, and Vermont. Follow-up 
surveys were administered 7 months after enrollment. 
Univariate, bivariate, and multivariate analyses were 
performed assessing differences in reported phone and 
web cessation modalities, demographics, and behavioral 
and smoking characteristics by using 30-day point 
prevalence abstinence as the outcome of interest. 
Results: For users of dual versus single interventions, 
demographic and baseline smoking characteristics were 
similar for male gender (38% vs 39%), white race (75% 
vs 79%), mean age (44 years vs 43 years), and mean 
cigarettes/day (18.6 vs 18.5), respectively. Statistically 
significant differences were seen for past 30-days 
smoking abstinence measurements, which were taken at 
7-month follow-up. Telephone-only users reported 32.3% 
cessation, whereas telephone users also reporting Web-
based intervention use reported 37.5% (P <.05). Similarly, 
Web-only users reported a 27.2% cessation rate, whereas 
Web-users also reporting telephone intervention use had 
a rate of 33.5% (P <.05).
Conclusions: Promoting tobacco cessation remains a 
high public health priority. Users of both telephone and 
Web-based interventions had higher cessation rates 
than users of either intervention alone. Providing access 
to multiple modalities may improve 30-day quit rates 








3:45 treNDS IN expOSure tO prO-tOBaccO aDvertISemeNtS vIa the INterNet, NeWSpaperS Or 
magazINeS, aND retaIl StOreS amONg u.S. mIDDle aND hIgh SchOOl StuDeNtS,  
2000–2012
Authors: Israel T. Agaku, B. King, S. Dube
Background: Pro-tobacco advertising is associated with 
tobacco use initiation among youth. We assessed trends 
and correlates of pro-tobacco advertising exposure 
among U.S. students in grades 6–12 during 2000–2012.
Methods: Data came from the National Youth Tobacco 
Survey, a school-based survey of U.S. middle and high 
school students conducted during 2000, 2002, 2004, 2006, 
2009, 2011, and 2012. Samples ranged from 18,866 (2011) 
to 35,828 (2000). Self-reported exposure to pro-tobacco 
advertisements was assessed for the Internet, newspapers 
or magazines, and retail stores. Logistic regression was 
used to assess trends and correlates in exposure overall 
and by current cigarette smoking, sex, school level, and 
race/ethnicity (P <.05).
Results: Overall prevalence of exposure to pro-tobacco 
advertisements via the Internet increased from 28.0% 
to 44.7% during 2000–2012 (P trend <.001), whereas 
exposure in newspapers or magazines (74.0% to 
46.4%) and retail stores (90.3% to 80.0%) declined 
(P trend <.001). Current smokers were more likely 
than nonsmokers to report exposure in newspapers 
or magazines (adjusted odds ratio [aOR] = 1.18; 95% 
confidence interval [CI]: 1.05–1.31). For all three 
advertisement media, exposure was lower among high 
school students and boys than middle school students 
and girls, respectively. Exposure at retail stores was higher 
among Non-Hispanic black students than non-Hispanic 
whites (aOR = 0.62; 95%CI: 0.53–0.73).
Conclusions: Pro-tobacco advertising exposure via the 
Internet increased by >50% during 2000–2012 among 
U.S. middle and high students, whereas declines in 
exposure in newspapers or magazines and retail stores 
occurred during the same period. However, four out 
of five students still reported exposure in retail stores 
in 2012. Enhanced efforts are needed to limit youth 
exposure to all pro-tobacco advertising.
4:05 actIve traNSpOrtatION SurveIllaNce acrOSS three SyStemS — uNIteD StateS,  
1999–2012 
Authors: Geoffrey P. Whitfield, A. Wendel
Background: Built environment interventions such 
as sidewalks and trails increase active transportation 
(AT), defined as utilitarian walking and bicycling. 
Such interventions may be a broad-reaching strategy 
to increase population participation in physical 
activity (PA). In the United States, <50% of adults meet 
recommendations for aerobic activity. Assessment of AT 
is therefore important, yet optimal assessment methods 
remain elusive. Our purpose was to quantify and 
compare national AT prevalence across three surveillance 
systems. 
Methods: From the 1999–2010 National Health and 
Nutrition Examination Survey (NHANES), we calculated 
the proportion of respondents reporting any past-week 
AT and the proportion meeting aerobic PA guidelines 
(≥150 minutes/week) through AT. From the 2001 and 
2009 National Household Travel Survey (NHTS), we 
calculated the proportion reporting any AT in a one-day 
trip log. From the 2005–2012 American Community 
Survey (ACS), we obtained the proportion of workers 
reporting AT as their primary past-week commute mode. 
Results: The presence of any past week AT in NHANES 
ranged from 23.9% (2001–2002) to 26.6% (2005–2007), 
while in the NHTS, one day estimates were 15.6% (2001) 
and 18.5% (2009). In the ACS, 2.9% (2005) to 3.5% 
(2009) of workers reported primarily active commuting. 
From 1999–2006, the proportion of NHANES 
respondents meeting PA guidelines through AT varied 
from 6.4% to 8.6%, then increased two-fold in 2007–2010 
after an assessment change. Only ACS provided estimates 
for small geographies.
Conclusions: Definitions and estimates of AT vary 
widely across surveillance systems. Within individual 
systems, AT prevalence is stable across time. As more 
AT infrastructure is built, AT surveillance may be used 
to measure effectiveness, but the choice of assessment 
strategy will clearly impact estimates.
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8:35 varIatION IN tularemIa clINIcal preSeNtatION — arkaNSaS, 2009–2012
Authors: Laura K. Lester, D.T. Haselow, J.G. Wheeler,  
S. Weinstein, W.R. Daley, C. Nelson
Background: Arkansas has the second highest number 
of tularemia cases reported annually in the United States. 
Tularemia can manifest as 7 major forms, depending on 
exposure. The ulceroglandular/glandular forms, which 
feature regional lymphadenopathy, have historically 
been reported most commonly and typically result from 
tick exposure or handling sick or dead animals. The 
typhoidal form (fever without early localizing symptoms) 
has been less commonly reported. We describe initial 
clinical presentation and exposure history associated 
with Arkansas tularemia cases to guide diagnostic 
recommendations.
Methods: We reviewed clinical records for positive 
Francisella tularensis laboratory reports from Arkansas 
for 2009–2012, and applied the standard case definition. 
A probable case was compatible symptoms with 1 
elevated antibody titer or positive fluorescent assay; a 
confirmed case was compatible symptoms plus a ≥4-
fold change in titer on a second sample or isolation 
of F. tularensis from a clinical specimen. Frequencies 
of disease manifestations on initial presentation and 
reported exposures were computed.
Results: We identified 99 cases: 67 (67.7%) probable 
and 32 (32.3%) confirmed. Among 92 cases with initial 
presentation data, 48 (52.2%) presented as typhoidal and 
34 (37.0%) as ulceroglandular/glandular. If limited to the 
26 confirmed cases with presentation data, 13 (50.0%) 
presented as typhoidal and 9 (34.6%) as ulceroglandular/
glandular. Tick exposure was reported in 72/99 (72.7%) 
cases; 39/72 (54.2%) initially presented as typhoidal and 
26/72 (36.1%) as ulceroglandular/glandular.
Conclusions: The predominant initial presentation of 
tularemia reported recently in Arkansas was typhoidal, 
even among patients reporting tick exposure. Using 
lymphadenopathy as a primary feature to initiate tularemia 
testing can delay recognition of individual cases or 
an outbreak. Recommendations regarding diagnostic 







8:55 cONtact INveStIgatION OF melIOIDOSIS caSeS revealS regIONal eNDemIcIty — puertO rIcO, 
2010 aND 2012
Authors: Thomas J. Doker, T. Sharp, B. Rivera Garcia,   
B.J. Perez-Padilla, D. Haberling, S. Shadomy, M. Glass 
Elrod, J. Gee, T. Benoit, A. Hoffmaster, W. Bower,  
H. Walke, D. Blaney
Background: Melioidosis results from infection by 
percutaneous inoculation, ingestion, or inhalation of the 
saprophyte Burkholderia pseudomallei, and is associated 
with case-fatality rates up to 40%. Improved survival 
rates are attributed to early diagnosis and treatment 
with appropriate antimicrobials. Sporadic cases have 
been identified in Puerto Rico, where the incidence and 
epidemiology is unclear. Following identification of one 
fatal and one non-fatal melioidosis case in 2010 and 2012, 
respectively, contact investigations were conducted to 
identify risk factors for infection. 
Methods: Questionnaires were administered and 
serum specimens were collected from co-workers and 
persons living within 250 meters of cases’ residences 
(neighborhood contacts) and from injection drug use 
(IDU) contacts of the 2012 case. Serum specimens were 
tested for evidence of prior exposure to B. pseudomallei 
by indirect hemagglutination assay (titer ≥ 1:40). 
Results: Serum specimens were collected from 51 and 
60 individuals associated with the 2010 and 2012 cases, 
respectively. None of the co-workers were seropositive 
for anti-B. pseudomallei antibody, whereas 2 (5%) of 
40 and 12 (23%) of 52 of 2010 and 2012 neighborhood 
contacts were seropositive, respectively, and 67% (2 of 
3) of IDU contacts. Of all seropositive persons, 39% 
reported no travel outside of Puerto Rico. Characteristics 
significantly associated with seropositivity were reporting 
skin wounds, sores, or ulcers (adjusted odds ratio [aOR] 
= 4.6; 95% confidence interval [CI]: 1.2–17.8) and IDU 
(aOR=18.0; 95% CI: 1.6–194.0). 
Conclusions: Sporadic reports of melioidosis and high 
seropositivity in case contacts suggest at least regional 
endemicity in Puerto Rico. Increased awareness 
of melioidosis among clinicians, laboratories, and 
public health professionals is needed to improve case 
identification, initiate appropriate antimicrobial therapy, 
and facilitate case reporting in Puerto Rico. 
9:15 Impact OF the NeW NatIONal SurveIllaNce caSe DeFINItION ON BaBeSIOSIS repOrtINg — 
cONNectIcut, 2001–2013
Authors: Jocelyn C. Mullins, M. Cartter, R. Nelson,  
P. Gacek
Background: Babesiosis is a potentially life-threatening 
tickborne and transfusion-associated parasitic disease. 
Connecticut Department of Public Health (CDPH) has 
conducted babesiosis surveillance since 1989. In 2011, 
CDPH adopted the Council for State and Territorial 
Epidemiologists’ new national surveillance case definition 
that includes laboratory and clinical criteria. Previously, 
cases were defined solely by laboratory testing. Since 
2011, CDPH contacts health care providers to obtain 
clinical information for each report meeting laboratory 
criteria; reports from nonresponding providers are 
excluded from case counts. We evaluated the impact of 
the new case definition on babesiosis reporting.
Methods: We compared reports received by CDPH 
during 2001–2010 and 2011–August 31, 2013. We 
assessed demographics, predictive value positive (PVP), 
and staff time to process reports. We used chi-square to 
compare proportions and Wilcoxon rank sum to compare 
continuous variables. 
Results: During 2001–2010, 1,786 reports met laboratory 
criteria; PVP was 97.3%. During 2011–2013, 1,280 
reports met laboratory criteria, of which 772 were 
excluded because of provider nonresponse; PVP was 
21.5%. Median patient age increased from 58.0 (range: 
0–98) to 61.0 (range: 0–100) years (P < 0.001); proportion 
of males increased from 54.7% to 66.3% (P <0.01). 
Median staff time increased from 12.7 (range: 6.6–28.0) 
to 200.0 (range: 184.5–255.5) hours/year (P <0.01). 
Median annual cases decreased from 152 (range: 79–334) 
to 82 (range: 69–124) (P >0.05); continuing the previous 
case definition would have resulted in 170 cases/year 
(range: 146–335) during 2011–2013.
Conclusions: Adoption of the new national surveillance 
case definition corresponded to changes to the reported 
epidemiology of babesiosis and increased the surveillance 
burden. The change limits understanding of babesiosis 
trends in Connecticut.






9:35 chaNgINg treNDS IN BackyarD FlOckS: revIeW OF OutBreakS OF humaN SalmONellOSIS 
lINkeD tO cONtact WIth lIve pOultry — uNIteD StateS, 1990–2013
Authors: Colin A. Basler, T. Nguyen, T. Anderson,  
T. Hancock, C. Barton Behravesh
Background: Ownership of backyard poultry flocks has 
increased in popularity concurrent with the increase in 
live poultry-associated salmonellosis (LPAS) in humans. 
These increases highlight the need to better understand 
practices that contribute to this emerging public health 
issue. We reviewed outbreak reports to describe the 
epidemiology of LPAS in the U.S.A, examine changes in 
trends, and inform prevention campaigns.
Methods: LPAS outbreaks were defined by having ≥2 
culture-confirmed human Salmonella infections with a 
combination of epidemiologic, laboratory, or traceback 
evidence linking illnesses to live poultry contact. 
Outbreak data was obtained through CDC’s outbreak 
database, CDC’s National Outbreak Reporting System, 
and literature review. Additionally, standardized poultry 
exposure questionnaires administered during 21 multi-
state outbreak investigations during 2008−2013 were 
analyzed to identify high-risk practices. 
Results: During 1990−2013, 51 LPAS outbreaks 
were documented, involving 2,188 illnesses, 306 
hospitalizations, and 5 deaths. The median outbreak size 
was 25 case-patients (range: 4−356). Outbreak onsets 
ranged from January−July; duration averaged 4.2 months; 
79% of outbreaks began during February−April. The 
median patient age was 9 years (range <1 to 92). Sixty 
percent (374/619) of case-patients reported exposure to 
chicks and 27% (170/619) to ducklings. The median time 
between obtaining poultry and illness onset was 17 days. 
Since 2007, outbreaks increased in size, occurred year-
round, and were more frequently linked to backyard flock 
ownership. High-risk practices included keeping poultry 
inside households [51% (194/381)] and kissing birds 
[14% (52/373)].
Conclusions: Live baby poultry remain an important 
source of human salmonellosis in the U.S.A, particularly 
among children. Recurring LPAS outbreaks highlight the 
need for strategies to prevent human illnesses associated 
with live poultry contact through a comprehensive 
One Health approach involving human, animal, and 
environmental health.
9:55 raccOON raBIeS vIruS varIaNt traNSmISSION thrOugh SOlID OrgaN traNSplaNtatION 
— uNIteD StateS, 2013
Authors: Neil M. Vora, S. Basavaraju, K. Feldman,  
C. Paddock, L. Orciari, S. Griese, R. Wallace, M. Said,  
D. Blau, A. Velasco-Villa, J. Ritter, J. Blanton, S. Recuenco, 
S. Zaki, I. Damon, R. Franka, and M. Kuehnert for 
the Transplant-Associated Rabies Virus Transmission 
Investigation Team
Background: The rabies virus causes a fatal encephalitis 
and is typically acquired through the bite of a rabid 
animal, although transmission has occurred after 
transplantation of solid organs from infected donors. 
In 2013, a man without reported exposure to rabid 
animals died of rabies. Because he had received a kidney 
transplant 18 months previously, transplantation was 
investigated as the route of transmission.
Methods: Donor and recipient medical records 
were reviewed. Tissue specimens from both 
patients were tested for rabies virus antigens using 
immunohistochemical staining. Nucleic acid was 
extracted, amplified using reverse transcriptase–
polymerase chain reaction targeting the rabies virus 
nucleoprotein gene, and sequenced.
Results: Chart review revealed that the donor’s illness 
was consistent with rabies. Rabies virus antigens were 
detected in autopsy donor brain tissues that had been 
archived for 18 months. Nucleoprotein gene sequences 
of the viruses infecting the donor and recipient were 
>99.9% identical and were consistent with the raccoon 
rabies virus lineage circulating in the donor’s home state. 
Three additional recipients of organs from the donor 
were identified. All were asymptomatic and did not have 
evidence of infection serologically or in biopsied tissues. 
Postexposure prophylaxis was administered and all 
seroconverted; to date, they have no evidence of rabies.
Conclusions: Our investigation confirmed 
transplantation as the route of rabies virus transmission. 
Unlike previous rabies cases associated with solid organ 
transplantation, the incubation period in the deceased 
recipient was long and the three other recipients survived 
despite not having received pre-transplant rabies 
vaccination. Prior to this, there was only one report of 
human infection with the raccoon rabies virus variant. 
Rabies should be considered in patients with unexplained 










8:35 tuBerculOSIS aND exceSS alcOhOl uSe IN the uNIteD StateS, 1997–2012
Authors: Tyson A. Volkmann, J. Oeltmann, P. Moonan, 
R. Miramontes
Background: Excess alcohol use (EAU) among 
tuberculosis (TB) patients complicates TB control 
strategies. No published nationwide study has addressed 
the convergence of EAU and TB in the United States. 
We determined the prevalence of EAU and assessed 
associations between EAU and TB transmission and 
treatment outcomes in TB patients aged 15 years and older.
Methods: We used data from the National Tuberculosis 
Surveillance System, a registry of cases meeting the 
national definition, which includes EAU (self-reported or 
medically documented). For 1997–2012, using univariate 
and then multivariate logistic regression, we examined 
associations between EAU and treatment outcomes and 
markers for increased transmission (involvement in an 
epidemiologic transmission cluster; laboratory-confirmed 
sputum-smear microscopy results). We used Cox 
regression analysis to examine the relationship between 
EAU and the rate of conversion from positive to negative 
sputum-culture results.
Results: EAU was reported by 31,207 (15.1%) of 207,307 
TB patients aged 15 years and older. Prevalence of EAU 
was greater among male (20.6%) and U.S.-born patients 
(24.6%). EAU was independently associated with cluster 
involvement (adjusted odds ratio (aOR): 1.37; 95% 
confidence interval (CI): 1.25–1.52), a positive sputum-
smear result (aOR: 1.23; CI: 1.18–1.28), and death 
during treatment (aOR: 1.16; CI: 1.10–1.22). In adjusted 
Cox regression, the rate of conversion from positive 
to negative sputum-culture results was higher among 
patients without EAU than among patients with EAU 
(adjusted hazard ratio: 1.22; CI: 1.19–1.25). 
Conclusions: EAU was common among TB patients 
and was associated with TB transmission, lower rates of 
sputum-culture conversion, and higher mortality. TB 
control and alcohol treatment programs should work 
together to treat the diseases of addiction and TB.
8:55 characterIzatION OF tuBerculOSIS Due tO mycobactErium africanum — uNIteD StateS,  
2004–2012
Authors: Aditya Sharma, E. Bloss, R. Yelk Woodruff,  
J. Posey, C. Heilig, E. Click.
Background: Tuberculosis (TB) is caused by a group 
of 8 closely related bacteria, including Mycobacterium 
africanum. In contrast to Mycobacterium tuberculosis, the 
epidemiology and clinical manifestations of M. africanum 
in the United States have not been systematically 
characterized. To address this knowledge gap, we 
compared reports of TB caused by M. africanum and 
TB caused by M. tuberculosis using data in the National 
Tuberculosis Surveillance System (NTSS).
Methods: We analyzed NTSS reports of culture-confirmed 
TB caused by M. africanum or M. tuberculosis, as identified 
by genotype, during 2004–2012. Genotype clusters were 
defined as 2 or more cases with identical genotype in the 
same county. We used multivariable logistic regression to 
examine patient attributes, genotype clustering, clinical 
characteristics (e.g., disease site), and social risk factors 
(e.g., homelessness) associated with M. africanum versus 
M. tuberculosis.
Results: Of 64,923 cases of TB, only 299 (0.5%) were 
caused by M. africanum. Compared to U.S.-born whites, 
TB caused by M. africanum was associated with West 
African origin (adjusted odds ratio [aOR]: 2.26; 95% 
confidence interval [CI]: 1.23–4.78) and U.S.-born black 
race (aOR: 2.39; CI: 1.12–5.53). The odds of genotype 
clustering were lower for M. africanum than for M. 
tuberculosis (aOR: 0.22; CI: 0.14–0.32). No significant 
differences in clinical characteristics or social risk factors 
were found between TB caused by M. africanum versus 
M. tuberculosis.
Conclusions: TB disease caused by M. africanum is 
uncommon in the United States and is significantly 
associated with West Africans and U.S.-born blacks. 
Clinical characteristics and social risk factors are 
similar for M. africanum and M. tuberculosis. Minimal 
genotype clustering suggests that M. africanum is rarely 
transmitted in the United States.






9:15 OppOrtuNItIeS FOr ImprOveD DetectION aND treatmeNt OF lateNt tuBerculOSIS INFectION 
amONg veteraNS — WeSterN uNIteD StateS, jaNuary 2010–july 2013
Authors: Tara Perti, P. Schirmer, C. Winston, E. Weiss,  
J. Cavanaugh, C. Lucero-Obusan, M. Holodniy
Background: The Veterans Health Administration 
(VHA) previously estimated that tuberculosis (TB) 
incidence among Veterans was over twice that for the 
U.S. population overall. Treatment of latent tuberculosis 
infection (LTBI) decreases progression to TB by 
approximately 90% among adherent persons. We describe 
characteristics of Veterans with TB and their previous 
screening and treatment for LTBI.
Methods: We queried VHA infection control 
practitioners and QC PathFinder, VHA’s infection 
surveillance application, to identify Veterans with TB 
(confirmed by laboratory or clinical criteria), diagnosed 
or treated during January 1, 2010–July 31, 2013 and 
evaluated for symptoms or signs of TB at VHA facilities 
in the western United States. We reviewed VHA medical 
records for TB risk factors and prior LTBI screening by 
tuberculin skin test or interferon-gamma release assay.
Results: We identified 69 Veterans with TB in 
Washington, Oregon, California, and Arizona. Sixty-
seven (97%) were men; median age was 60 years (range: 
30–92 years). Among 65 with known race or ethnicity 
and national origin, 19 (29%) were foreign-born: 18 
from the Philippines and 1 from Vietnam. Twenty-eight 
(43%) were non-Hispanic white; 11 (17%) were black; 6 
(9%) were Hispanic; and 1 (2%) was American Indian or 
Alaska Native. Among 63 not previously treated for TB, 
47 (75%) had risk factors, 31 (66%) of whom reported or 
had VHA-documented screening. Of 24 diagnosed with 
LTBI, only 9 (38%) had initiated and 8 (33%) completed 
LTBI treatment.
Conclusions: TB could have been prevented in some 
Veterans by targeted testing and treatment of LTBI per 
current guidelines. Investigating reasons certain Veterans 
with TB risk factors are not screened and others with 
LTBI are not treated may help tailor prevention efforts.
9:35 cONtact INveStIgatION OF health care perSONNel expOSeD tO materNal aND NeONatal 
tuBerculOSIS — clark cOuNty, NevaDa, 2013
Authors: Kaci L. Hickox, N. Williams, J. Wortham,  
T. Coleman
Background: Despite declining tuberculosis (TB) rates 
in the United States, missed TB diagnoses threaten the 
health of patients, contacts, and progress toward TB 
elimination. In July 2013, TB was diagnosed during 
autopsy of a postpartum woman after a prolonged 
nonspecific illness. She frequently had visited her 
newborn in the neonatal intensive care unit (NICU); 
after the mother’s death, the newborn was identified as 
having TB and placed under respiratory precautions. 
To help interrupt transmission, we performed a contact 
investigation of health care personnel (HCP).
Methods: We reviewed medical records and work 
schedules and interviewed staff to identify HCP contacts. 
Contacts were evaluated with tuberculin skins tests 
(TSTs) or Quantiferon®-TB tests (QFTs); persons with 
induration of ≥5 mm or QFT-positive results were 
considered TB infected. Those with an increase of ≥10 
mm, compared with previous TST or positive QFT after 
a previous negative within 2 years, were considered 
recently infected (conversion). HCP with clinical, 
radiographic, or microbiologic evidence of TB disease 
were considered to have active TB disease. We compared 
conversion rates of HCP contacts with noncontacts’ rates.
Results: Of 195 HCP contacts, 24 had previous TB 
infections, 7 were unavailable, and 164 were tested. Of 
those tested, 20 (12%) were infected, including 15 with 
test conversions. One NICU staff member had active TB 
disease. Conversions were observed among 15/164 (9%) 
HCP contacts, compared with 11/646 (1.7%) among 
other staff (P <0.01).
Conclusions: TB transmission to HCP occurred, 
and recently acquired infections (conversions) were 
associated with being an HCP contact to the woman 
or newborns. Our findings highlight the importance 
of prompt TB diagnosis and initiation of infection 







9:55 chIlDhOOD tuBerculOSIS — BOtSWaNa, 2008–2011
Authors: Negar N. Alami, T. Arscott-Mills, L. Masole,  
G. Machao, J. Cavanaugh, H. Menzies, A. Steenhoff,  
R. Ncube
Background: Childhood tuberculosis (TB) has been 
a low public health priority because TB in children is 
difficult to diagnose and generally less infectious than 
in adults. Consequently, data are sparse for childhood 
TB. We assessed the epidemiology of childhood TB and 
associations with treatment outcomes in 9 districts in 
Botswana, a high TB-burden country.
Methods: We collected data from clinic TB registers 
on children aged <15 years whose treatment began 
during January 2008–September 2011. We abstracted 
demographics, TB treatment history, and HIV-status 
(infected, negative, or unknown). We performed log-
binomial regression to determine factors associated with 
poor outcome: death, incomplete treatment, or treatment 
failure. 
Results: TB treatment was initiated for 903 children; 
661 (73%) had pulmonary TB, 120 (18%) of whom 
were bacteriologically confirmed cases. Median age 
was 4 years; 442 (49%) were female; and 42 (5%) had 
been previously treated. Of 558 (62%) children with 
documented HIV results, 207 (37%) were HIV-positive, 
and 102 (49%) received antiretroviral therapy. Of 732 
children with a recorded outcome, 657 (90%) were 
cured or completed treatment, 48 (6.5%) defaulted 
from treatment, treatment failed in 4 (0.5%), and 23 
(3%) died. In multivariate analysis, poor outcomes were 
associated with previous treatment (relative risk [RR]: 
2.8; confidence interval [CI]: 1.5–5.1), HIV infection (RR: 
2.8; CI: 1.6–5.3), and unknown HIV status (RR: 2.5; CI: 
1.4–4.5). 
Conclusions: HIV coinfection is high among children 
with TB, but HIV status was not recorded for >1/3 of 
children. HIV infection and unknown HIV status were 
associated with poor outcomes. Because HIV treatment 
can improve TB treatment outcomes in coinfected 
children, HIV testing and treatment should be expanded 
for children with TB.




10:50 uNINteNtIONal INjury chIlD DeathS aND the NatIONal chIlD Death revIeW caSe 
repOrtINg SyStem — 13 u.S. StateS, 2006 aND 2009
Authors: Melissa C. Mercado-Crespo, E. Shaw, R. Lee
Background: The National Child Death Review 
Case Reporting System (NCDR-CRS) is a voluntary 
surveillance platform to systematically and 
comprehensively review the circumstances surrounding 
child deaths. Although preventable, unintentional 
injuries are the leading cause of death among U.S. 
children. This study assessed changes in NCDR-CRS’ 
sensitivity, representativeness and data quality in 
monitoring unintentional child injury deaths (i.e., motor 
vehicle (MV), drowning, fire/burns, falls), within 13 
NCDR-CRS reporting States between 2006 and 2009.
Methods: Proportions and standardized mortality 
ratios (SMR) of aggregated data were used to test the 
sensitivity and representativeness of NCDR-CRS data, 
using National Vital Statistics System (NVSS) data as the 
gold standard. Statistical significance was determined 
by comparing 95% confidence intervals (CI). To assess 
data quality, we calculated the proportion of missing data 
(data asked but not recorded) by cause of death. Analyses 
were conducted in SAS version 9.3.
Results: In 2006 and 2009 respectively, NCDR-CRS 
had a sensitivity of 66% and 67% for MV, 60% and 72% 
for drowning, and 87% and 80% for fire/burns deaths. 
NCDR-CRS 2006 data were representative of fire/burns 
deaths (SMR: 0.4; 95% CI: 0.4–0.5) when compared with 
NVSS reports (SMR: 0.5; 95% CI: 0.4–0.6). Similarly, 
NCDR-CRS falls death data (SMR: 0.2; 95% CI: 0.2–0.3) 
were representative of NVSS reports (SMR: 0.2; 95% CI: 
0.1–0.2). MV death reports had the highest proportion 
of records with missing data (96%); fire/burns and falls 
deaths had the lowest proportion.
Conclusions: Circumstance data from NCDR-CRS could 
inform child health and safety policies and practices. 
Further analyses are needed by State to assess the needs 
and strengths of each State’s NCDR-CRS.






11:10 glOBal DIFFereNceS IN BurDeN OF chIlDhOOD Sexual vIOleNce agaINSt BOyS — haItI, 
keNya, aND camBODIa, 2010–2013
Authors: Steven A. Sumner, J. Mercy, R. Buluma,  
K. Brookmeyer, L. Marcelin, S. Al Hebshi, V. Lea,  
H. Kress, S. Hillis
Background: Globally, little evidence exists on sexual 
violence against boys. We sought to produce the first 
internationally comparable estimates of the magnitude, 
characteristics, and consequences of sexual violence 
against boys in three diverse countries. 
Methods: We conducted nationally-representative, 
multistage cluster, Violence Against Children Surveys 
in Haiti, Kenya, and Cambodia among males age 13–24. 
Differences between countries in experiencing sexual 
violence (including sexual touching, attempted sex, and 
forced/coerced sex) before age 18 were examined using 
chi-square and logistic regression analyses.
Results: In Haiti, Kenya, and Cambodia, respectively, 
1,459, 1,456, and 1,255 males completed surveys 
(response rates all ≥80.4%). The prevalence of 
experiencing any form of sexual violence ranged from 
23.1% (95% confidence Interval [CI]: 20.0–26.2) in 
Haiti, to 14.8% (95% CI: 12.0–17.7) in Kenya, and 5.6% 
(95% CI: 4.0–7.2) in Cambodia. The largest share of 
perpetrators in Haiti, Kenya, and Cambodia, respectively, 
were friends/neighbors (64.7%), romantic partners 
(37.2%), and relatives (37.0%). Most episodes occurred 
inside perpetrators’ or victims’ homes in Haiti (60.4%), 
contrasted with outside the home in Kenya (65.3%) and 
Cambodia (52.1%). The most common time-period 
for violence in Haiti, Kenya, and Cambodia was the 
afternoon (55.0%), evening (41.3%), and morning 
(38.2%), respectively. All differences between nations 
were statistically significant (chi-square P<.001). Health 
risks associated with violence were common, including 
up to a three-fold increased odds of transactional sex 
in Haiti (Odds ratio: 3.3; 95% CI: 1.5–7.6), as well as 
elevated rates of alcohol abuse, sexually transmitted 
infections, anxiety/depression, suicidal ideation/attempts, 
and violent gender attitudes across nations.
Conclusions: Marked differences were noted between 
countries in the characteristics of sexual violence yet 
associations with health risks were pervasive. Prevention 
strategies tailored to individual locales are needed.
11:30 INjurIeS amONg hIgh SchOOl FOOtBall playerS — NeBraSka, Fall 2013
Authors: Deborah L. Hastings, B. Buss
Background: An estimated 25% of Nebraska male high 
school (HS) students play football and are at risk for 
injury, long-term disability, or death. In 2011, Nebraska 
passed the “Concussion Awareness Act,” to decrease 
concussions and limit morbidity among HS athletes. 
However, Nebraska Department of Health and Human 
Services (NEDHHS) has no system for collecting data 
on concussions or other HS football-related injuries. 
We piloted a method of estimating injury rates among 
Nebraska HS football players.
Methods: During September–November 2013, NEDHHS 
requested representatives (athletic trainers, coaches, 
school nurses, or administrators) of all 284 HSs with 
football teams complete a weekly Internet-based survey 
to report athletes who suffered a concussion or fracture, 
had an injury requiring medical attention and resulting 
in the loss of ≥1 day’s participation, or if no reportable 
injuries had occurred. Data were collected regarding 
number of participants, injury setting (game or practice), 
injury type, and severity. Injury rates were calculated for 
these elements.
Results: Forty-nine (17.3%) team representatives 
completed surveys during the study period. Among 
2,220 players, 309 (13.9%) injuries were reported. The 
majority of injuries (206; 66.7%) occurred during games. 
The most commonly reported injuries were concussions 
(108; 35%), sprains (59; 19.1%), knee injuries (43; 13.9%), 
fractures (29; 9.4%), and contusions (15; 4.9%). Of the 
309 injuries, 190 (61.5%) athletes required a physician’s 
care; 10 (3.2%) were hospitalized; 16 (5.2%) required 
surgery; and 35 (11.3%) might need surgery.
Conclusions: Concussions affected 4.9% of Nebraska 
HS football players, comprising 35% of all reported 
injuries. Our survey proved effective for estimating HS 
football injury rates; its ongoing use and expansion can 







11:50 DO chIlDreN IN DOmeStIc ServItuDe experIeNce mOre vIOleNce? — reSultS FrOm the 
vIOleNce agaINSt chIlDreN Survey, haItI, 2012
Authors: Leah K. Gilbert, A. Reza, J. Mercy, V. Lea, J. Lee, 
M. Hast, J. Vertefeuille, L. Marcelin
Background: Child domestic servants (CDS) are 
considered property of the household for which they 
perform excessive, unpaid labor. Although servitude 
violates human rights law, the United Nations Children’s 
Fund estimates there are over 250,000 CDS in Haiti. 
Of public health concern, CDS face documented risk 
factors for child maltreatment including discrimination, 
isolation from family, and denial of education. In the 
absence of national data on CDS in Haiti, the study 
objective was to determine if domestic servitude 
increased the odds of experiencing childhood violence. 
Methods: The Violence Against Children Survey was 
a nationally representative, cross-sectional household 
survey of 13–24 year olds (n = 2,916) conducted May–
June 2012 in Haiti. A stratified three-stage cluster design 
was used to sample households and camps containing 
persons displaced by the 2010 earthquake. Respondents 
were interviewed to assess lifetime prevalence of sexual, 
physical, and emotional violence occurring before age 18. 
The association between domestic servitude and violence 
was assessed using odds ratios. 
Results: In this study 21.1% of females and 13.1% of 
males reported having been CDS. Female CDS had 
higher odds of reporting childhood sexual (odds ratio 
[OR]: 1.83; 95% confidence interval [CI]: 1.30–2.57); 
physical (OR: 2.05; CI: 1.43–2.93), and emotional 
violence (OR: 2.42; CI: 1.84–3.19) compared to female 
non-CDS. Male CDS did not have significantly increased 
odds of sexual violence (OR: 1.50; CI: 0.94–2.39), but 
did have higher odds of physical (OR: 1.51; CI: 1.01–
2.25) and emotional violence (OR: 2.85; CI: 1.88–4.32) 
compared to male non-CDS. 
Conclusions: This study demonstrates that domestic 
servitude increases a child’s risk of maltreatment, 
further highlighting the importance of human rights law 
enforcement in Haiti.
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10:50 IS vaccINe type SerOpOSItIvIty a marker FOr humaN papIllOmavIruS vaccINatION? — 
reSultS FrOm the NatIONal health aND NutrItION examINatION Survey, 2003–2010
Authors: Emiko Y. Petrosky, E. Dunne, S. Hariri,  
G. Panicker, E. Unger, L. Markowitz
Background: Since 2006, a 3-dose human papillomavirus 
(HPV) vaccine has been routinely recommended for 
adolescent females in the United States to prevent 
cervical cancer. Monitoring HPV vaccine coverage is 
essential in guiding vaccination programs. Because 
vaccination induces long-term seropositivity to at least 
3 of 4 vaccine types (HPV 6, 11, 16, 18), seropositivity 
could be used as a marker of vaccination coverage.
Methods: We evaluated vaccine type seropositivity 
(defined as seropositivity to at least 3 HPV vaccine 
types) among females aged 14–26 years, using data 
from the National Health and Nutrition Examination 
Survey (cross-sectional, nationally representative 
surveys). Antibodies to HPV vaccine types were assessed. 
Adjusting for the complex survey design, we compared 
seropositivity in the prevaccine era (2003–2006) with 
the vaccine era (2007–2010). In the vaccine era, we 
assessed agreement between seropositivity and reported 
vaccination by kappa statistic.
Results: Overall, seropositivity was 23.5% among 1,420 
females in the vaccine era compared with 1.8% among 
2,151 females in the prevaccine era (P <0.001). In the 
vaccine era, of the 1,382 females who reported vaccine 
status, 14.6% reported receipt of 3 doses; kappa for 
seropositivity and report of 3 vaccine doses was 0.80 
(95% confidence interval: 0.74–0.86). Among seropositive 
females, 18.4% reported no vaccination; among those 
seronegative to all vaccine types, 3.2% reported receipt of 
at least one vaccine dose.
Conclusions: The increase in seropositivity in the vaccine 
era likely reflects vaccination uptake. The high agreement 
between seropositivity and self-reported vaccination 
suggests seropositivity is useful to estimate vaccination 
coverage. Discordance between seropositivity and self-
reported vaccination may be explained by inaccurate 







11:10 erectIle DySFuNctION meDIcatION uSe aSSOcIateD WIth Sex WIthOut a cONDOm IN hIv-
INFecteD meN WhO have Sex WIth meN — meDIcal mONItOrINg prOject, uNIteD StateS, 
2009
Authors: Xia Lin, C. Mattson, M. Freedman, J. Skarbinski
Background: In 2010, an estimated 77% (29,194) of all 
newly diagnosed HIV infections among U.S. adult and 
adolescent males were attributed to male-to-male sexual 
contact. Limited data suggest an association between 
erectile dysfunction medication (EDM) use and increased 
sexual-risk behavior. We assessed the association between 
prescribed EDM and sex without a condom among a 
national sample of HIV-infected men who have sex with 
men (MSM) receiving medical care and whether MSM 
prescribed EDM received risk-reduction counseling, a 
recommended preventive service.
Methods: We analyzed 2009 data from the Medical 
Monitoring Project, a nationally representative, cross-
sectional survey of HIV-infected adults receiving medical 
care. Using the 12 months before the interview as the 
period, we defined EDM prescription as medical record 
documentation of sildenafil, vardenafil, or tadalafil and 
defined sex without a condom as any self-reported anal 
or vaginal sex without a condom. Using multivariable 
logistic regression, we determined the association 
between EDM prescription and sex without a condom. 
Results: Among 136,320 sexually active HIV-infected 
MSM, 56% (95% confidence interval [CI]: 50–61) 
reported sex without a condom and 13% (CI: 10–15) 
received an EDM prescription. Sex without a condom 
was significantly more prevalent among MSM prescribed 
EDM (prevalence ratio: 1.2; CI: 1.1–1.4; adjusted for 
confounding by drug use and other risk factors). Of 
MSM prescribed EDM, 40% reported that they received 
risk-reduction counseling from their providers.
Conclusions: Sex without a condom is common 
among HIV-infected, sexually active MSM, especially 
those prescribed EDM. Only 40% of HIV-infected 
MSM prescribed EDM received counseling despite 
CDC’s recommendation that such counseling should 
be provided at least twice a year. HIV care providers 
should be aware of the potential for HIV transmission 
risk among MSM prescribed EDM and should provide 
counseling accordingly.
11:30 SyphIlIS tIme-tO-treatmeNt IN StD clINIcS verSuS prIvate clINIcS — arIzONa, 2009–
2012
Authors: Candice L. Williams, L. Young, K. Bisgard,  
M. Taylor
Background: During 2011, in the United States, ~46,000 
syphilis cases were reported. In a 2007 Arizona syphilis 
study, the time-to-treatment was longer for private, 
compared with public-funded, clinics, yet health care 
reform might provide more access to private clinics 
and less need for public-funded clinics. We sought to 
compare time-to-treatment by syphilis screening site 
(public-funded versus private clinics).
Methods: We reviewed reported incident syphilis cases 
from 2 Arizona counties during 2009–2012 and formed 
3 categories: (1) screened and treated at public-funded 
STD clinics; (2) screened at private clinics but treated at 
public-funded STD clinics; and (3) screened and treated 
at private clinics. The median time-to-treatment (days) 
was calculated for each category and assessed with the 
Kruskal-Wallis test.
Results: Of 884 reported syphilis cases, 818 (93%) were 
among males; 813 (92%) had documented treatment. 
Untreated patients were more likely to have been screened 
at a private clinic (54 [76%]), compared with at a public-
funded clinic (17 [24%]; P <.001). Category 1 patients (290 
[36%]) received the timeliest treatment (median: 0 days; 
interquartile range [IQR]: 0–6.5 days); Category 2 patients 
(151 [19%]) received the least timely treatment (median: 
8 days; IQR 2–25 days; P <.01); and Category 3 patients 
(372 [46%]) received less timely treatment, compared 
with Category 1 patients (median: 5 days; IQR: 0–18 days; 
P <.001). Patients seeking care at public-funded clinics, 
compared with private clinics, were younger (mean age: 
32.4, compared with 36.2 years; P <.001), and more likely 
Hispanic (66% versus 47%; P <.001).
Conclusions: Fewer patients were evaluated and treated 
at public-funded STD clinics but received the timeliest 
treatment; these clinics remain crucial to syphilis  
disease control.






11:50 OverSeaS ScreeNINg FOr SyphIlIS amONg u.S.-BOuND reFugeeS, 2008–2013
Authors: Edith Nyangoma, R.S. Benoit, K.C. Olson,  
J. Painter
Background: Despite elimination efforts, syphilis 
remains an endemic disease in the United States, with 
approximately 15 cases per 100,000 reported yearly from 
2008 through 2011. Infected refugees can contribute to 
the overall disease burden and may be a potential source 
of further transmission in the U.S.. CDC requires syphilis 
screening, with treatment of confirmed positives, for all 
U.S.-bound refugees ≥15 years of age and those ≤14 years 
who have syphilis risk factors. 
Methods: We reviewed overseas screening results for 
syphilis among all U.S.-bound refugees from October 1, 
2008, through September 30, 2013. Syphilis results were 
considered positive when serologic non-treponemal 
tests (e.g., Venereal Disease Research Laboratory) 
were qualitatively positive and confirmed by positive 
treponemal tests (e.g. T. pallidum microhemagglutination 
assays). Data were analyzed according to age group, sex, 
pregnancy status, tuberculosis classification, and country 
of origin. Multivariable logistic regression was conducted 
to examine factors associated with syphilis. 
Results: Of 289,229 refugees aged ≥15 years examined 
over 5 years, 467 (<1%) were classified as having syphilis. 
Ten countries contributed 85% of the cases, with 
Vietnam, Burundi, and Democratic Republic of Congo 
having the highest rates: 271, 237 and 147 per 100,000 
examined, respectively. Of those with syphilis, 43 (9%) 
had evidence of tuberculosis infection and five (1%) were 
pregnant. Of 115,399 children who were screened for 
syphilis, 3 were diagnosed as positive. In multivariable 
analysis, increasing age (≥65 vs.15–24 years) (OR=6.5), 
self-reported history of sexually transmitted diseases 
(OR=11.9.) and male sex (OR=1.8) were associated with 
syphilis (p<0.0001).
Conclusions: Overseas screening for syphilis provides 
an opportunity to identify and treat syphilis among 
U.S.-bound refugees and is critical to elimination efforts. 






SpecIal SeSSION: creatIve SOlutIONS FOr OutBreak Data  
maNagemeNt aND cONtact tracINg WIth epI  





SPONSORS: National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
We will begin the session by outlining the elements of viral hemorrhagic fever (VHF) outbreak response, focusing on 
data management needs and how efficient data management can improve overall outbreak management. Problems 
with data management and communication encountered in the four Ebola and Marburg hemorrhagic fever outbreaks 
of 2012 will be addressed. Then the development of an Epi Info™ application for VHF outbreaks will be discussed  — 
a project which was undertaken to solve existing data management obstacles in VHF outbreaks. This will include 
the reasons for and goals of the project, the development process, a brief demonstration of the application, and the 
generation of support and feedback from multiple international organizations involved in VHF outbreak response. We 
will conclude with plans for the future of this project, as well as a broader discussion on Epi Info and the many ways 
that it can be used to support epidemiologic investigations of any disease.
The Epi Info VHF project was initiated and led by a current EIS officer (Ilana Schafer, EIS class of 2012). It was the 
result of challenges encountered with data management during Epi-Aids responding to four VHF outbreaks in 2012. 
Additionally, it is an example of how informatics, a current focus of the EIS Program, can be utilized to improve both 
the EIS experience, as well as the epidemiologic process in general. This session will also highlight how Epi Info, a 
unique CDC program, can be of use to EIS officers and epidemiologists.
SPEAKERS:
 • The Ebola and Marburg Hemorrhagic Fever Outbreaks of 2012: Outbreak Response Components and How We 
Can Improve the Process. Ilana Schafer
 • Developing and Promoting a Viral Hemorrhagic Fever Epi Info Application. Erik Knudsen
 • The Way Forward and the Versatility of Epi Info. Asad Islam









Moderator: Fred Angulo 
During the first 30 minutes of the Poster Symposium, the authors will each give a 2-minute oral presentation at the 
podium in front of a seated audience. During the remaining time, the audience is encouraged to view the individual 
posters and engage in direct discussion with the authors.
P2.1 FuNgemIa OutBreak amONg INjectION-Drug uSerS — laNe cOuNty, OregON,  
2012–2013
Authors: Kara M. Levri, J. Leahy, D. Appelgate, P. Cieslak
Background: Fungemia are usually healthcare–acquired 
infections. The most common fungemia, candidemia, 
has a case fatality rate of 40%–70%. Community-
acquired fungemia are rare. In May 2013, a Lane County 
hospital reported 3 community-acquired fungemia 
among injection-drug users (IDUs). We investigated to 
determine the source and recommend control measures.
Methods: We determined baseline (2009–2012) and 
recent (January–June 2013) community-acquired 
fungemia hospitalization rates as well as prevalence 
among IDUs. Cases were community-acquired fungemia 
among Lane County IDUs after September 2012. We 
queried laboratories, distributed health alerts, and 
contacted clinicians and infection preventionists to 
identify cases. Medical records were abstracted to 
ascertain patient demographics and clinical courses. 
Patients were interviewed to assess drug practices.
 
Results: In 2013, IDU admissions for fungemia increased 
from a baseline of 0.5 to 8.6/10,000 admissions in Lane 
County hospitals (prevalence: 8.2/10,000); 7 cases were 
identified. All patients were HIV-negative men, aged 
23–56 (median: 32) years. All reported intravenous heroin 
use. Six of 7 cases grew Candida species: albicans (4), 
pelliculosa (1), and krusei (1); 2 cases grew additional 
fungal organisms, Rhodotorula and Penicillium; 1 case 
grew only Rhodotorula. Patients were hospitalized for 2–27 
(median: 6) days; 1 required cardiac surgery; 4 received 
long-term outpatient intravenous antifungals; none died. 
All interviewed patients admitted to unsafe injection 
practices, including lack of boiling heroin or preinjection 
site cleaning. One patient reported that the practice of not 
heating heroin was increasing among local IDUs.
Conclusions: Changing heroin preparation and injection 
practices may have contributed to this outbreak. 
Prevention efforts should focus on safer injection practice 
education. We recommend continuing active case finding 






P2.2 a cluSter OF cryptococcus nEoformans INFectIONS at a cOmmuNIty hOSpItal —  
arkaNSaS, 2013
Authors: Snigdha Vallabhaneni, S. Lloyd, D. Haselow,  
G. Wheeler, L. Gladden, K. Garner,  
H. Moulton-Meissner, S. Lockhart, B. Park, J. Harris
Background: Clusters of infections caused by 
Cryptococcus neoformans (Cn), an environmental fungus 
causing pneumonia and meningitis, are rare; active 
disease usually results from immunosuppression-related 
reactivation of latent infection. We investigated a Cn 
cluster at a 330-bed hospital (Hospital X) to determine 
the source of infections.
Methods: Cases, defined as culture-confirmed Cn 
infections at Hospital X, were identified using laboratory 
records. We abstracted data from medical records, 
assessed clinical specimen handling, interviewed 
hospital personnel, case-patients, and family members, 
and queried surrounding hospitals for Cn cases. 
Epidemiological data prompted culturing of the Hospital 
X intensive care unit (ICU) surfaces, and the external air 
intake filter.
Results: During 1992−2012, Hospital X averaged two Cn 
cases annually. During April−June 2013, Cn was isolated 
from respiratory (n=2) and blood (n=3) cultures from five 
case-patients. No case-patients were HIV-infected; one was 
post-kidney transplant. Four died of respiratory failure or 
sepsis ≤5 days after their Cn cultures were obtained. Case-
patients resided in four distant towns; interviews revealed 
no common community exposures. Surrounding hospitals 
reported no increases in patients with Cn infections. 
Laboratory procedure review did not demonstrate 
evidence of contamination. During April 6−14, 2013, three 
case-patients were the only occupants in two adjacent ICU 
rooms; another case-patient occupied a nearby ICU room 
during June 2013. The surviving case-patient did not have 
ICU exposure; he was post-kidney transplant and likely 
had reactivation disease. Environmental sampling of the 
ICU did not yield Cn.
Conclusions: Temporospatial commonalities suggested 
nosocomial acquisition of Cn in the ICU for at least 
three case-patients; the source remains undetermined. 
Clinicians should consider the possibility of nosocomial 
cryptococcosis.
P2.3 uNIverSIty-BaSeD gaStrOINteStINal IllNeSS OutBreak cauSeD By Dual pathOgeNS — 
teNNeSSee, 2013
Authors: Joshua L. Clayton, M. Zylstra, D. Walker,  
K. Garman, J. Dunn, W. Schaffner, T. Jones
Background: School-related foodborne disease 
outbreaks accounted for 17,266 illnesses in 286 outbreaks, 
the third most illnesses reported among all U.S. settings 
during 1998–2008. We investigated gastrointestinal 
illness among persons dining in a university cafeteria 
during August–September 2013 to determine the etiology 
and vehicle.
Methods: We defined a case as diarrhea (≥3 stools 
in 24 hours) in a student or staff member after eating 
at the cafeteria August 17–August 24. We conducted 
hypothesis-generating interviews and reviewed meal-plan 
data to identify exposures and performed a case-control 
study. Control subjects were selected from nonill diners 
at an implicated meal. We performed an environmental 
assessment of the cafeteria. Isolates from case-patients 
and food were subtyped by using pulsed-field gel 
electrophoresis (PFGE) and tested for antimicrobial 
susceptibility.
Results: We identified 23 cases (median age: 18 years; 
range: 18–44); 18 (78%) were male. Dinner in the 
university cafeteria on August 20 was the common 
exposure. The case-control study included 19 cases and 
91 control subjects. Italian-stuffed peppers containing 
ground chicken were associated with illness (odds ratio: 
7.0; 95% confidence interval: 2.1–23.5). Of 10 stool 
specimens tested, 2 were positive for Campylobacter 
jejuni only, 3 for Salmonella Enteritidis only, and 4 for 
both. All 4 lots of raw ground chicken tested yielded 
both pathogens, with PFGE patterns indistinguishable 
from those of case-patients. C. jejuni isolates were 
fluoroquinolone resistant. The environmental assessment 
identified unsafe food handling practices, including 
inadequate cooking and lack of temperature monitoring 
of ground chicken.
Conclusions: Contaminated raw chicken and multiple 
unsafe food handling practices contributed to this dual-
pathogen outbreak. Education of food handlers can 
minimize illnesses associated with such high-risk foods 
as ground chicken.






P2.4 rapID IDeNtIFIcatION OF prepackageD, reaDy-tO-eat SalaDS aSSOcIateD WIth aN OutBreak 
OF EschErichia coli O157:h7 INFectIONS — multIple StateS, 2013
Authors: Patrick R. Ayscue, V. Peralta, T. Libby,  
W. Probert, A. Barnes, J. Lidgard, M. Needham,  
B. Melius, D. Gillis, D. Vugia, J. Watt, A. Kimura
Background: On October 29, 2013, the California 
Department of Public Health (CDPH) identified a cluster 
of 4 Escherichia coli O157:H7 (O157) isolates with a 
novel pulsed-field gel electrophoresis (PFGE) pattern. We 
investigated to identify the source and prevent further 
illness.
Methods: We queried PulseNet for O157 isolates 
matching the outbreak strain outside California. CDPH 
also screened O157 isolates by using multilocus variable-
number tandem-repeat analysis (MLVA), a more rapid 
subtyping technique. We interviewed patients with 
hypothesis-generating questionnaires updated during the 
investigation, reviewed October 2013 purchases from the 
implicated grocery Chain A, and conducted a traceback 
investigation.
Results: We identified 33 O157 isolates matching 
the outbreak strain among patients in California, 
Washington, Arizona, and Texas, with sample collection 
dates during 10/15/13–11/08/13. Ten were initially 
identified by MLVA and were interviewed an average of 
2.6 days earlier (95% confidence interval: 0.18–5.0) than 
patients identified by PFGE. Patients’ median age was 
28 years (range: 2–78); 64% were female. The majority 
(28/31; 90%) shopped at Chain A; 24/30 (80%) reported 
consumption/likely consumption of a prepackaged salad 
from Chain A during the week before illness onset, 
compared with an expected 18% of Chain A customers 
on the basis of purchase history (p <.0001). Among 24 
who reported prepackaged salad consumption, 22 (92%) 
reported 1 of 2 specific salad varieties, which traced back 
to a single producer. Chain A promptly discontinued 
stocking the implicated salads, followed by a recall by the 
salad producer.
Conclusions: This outbreak highlights the need for 
increased food safety efforts targeting ready-to-eat 
foods, including prepackaged salads. Conducting PFGE 
and MLVA testing in parallel contributed to timely 
interventions to prevent further illness.
P2.5 acute gaStrOeNterItIS amONg SemINar atteNDeeS aFter a catereD luNch — 
WaShINgtON, Dc, 2013
Authors: Sasha A. McGee, G. Ray, H. Kebede, A. Gibson, 
I. Cooper, T. Jemaneh, M. Blaylock, A. Diallo,  
F. Johnson-Clarke, J. Davies-Cole
Background: Foodborne diseases cause approximately 
48 million illnesses annually in the United States. In 
August, the District of Columbia Department of Health 
was notified of gastroenteritis among seminar attendees 
who had eaten a catered lunch. We investigated to 
determine the outbreak source and etiology.
Methods: Cases were defined as any gastrointestinal 
illness among attendees <48 hours after eating the catered 
lunch. A retrospective cohort study was conducted 
by using food history questionnaire data to calculate 
the relative risk (RR) for illness. We also interviewed 
restaurant staff and conducted a restaurant inspection, 
during which food samples were collected.
Results: Twenty-eight of 52 attendees (53.8%) completed 
the survey. Of these, 15 (53.6%) met the case definition. 
The attack rate among respondents who had eaten the 
lunch was 57.7%. Neither of the 2 respondents who 
had not eaten the lunch reported illness. The median 
time until illness onset was 30.3 (range: 6–38) hours. 
Illness duration was <24 (range: 6–72) hours for 46.7% 
of ill respondents, and none sought medical attention; 
therefore, clinical samples were unavailable. The 2 most 
common symptoms were diarrhea (80.0%) and vomiting 
(73.3%). All 4 respondents who had eaten the falafel-
stuffed pita became ill, compared to 8/17 (47.1%) of the 
respondents who had not (RR: 2.13; 95% confidence 
interval: 1.28–3.52). None of the other food items were 
associated with becoming ill. Food samples tested 
negative for common foodborne bacterial pathogens. 
None of the restaurant employees reported illness.
Conclusions: Epidemiologic evidence indicated the 
falafel-stuffed pita was associated with illness. Norovirus 
was the likely etiologic agent as the incubation period, 
attack rate, and illness duration are consistent with 






P2.6 gaStrOeNterItIS aSSOcIateD WIth raFtINg the mIDDle FOrk OF the SalmON rIver — 
IDahO, 2013
Authors: Mariana Rosenthal, M. Taylor, K. Anderson,  
K. Carter
Background: Annually, ~10,000 persons from the 
United States and abroad raft Idaho’s 104-mile Middle 
Fork of the Salmon River on 4–10-day trips without road 
access. During July–August 2013, rafters experienced a 
gastroenteritis outbreak, requiring air evacuations. We 
investigated to identify the agent, source, and risk factors 
for illness, and provided prevention recommendations.
Methods: We solicited participants for a case-control 
study through the media, in person, and by e-mailing 
rafting permit holders. We provided an online 
questionnaire regarding symptoms, meals, drinking 
water, and environmental exposures. A case was defined 
as nausea, vomiting, or diarrhea within 25 days of rafting, 
in a person who had rafted during July 1–September 23. 
Control subjects were well rafters from the same period. 
Ill persons provided stool specimens and we collected 
environmental samples at locations along the river for 
laboratory-testing.
Results: We identified 102 case-patients and 293 control 
subjects. Illness was associated with drinking filtered 
river water (odds ratio [OR]: 3.9; 95% confidence interval 
[CI]: 2.4–6.4). This association was stronger among case-
patients ill <4 days (norovirus gastroenteritis-like), (n = 
63; OR: 6.6; 95% CI: 3.3–12.9) than those ill ≥4 days (n 
= 38; OR: 2.2; 95% CI: 1.1–4.3). Norovirus (n = 3) and 
giardia (n = 8) were detected in stool specimens from 
11 ill rafters. Norovirus was detected on water spigots 
and outhouses; Escherichia coli was detected in an 
unregulated water source.
Conclusions: This multiple-etiology outbreak apparently 
was associated with drinking filtered river water; 
examination of filtering methods used is warranted. 
Strict adherence among river rafters to disseminated 
guidelines for gastrointestinal illness prevention, 
including sanitation, food handling, and water treatment, 
is advised.
P2.7 repOrteD reaSONS FOr teStINg amONg hepatItIS B vIruS-INFecteD patIeNtS — chrONIc 
hepatItIS cOhOrt StuDy, uNIteD StateS, 2006–2010
Authors: Gemechu B. Gerbi, L.B. Rupp, S.C. Ko,  
A. Moorman, S.D. Holmberg, F. Xu
Background: Chronic infection with hepatitis B virus 
(HBV) is a common cause of death associated with liver 
failure, cirrhosis, and liver cancer. Of the estimated 
800,000–2 million persons in the United States with HBV 
infection, only about two-thirds have been diagnosed. 
Identifying reasons why persons diagnosed with HBV 
infection were tested may help identify opportunities 
to facilitate diagnosis and treatment of persons who are 
infected but have not been diagnosed. 
Methods: We surveyed participants enrolled in the 
Chronic Hepatitis Cohort Study, an observational study 
of persons with chronic viral hepatitis in the United 
States. Of 3,358 patients aged ≥18 years who had HBV 
infection, 2,725 (81.2%) were randomly sampled for 
survey during 2010–2011. After the exclusion of 450 
patients who died or otherwise could not be contacted, 
the remaining 2,275 (67.7%) patients were surveyed by 
U.S. mail or telephone. Participants selected 1 or more 
reasons for initial HBV testing from a list of seventeen 
reasons.
Results: Of the 2,275 patients sampled, 1,044 (46%) 
completed the survey: mean age: 50 years; men: 53.4%; 
Asian: 57.8%. Most participants gave one reason for 
testing. Of 1,386 reasons for testing (reported by 1,044 
respondents), 41.1% of respondents indicated symptoms 
and signs of liver disease or doctor recommendation; 
26.4% indicated birth in endemic country or high-risk 
sexual behaviors; and 14% indicated blood donation or 
insurance. Seven percent of participants sought testing 
only after experiencing liver-related symptoms.
Conclusions: Clinical indications, including doctor 
recommendation, were the most common reason for 
HBV testing. Promoting awareness among health care 
providers and persons at high risk for HBV infection may 
help facilitate identification of infection and reduce HBV-
related morbidity and mortality.






P2.8 mOrtalIty rISk aFter OppOrtuNIStIc IllNeSS DIagNOSeS amONg hIv-INFecteD perSONS — 
SaN FraNcIScO, 1980–2012
Authors: Kpandja Djawe, K. Buchacz, L. Hsu, M.J. Chen, 
C. Rose, T. Williams, J.T. Brooks, S. Schwarcz
Background: Despite substantial decreases in incidence 
of opportunistic illness (OIs) since the introduction of 
combination antiretroviral therapy (cART), OIs remain 
a common cause of HIV-related mortality. We examined 
whether improved HIV treatment was associated with 
better survival after OI diagnosis and how survival 
differed by OIs. 
Methods: We analyzed HIV surveillance data and 
estimated Kaplan-Meier survival probabilities after first 
OI diagnosis among AIDS patients aged ≥13 years in 
San Francisco during 3 periods: 1980–1986 (pre-ART); 
1987–1996 (mono-/dual ART); and 1997–2012 (cART). 
We used Cox proportional hazards models to determine 
adjusted mortality risk by OI in the cART period 
(referent group: patients with Pneumocystis pneumonia 
[PCP]).
Results: Of 20,860 persons with AIDS, 3,004 were first 
diagnosed with an OI (deaths: 2,957) in 1980–1986; 
14,097 (deaths: 12,569) in 1987–1996; and 3,759 (deaths: 
1,573) in 1997–2012. The most frequent OI diagnoses 
were PCP (39.1%) and Kaposi’s sarcoma (20.1%). Overall 
5-year survival probability increased from 7% in 1980-
1986 to 65% in 1997-2012. Increases in survival by OI 
ranged from a 1.8-fold increase (33% to 59%) for patients 
with HIV wasting to a 69-fold increase (1% to 69%) for 
patients with PCP. In 1997–2012, after adjustment for 
clinical and demographic factors, survival after first OI 
was poorest for brain lymphoma (hazard ratio [HR]: 5.14; 
95% confidence interval [CI]: 2.98–8.87) and progressive 
multifocal leukoencephalopathy (HR: 4.22; CI: 2.49–
7.17). 
Conclusions: Survival after first OI diagnosis has 
improved markedly since 1980. Some OIs remain 
associated with substantial mortality risk even after 
adjustment for clinical factors (e.g., CD4 cell count). 
Better prevention and treatment strategies are still needed 
for OIs occurring in the cART period.
P2.9 DelayeD DIagNOSIS OF multIDrug-reSIStaNt tuBerculOSIS aND the reSultINg OutBreak — 
SheBOygaN, WIScONSIN, 2012–2013
Authors: Abbey J. Canon, C. Yuen, J. Beinemann,  
P. Vang, P. Wegner, L. Will, J.P. Davis
Background: Prompt diagnosis and treatment of 
tuberculosis (TB), caused by Mycobacterium tuberculosis, 
can prevent transmission and death. On April 12, 2013, 
an adult foreign-born Sheboygan resident (index patient) 
from a high-incidence country and with a history of 
being exposed to TB received a diagnosis of pulmonary 
TB disease (later identified as isoniazid and rifampin 
resistant, or multidrug-resistant) 8 months after cough 
onset. Concerned about a prolonged infectious period, 
we investigated to find and prevent additional cases.
Methods: We defined a case as TB disease caused by 
M. tuberculosis with the index case strain genotype in 
a Wisconsin resident that was diagnosed during May 
2012–August 2013; persons with latent TB infection 
(LTBI) had a positive TB test and an epidemiologic link 
to a TB patient. To determine factors contributing to 
transmission and to find contacts, we reviewed medical 
records and interviewed patients.
Results: Beginning October 2012, the index patient 
sought medical care for TB symptoms during 9 visits 
to 7 different providers. Chest radiographs obtained 
during 3 separate visits were consistent with but not 
interpreted as TB; TB was first considered during April 
2013, approximately 6 months after the first medical 
visit. Among >700 evaluated contacts, the investigation 
detected 31 persons with LTBI and 11 secondary TB 
cases. Among the 12 TB patients, median age was 19 
(range: 11–39) years. The index patient had resided in the 
United States for 19 years. 
Conclusions: Because of delayed diagnosis, the index 
patient’s prolonged infectious period resulted in extensive 
transmission. To prevent outbreaks and promptly 
interrupt TB transmission, clinicians, even in low-
incidence settings, should have a high index of suspicion 






P2.10 mIcrONutrIeNt pOWDer uSe aND INFaNt aND yOuNg chIlD FeeDINg practIceS —  
Nepal, 2011
Authors: Kelsey R. Mirkovic, C. Perrine, G. Subedi,  
S. Mebrahtu, P. Dahal, M. Jefferds
Background: The World Health Organization (WHO) 
recommends home-fortification of foods using 
micronutrient powders (MNP) for children 6–23 months 
at risk for micronutrient deficiencies. However, the 
influence of MNP use on infant and young child feeding 
(IYCF) practices is not well understood. We assessed the 
association of MNP use and IYCF practices. 
Methods: Representative cross-sectional surveys on 
MNP use and IYCF practices were conducted with 
mothers of eligible children in 2 rural pilot districts, 3 
months after implementation of an integrated MNP/
IYCF program made free MNPs available to children 
6–23 months (n = 696). Standard WHO definitions 
of 5 key IYCF practices, chi-square tests, and logistic 
regression were used to assess whether practices varied 
by MNP use (yes/no). 
Results: MNPs were used by 62% of children 6–23 
months. Continued breastfeeding among children 12–15 
months (n = 225) was high and did not differ by MNP 
use (93.7% vs 96.6%; P = .40). Timely introduction of 
complementary foods among children 6–8 months (n 
= 98) was more frequent among MNP users; however, 
the association was not significant (91.4% vs 74.6%; P 
= .10). Children 6–23 months who used MNPs were 
more likely to receive a diet that met the criteria for 
minimum dietary diversity (39.7% vs 21.4%, P <.001), 
minimum meal frequency (68.7% vs 55.3%, P = .005), 
and minimum acceptable diet (29.4% vs 14.7%, P <.001). 
Significant relationships remained after adjusting for 
maternal education and household economic status. 
Conclusions: MNP use is associated with better IYCF 
practices in 2 districts of Nepal. These findings contribute 
to ongoing project evaluation, which will guide future 
policy decisions on program implementation and scale-
up.
P2.11 aDverSe Drug eveNtS aSSOcIateD WIth aN electrONIc muSIc FeStIval —  
NeW yOrk cIty, 2013
Authors: Alison D. Ridpath, C. Driver, H. Kunins,  
D. Paone, D. Kass, RS. Hoffman, N. Lundy De La Cruz, 
A. Jakubowski, A. Karpati
Background: Synthetic club drugs (SCDs), including 
molly and ecstasy, are often used at electronic music 
festivals (EMFs) and thought to be 3,4-methylenedioxy-
N-methylamphetamine (MDMA), known to cause 
adverse events. In September 2012, New York City 
Department of Health and Mental Hygiene (DOHMH) 
investigated adverse events among attendees of an annual 
EMF, Festival A, resulting in initiation of surveillance 
of emergency department transports during subsequent 
EMFs. In September 2013, surveillance at Festival A 
identified 2 deaths from suspected drug overdose. 
DOHMH investigated to characterize adverse drug 
events.
Methods: Cases were drug-related deaths or emergency-
department transports among attendees of 2013 Festival 
A ≤12 hours after the event. Severe cases were seizure, 
intubation, intensive care unit (ICU) admission, or 
death. We reviewed medical records and medical 
examiner case reports. Drug use (including alcohol) was 
considered present by laboratory test or medical record 
report. Available biologic samples underwent additional 
toxicologic testing.
Results: We identified 21 cases, including 9 severe cases 
[5 ICU admissions, 2 deaths], during the 2-day EMF 
(daily attendance, 40,000 persons). Median age was 21 
years (range: 16–29). Drug use included alcohol only 
(6), SCDs (12), marijuana (3), and cocaine (1). Eight of 
9 severe cases used SCDs compared to 1/9 who did not 
(prevalence ratio: 6.7; 95% confidence interval: 1.0–44.7). 
Among 17 patients with additional toxicology, 11 had 
evidence of SCDs (MDMA or methylone, a synthetic 
cathinone stimulant often sold as “bath salts.”) 
Conclusions: The majority of severe adverse drug 
events at Festival A involved SCDs. Methylone is newly 
identified as a cause of adverse drug events at EMFs. 
Public health messages about SCDs should be developed 
to reduce adverse drug events at EMFs.






P2.12 SuDDeN carDIac Death IN patIeNtS WIth uNrecOgNIzeD lyme carDItIS — uNIteD StateS,  
2012–2013
Authors: Joseph D. Forrester, G. Ray, T. Schulz,  
W. Daniels, E. Daly, T. Andrew, C. Brown, P. Cummings, 
R. Nelson, S. Ertel, J. Mullins, M. Cartter, P. Backenson,  
J. White, P. Kurpiel, R. Rockwell, A. Rotans, C. Hertzog, 
L. Squires, J. Linden, M. Prial, J. House, P. Pontones,  
K. Waller, E. Schiffman, D. Neitzel, B. Batten, D. Blau,  
M. DeLeon-Carnes, A. Muehlenbachs, J. Ritter,  
J. Sanders, S. Zaki, C. Molins, M. Schriefer, A. Perea,  
K. Kugeler, C. Nelson, A. Hinckley, P. Mead
Background: Each year an estimated 300,000 Americans 
are diagnosed with Lyme disease (LD), a multisystem 
tickborne illness caused by Borrelia burgdorferi. Infection 
of the heart, Lyme carditis (LC), is an uncommon 
complication and rarely fatal, with four deaths reported 
worldwide over 35 years. From November 2012 through 
July 2013, pathologists at a tissue bank and CDC detected 
evidence of LC in three cases of sudden cardiac death 
(SCD). We conducted an investigation to confirm the 
diagnosis, identify risk factors, and define populations at 
risk of LC.
Methods: Medical records of index cases were reviewed; 
specimens were tested for evidence of B. burdorferi. 
Frequency and demographic features of LC were 
determined from national LD surveillance data using Epi 
Info™. Vital records in 4 states were searched to identify 
deaths among reported LC cases.
Results: The decedents, two males and one female 
aged 26–38 years, were residents of Connecticut, 
Massachusetts, and New York. Two patients did not seek 
care. All had serologic evidence of early disseminated 
LD, and spirochetes were detected in cardiac tissues by 
microscopy, immunohistochemistry, and polymerase 
chain reaction assays. Among 154,405 LD cases with 
clinical information reported to CDC from 2001–2010, 
1,710 (1.1%) had LC. Relative to other LD cases, patients 
with carditis were more likely to be male (odds ratio 
[OR]:1.55; 95% confidence interval [CI]:1.40–1.71) and 
aged 15–44 (OR:1.52; CI:1.37–1.68). Review of vital 
records for 608 patients diagnosed with LC did not 
identify any deaths attributed to LC.
Conclusions: Carditis occurs in ~1% of reported LD 
cases and is disproportionately common in young adults 
and males. Mortality is rare among recognized cases, but 






CONCURRENT SESSION F1: Foodborne Diseases
3:00–5:05pm
Ravinia Ballroom
Moderators: Ian Williams and Barbara Mahon
3:05 multIState OutBreak OF lISterIOSIS lINkeD tO cOmpaNy a artISaNal cheeSeS — uNIteD 
StateS, 2013
Authors: Mary J. Choi, C. Medus, K. Smith, C. Rigdon,  
M. Forstner, W. Ishow, S. Slette, L. Bottichio, J. Ball,  
S. Bosch, K. Jackson, B. Mahon, C. Tarr, M. Wise, J. Beal, 
D. Melka, B. Silk
Background: Invasive listeriosis, a foodborne disease, 
causes ~260 deaths annually in the United States. 
Older adults, pregnant women, and persons with 
immunocompromising conditions are at increased risk. In 
June 2013, the Minnesota Department of Health notified 
CDC of 2 patients with isolates that had indistinguishable 
pulsed-field gel electrophoresis (PFGE) patterns. We 
investigated to identify the source and prevent additional 
infections.
Methods: We queried PulseNet for indistinguishable 
environmental and clinical isolates. Outbreak-related 
cases were defined by Listeria monocytogenes isolation 
with the outbreak PFGE pattern, and a pattern upload 
date of May 20–June 28, 2013. Patients were interviewed 
about food exposures and case-case analyses compared 
outbreak-related cases with sporadic cases reported during 
2004–2013. Microbiologic and traceback investigations 
were conducted.
Results: Twenty-nine environmental isolates with a 
PFGE pattern indistinguishable from the outbreak 
pattern were identified at Company A’s production 
facility during 2010–2011. Five cases from 4 states were 
identified. All patients were hospitalized. One death and 
a miscarriage were reported. Soft-cheese consumption 
was associated with outbreak-related illness (odds ratio: 
10.8; 95% confidence interval: 1.8–∞). All patients 
definitely or probably had eaten Company A’s pasteurized 
soft cheeses. The outbreak strain was isolated from 2 
Company A cheeses collected at 2 Minnesota grocery 
stores. Implicated restaurants and grocery stores received 
these cheeses as intact wheels from multiple distributors. 
Inspection of the cheese-making facility revealed 
sanitation deficiencies. The cheeses were recalled and 
production was halted.
Conclusions: Environmental contamination of cheese 
at Company A’s production facility likely caused this 
outbreak. Persons at increased risk should be aware that 
soft cheeses made under insanitary conditions, whether 
or not the milk is pasteurized, have been shown to  
cause illness.






3:25 EschErichia coli O157:h7 OutBreak aSSOcIateD WIth a mexIcaN FOOD reStauraNt — 
arIzONa, 2013
Authors: Laura E. Adams, M. Eguchi, A. Mitchell,  
C. Arbalaez Piedrahita, J. Stewart, R. Klein, T. Sylvester,  
J. Weiss, K. Bisgard, B. Robinson, K. Komatsu,  
R. Sunenshine
Background: Escherichia coli O157:H7 is a leading cause 
of foodborne-related hospitalization in the United States, 
with ~63,000 illnesses and 20 deaths annually. In July, 
Maricopa County Public Health was notified of bloody 
diarrhea in 3 hospitalized patients who reported having 
eaten at Restaurant A. We sought to identify cases and 
sources to prevent additional illnesses.
Methods: Probable cases were defined as diarrhea (≥3 
loose stools in 24 hours) or hemolytic uremic syndrome 
(HU.S.) ≤10 days after Restaurant A patronage during 
July 18–30; confirmed cases had E. coli O157:H7 isolates 
indistinguishable by pulsed-field gel electrophoresis. We 
conducted a case-control study; case-patients and control 
subjects were identified through Restaurant A receipts, 
fellow diners, and press releases encouraging Restaurant 
A patrons to contact public health. Control subjects had 
eaten at Restaurant A and had no subsequent illness. 
We conducted logistic regression analysis of ingredients 
with statistically significant bivariate associations. 
Environmental investigation included restaurant 
inspection, food ingredient traceback, and laboratory 
analysis.
Results: We identified 94 (including 11 confirmed) cases 
among patients aged 2–88 (median 32) years; 53 (56.4%) 
were female. Thirty-three (35.1%) persons sought 
medical care, including 2 (2%) with HU.S.; none died. In 
the model, only lettuce remained significant (odds ratio: 
3.2; 95% confidence interval: 1.5–6.8). Lettuce had been 
consumed by 72.8% (59/81) of case-patients and 42.4% 
(42/99) of control subjects. No pathogenic E. coli were 
identified in environmental samples, but total coliforms 
>1,400 were isolated from lettuce. Traceback revealed 
the lettuce distributer supplied other restaurants without 
reported illnesses. Restaurant A reported no employee 
illnesses.
Conclusions: An E. coli O157:H7 outbreak was traced to 
one restaurant; data indicate that contaminated lettuce 
was associated with illness.
3:45 DIStINct epIDemIOlOgIc patterNS OF FOODBOrNe verSuS perSON-tO-perSON NOrOvIruS 
OutBreakS IN the uNIteD StateS, 2009–2012
Authors: Kimberly D. Pringle, M. Wikswo, L. Gould,  
U. Parashar, A. Hall
Background: Norovirus is the leading cause of epidemic 
acute gastroenteritis (AGE) worldwide. Previously, U.S. 
surveillance for norovirus only included foodborne 
and waterborne disease outbreaks, highlighting its 
leading role in foodborne disease. Since 2009, states 
may also report person-to-person norovirus outbreaks 
to the passive National Outbreak Reporting System 
(NORS), providing opportunity to better understand 
the epidemiology of norovirus outbreaks and the public 
health importance of person-to-person transmission.
Methods: We included all suspected or confirmed single-
etiology norovirus outbreaks reported to NORS from 
2009–2012. An outbreak was defined as ≥2 ill persons 
with a common exposure. We performed descriptive 
analyses by transmission mode and used chi-square tests 
to compare proportions.
Results: A total of 4,098 norovirus outbreaks were 
reported affecting 152,068 people (median=25 people 
per outbreak; IQR=12–47) from 2009–2012. The 
primary transmission mode in most outbreaks reported 
was person-to-person (n=2816, 69%); 1001 (24%) 
were foodborne. More pronounced winter seasonality 
(October–March) was observed among person-to-person 
outbreaks (2407 [63%]) compared with foodborne 
outbreaks (641 [17%]; p<0.001). Most (53%) foodborne 
norovirus outbreaks occurred in restaurants while 79% 
of person-to-person norovirus outbreaks occurred in 
nursing homes. Compared with foodborne norovirus 
outbreaks, person-to-person norovirus outbreaks had 
a higher case-hospitalization rate (2.3% versus 1.2%, 
p<0.001) and affected a greater proportion of patients 
≥50 years-old (70% versus 38%, p<0.001).
Conclusions: Expanded surveillance through NORS 
illustrates that person-to-person and foodborne 
transmission account for most norovirus outbreaks. 
Compared with foodborne norovirus outbreaks, those 
spread via person-to-person were reported to occur 
more frequently in vulnerable, elderly populations 
with elevated rates of severe outcomes. Prevention and 
control efforts should target such outbreaks through early 
recognition and aggressive infection control, recognizing 






4:05 multIState OutBreak OF multIDrug-reSIStaNt salmonElla heIDelBerg INFectIONS lINkeD tO 
FOSter FarmS BraND chIckeN — uNIteD StateS, 2013
Authors: Jolene H. Nakao, J. Higa, V. Peralta, H. Rosen, 
T. Libby, N. Marsden-Haug, A. Kimura, C. Schwensohn, 
J. Pringle, A. Green, B. Kissler, K. Robertson, J. Grass,  
A. Bicknese, B. Tolar, S. Defibaugh-Chávez, M. Wise,  
C. Barton Behravesh, I. Williams, L. Gieraltowski
Background: Salmonella causes ~1.2 million infections 
and 400 deaths annually in the United States. On 
6/13/2013, PulseNet, a national subtyping network, 
identified a cluster of human infections of Salmonella 
Heidelberg (SHg) with indistinguishable genetic 
fingerprints. States and CDC initiated an investigation to 
identify the source and prevent additional illnesses. 
Methods: We defined a case as illness with an outbreak 
strain with onset 3/1/2013–present. Our investigation 
included collection of patient exposures and comparison 
to a population survey, isolate testing for antimicrobial 
resistance, and traceback and culture of retail chicken. 
U.S.DA-FSIS conducted intensified Salmonella testing at 
four production facilities.
Results: We identified 403 case-patients in 23 states 
and PR; 40% (128/318) were hospitalized. A higher 
percentage (82% [51/61]) consumed chicken prepared at 
home than reported in the FoodNet Population Survey, 
(65%, p-value <0.002); 80% (16/20) reported eating 
Foster Farms (FF) brand. One sub-cluster was linked to 
FF-sourced rotisserie chicken from a single store location 
which subsequently recalled >23,000 units of rotisserie 
chicken products. Chicken products collected from FF 
facilities, FF retail chicken samples, and leftover case-
patient food yielded the outbreak strains. Case-patient 
and poultry isolates were resistant to combinations 
of seven different antimicrobials, with 50 exhibiting 
multidrug resistance. On 10/7/13, U.S.DA-FSIS issued an 
alert about chicken from three FF facilities, reminding 
consumers to properly handle raw poultry. On 10/11/13, 
FF began implementing process enhancements. 
Conclusions: This outbreak, in which epidemiologic, 
traceback, and laboratory evidence identified FF chicken 
as the source, highlights the need for more rigorous 
Salmonella control in raw chicken products. In response, 
FF implemented measures to decrease Salmonella burden 
in chicken parts, which may stimulate nationwide 
adoption of more stringent standards by other producers.
4:25 OutBreakS OF cyclOSpOrIaSIS — uNIteD StateS, juNe–auguSt 2013
Authors: R. Reid Harvey, F. Abanyie, J. Harris,  
R. Wiegand, M. Parise, I. Williams,  
M. desVignes-Kendrick, K. Reynolds, T. Lee,  
K. Klein, L. Gaul
Background: Cyclosporiasis is a nationally notifiable 
gastrointestinal illness caused by the parasite Cyclospora 
cayetanensis. During summer 2013, 631 infections from 
25 states, primarily Iowa, Nebraska, and Texas, were 
reported to CDC (compared to 123 reported infections 
in 2012). In Iowa and Nebraska, most infections occurred 
in June, and were associated with consumption of bagged 
salad mix containing lettuce, cabbage, and carrots. In 
Texas, most infections occurred during July–August; no 
subtyping methods to link illness clusters currently exist 
for cyclosporiasis. We investigated a cluster of illnesses 
at a Texas Mexican-style restaurant (Restaurant A) to 
identify possible additional contaminated food vehicles. 
Methods: Cases were persons with gastrointestinal 
illness who ate at Restaurant A after June 1; controls were 
matched by Restaurant A meal dates and reported no 
diarrhea ≤14 days afterwards. We administered a menu-
specific questionnaire, and performed a case-control 
study including ingredient-level analyses. 
Results: We interviewed 21 case-patients and 65 
controls. Four fresh produce items were significantly 
associated with illness: fresh cilantro (matched odds ratio 
[mOR]:19.8; 95% confidence interval [CI]:4.0–∞), onions 
(mOR:15.3; CI:2.1–697.7), garlic (mOR:10.7; CI:1.5–
475.4), and tomatoes (mOR:5.5; CI:1.1–54.1). Of these, 
only cilantro was consumed by all case-patients. Among 
the four salsas prepared at Restaurant A, three containing 
uncooked cilantro were significantly associated with 
illness (hot salsa mOR:8.0; CI:2.3–31.4; side salsa 
mOR:5.7; CI:1.6–23.7; fire salsa mOR:3.5; CI:1.1–12.7); 
salsa containing cooked cilantro was not (salsa ranchera 
mOR:6.0; CI:0.7–75.2). 
Conclusions: Cilantro was the likely source of illnesses 
in this Texas restaurant cluster. Although these illnesses 
overlapped with a multistate outbreak linked to bagged 
salad mix, epidemiologic studies suggest that the large 
increase in cyclosporiasis during summer 2013 was 
caused by at least two different food vehicles.






4:45 humaN EschErichia coli O121 INFectIONS lINkeD tO multIple FrOzeN SNack FOODS — 
uNIteD StateS, 2013
Authors: Tara C. Anderson, J. Pringle, S. Im, M. Anand, 
T. Root, V. Cantu, S. Viazis, J. K. Beal, A. M. Hardin,  
A. Clendenin, S. Lance, A. Green, B. Kissler, M. Wise,  
S. Bosch
Background: Shiga toxin-producing Escherichia coli 
(STEC) infections cause ~175,000 illnesses, 2,400 
hospitalizations, and 20 deaths annually in the United 
States. In February 2013, PulseNet, the national bacterial 
subtyping network for foodborne disease surveillance, 
identified a cluster of human infections with a previously 
unreported strain of STEC O121.
Methods: A case was defined as illness in a person 
infected with the STEC O121 outbreak strain determined 
by pulsed field-gel electrophoresis with illness onsets 
between 12/1/12–5/13/13. We collected information on 
patients’ exposures using questionnaires and open-ended 
iterative interviews. Public health and regulatory agencies 
collaborated to culture leftover foods and conduct 
traceback investigations.
Results: We identified 35 cases in 19 states. Illness onsets 
ranged from 12/30/12–4/15/13. The median patient age 
was 17 years (range: 1–75 years); 60% were female. Among 
29 patients with available information, 9 (31%) were 
hospitalized. Twenty-four (100%) of 24 patients reported 
eating multiple frozen foods in the week before illness; 
13/19 (68%) ate Brand A frozen snack foods produced at 
a single facility. The outbreak strain was isolated from two 
leftover Brand A heat-treated, not-fully-cooked frozen 
foods collected from patients’ homes in New York and 
Texas, leading to recalls totaling >10.5 million pounds of 
frozen snack foods. FDA investigated common ingredients, 
including flour, but did not identify the outbreak strain at 
the snack food or flour production facilities. 
Conclusions: A novel vehicle for STEC O121, frozen 
snack foods, was identified using an open-ended iterative 
interviewing approach combined with targeted product 
testing. Public health and regulatory collaborations were 
key to identifying the outbreak vehicle, resulting in multiple 
recalls, and preventing further illness. Food manufacturers 
should consider flour as a potential STEC source.
CONCURRENT SESSION F2: Occupational Safety and Health
3:00–5:05pm
Dunwoody Suite
Moderator: RADM Boris Lushniak, Acting Surgeon General  
  of the United States
3:05 aNalySIS OF INjurIeS aND IllNeSSeS amONg amerIcaN reD crOSS® reSpONDerS —  
uNIteD StateS, 2008–2012
Authors: Kimberly Brinker, C.A. Head, C.Y. Johnson,  
R. Funk
Background: Occupational injury and illness rates for 
responders are not well documented and are difficult 
to compare with rates for full-time workers; rates for 
volunteers are unknown. Such injuries and illnesses, 
however, are preventable and should be a focus of 
responder organizations. In recent years, the American 
Red Cross (ARC) noted health concerns among 
responders and developed a staff wellness program to 
collect health data. We sought to identify risk factors for 
occupational injuries and illnesses during disasters and to 
make recommendations. 
Methods: We analyzed data collected by ARC during 
2008–2012 to estimate injury and illness rates by several 
variables, including disaster relief operation (DRO) level, 
which indicates operational costs (ranging from 3 [lower] 
to 5+ [higher]). We also calculated rates by disaster type, 
region, and year. We estimated injury and illness rate 
ratios (RRs) with 95% confidence intervals (CIs), using 
negative binomial regression.
Results: We analyzed 113 disasters. Hurricanes had the 
highest rates of injuries (14 per thousand responders) and 
illnesses (18 per thousand responders). In the adjusted 
model for injuries, RRs were higher for DRO levels 4 (3.6 
[CI, 2.0–6.7]) and 5+ (4.9 [CI, 2.2–11.0]) than for level 3. 
In the adjusted model for illnesses, RRs also were higher 
for DRO levels 4 (4.4 [CI, 2.6–7.3]) and 5+ (8.6 [CI, 
4.1–17.7]) than for level 3. 
Conclusions: Higher DRO levels were a significant 
predictor of greater rates of occupational injuries and 
illnesses. DRO level may be a proxy for other factors such 
as multiple or longer deployments, larger numbers of 
responders, and austerity of conditions. Careful selection 
of responders, including volunteers, is warranted for 






3:25 OccupatIONal hazarDOuS SuBStaNce expOSure SurveIllaNce uSINg pOISON ceNter Data 
— WIScONSIN, 2004–2012
Authors: Jon Meiman, C. Tomasallo, H. Anderson
Background: Occupational hazardous substance 
exposures (HSEs) cause worker injury and lost 
productivity; in 2011, in the United States, 12,640 
exposures to chemicals resulted in >80,000 lost work-
days. The Wisconsin Division of Public Health has 
no system for tracking worker HSEs. We evaluated 
Wisconsin Poison Center (WPC) data as a potential 
occupational HSE surveillance system.
Methods: A total of 482,286 HSEs were reported to WPC 
during 2004–2012. We abstracted case summaries from 
the Wisconsin Public Health Information Network coded 
as occupation-related by WPC. We defined a case as an 
unintentional hazardous substance(s) exposure occurring 
in the workplace, excluding food or drugs. Data were 
examined for timeliness and completeness.
Results: During 2004–2012, a total of 8,039 occupational 
HSEs met the case definition; 5,210 (65%) were among 
men; median age was 33 (range: 16–88) years. HSE 
information was available <24 hours after exposure. 
Chemical type and outcome information were missing in 
7.2% and 10.6% of cases, respectively. Of cases missing 
the chemical type, 0.8% had unknown outcomes. Specific 
industry and occupation data were unavailable. The most 
frequent HSEs were carbon monoxide (327 cases; 4.1%), 
alkali (315 cases; 3.9%), and chlorine gas (294 cases; 
3.7%). A total of 3,626 cases (45%) among 3,283 persons 
required medical evaluation; 104 (1.3%) and 77 (1.0%) 
cases resulted in hospital and critical care unit admission, 
respectively. Nine deaths (median age: 43 years) (100% 
male) resulted from HSEs: hydrogen sulfide (6), carbon 
monoxide (1), toluene (1), and alkali (1).
Conclusions: Poison center data is a novel and timely 
data source for occupational HSE surveillance. Although 
data are incomplete, they can be used to guide workplace 
safety education and improve regulatory oversight.
3:45 kNOWleDge, attItuDeS, aND practIceS regarDINg aNtImalarIal chemOprOphylaxIS IN 
peace cOrpS vOluNteerS — aFrIca, 2013 
Authors: Keren Z. Landman, K. Tan, P. Arguin
Background: Falciparum malaria is a fatal disease for 
which long-term travelers to endemic areas are at high 
risk. However, infection can be prevented with malaria 
chemoprophylaxis. In 2013, a Peace Corps Volunteer 
(PCV) who stopped chemoprophylaxis died of malaria. 
Concurrently, the Peace Corps noted an increase in 
severe malaria among PCVs. We investigated PCVs’ 
and Peace Corps medical officers’ knowledge, attitudes, 
and practices regarding chemoprophylaxis to develop 
recommendations to improve adherence.
Methods: We administered internet-based surveys 
assessing knowledge about, experience with, and 
perceptions of malaria and chemoprophylaxis to PCVs 
and medical officers August 19–September 30, 2013. 
Adherence was defined as missing no doses of prescribed 
malaria chemoprophylaxis (mefloquine, doxycycline, 
or atovaquone-proguanil). Survey data were analyzed 
to identify programmatic deficiencies amenable to 
interventions for improvement.
Results: Of 1,184 PCVs responding, 545 (55%) reported 
adherence. Adherence was highest among those 
taking atovaquone-proguanil (n=108, 86%). The most 
common reasons for non-adherence were forgetting to 
take chemoprophylaxis (n=706, 60%), usually during 
in-country travel (n=368, 52%); fear of long-term side 
effects (n=469, 40%); and current side effects (n=524, 
49%), most commonly associated with mefloquine. Two 
hundred seventy-nine (24%) PCVs were not worried 
about malaria, mostly because they believed malaria was 
a minor illness easily cured without consequence (n=239, 
86%). Of 47 medical officers responding, 44 (94%) 
appropriately indicated that known side effects were 
important reasons for changing chemoprophylaxis.
Conclusions: Our survey found low adherence and 
high perception of long-term side effect risk among 
PCVs. Adherence might be improved by implementing 
reminder strategies, increasing education about 
chemoprophylaxis safety and malaria risk, and promoting 
prompt management of chemoprophylaxis side effects. 






4:05 BIgger IS Better: aBNOrmal luNg FuNctION aND cOal WOrkerS’ pNeumOcONIOSIS By 
mINe SIze amONg actIve uNDergrOuND cOal mINerS — uNIteD StateS, 2005–2012
Authors: David J. Blackley, C. Halldin, M-L. Wang,  
A. Laney
Background: Inhalation of coal mine dust (CMD) 
causes coal workers’ pneumoconiosis (CWP) and other 
diseases affecting lung function. The prevalence of CWP 
among coal miners has increased two-fold since the late-
1990s. Previously, small mine size (<50 employees) was 
associated with increased risk of CWP. It is unclear how 
mine size affects lung function. We characterized the 
prevalence of lung function impairment and CWP by 
mine size among underground coal miners. 
Methods: During 2005–2012, miners received lung 
function tests (spirometry) and chest radiography at a 
NIOSH mobile unit. Spirometry and radiography were 
interpreted using U.S. and international standards, 
respectively. We used log-binomial regression to estimate 
risk of abnormal spirometry and CWP among those from 
small mines, compared to large mines. 
Results: We analyzed data from 6690 miners. Those 
from small mines were more likely to have abnormal 
spirometry (16.3% vs. 11.8%, P<.01), CWP (9.3% vs. 
3.3%, P<.01), and the severe form of CWP, progressive 
massive fibrosis (2.0% vs. 0.6%, P<.01). Working in 
small mines was associated with 1.4 times higher risk of 
abnormal spirometry (CI: 1.22–1.65, job tenure, BMI, 
and smoking adjusted), and 2.9 times higher risk of CWP 
(CI: 2.29–3.58, tenure and smoking adjusted). 
Conclusions: Most of these miners worked exclusively 
under dust regulations implemented in 1970 to protect 
health, yet 15.7% had abnormal spirometry, CWP or 
both. A higher burden of disease was observed among 
small mine workers. Environmental and/or work-
practice differences between small and large mines could 
influence exposure characteristics. Workers in small 
mines may engage in more job tasks at risk for exposure 
to CMD. Factors influencing the higher prevalence of 
respiratory disease in small mines should be identified.
4:25 BlOWINg IN the WIND: cOccIDIOIDOmycOSIS amONg SOlar pOWer Farm cONStructION 
WOrkerS — calIFOrNIa, 2011–2013
Authors: Jason A. Wilken, G. Sondermeyer,  
D. Shusterman, J. McNary, A. McDowell, P. Borenstein, 
D. Vugia, D. Gilliss, B. Ancock, J. Prudhomme, D. Gold, 
G. Windham, L. Lee, B. Robinson, B. Materna
Background: Coccidioidomycosis, endemic in 
California, is associated with soil disturbances. Physician 
occupational illness reports identified coccidioidomycosis 
among employees constructing 2 solar power-generating 
facilities in San Luis Obispo County (SLO). We 
investigated confirmed cases to recommend preventive 
measures.
Methods: A case was defined as clinical- and laboratory-
confirmed coccidioidomycosis in an employee of either 
solar farm after August 2011 and before symptom onset. 
Patients were interviewed for demographics, missed 
work days, daily work activities, and protective practices. 
Hazard ratios for time from employment to symptom 
onset, adjusted for smoking (aHR), were calculated 
by Cox proportional hazards regression. Incidence 
rate (IR)/100,000 population/year was calculated for 1 
employer and compared with the SLO IR.
Results: Of 43 patients, 40 were male and 10 Hispanic; 
ages ranged from 21 to 63 (median: 47) years. Nine 
(21%) were hospitalized. Of 42 interviewed, 34 (81%) 
had missed work (1–547 days; median: 22). The most 
common occupations were electrician (13), heavy 
equipment operator (10), and laborer (6). Twenty-one 
performed soil-disruptive work daily; of these, 6 always 
used respiratory protection. Fourteen never performed 
soil-disruptive work. Thirty reported dusty conditions 
all or the majority of days. Shorter time to symptom 
onset was associated with performing soil-disruptive 
work daily (aHR: 4.15; 95% confidence interval [CI]: 
1.61–10.67). For 1 employer with 29 patients, IR was 
5,342/100,000/year, 139 (95% CI: 86–226) times the SLO 
IR of 38/100,000/year.
Conclusions: Risk for coccidioidomycosis was not 
limited to employees performing soil-disruptive work at 
the solar farms; however, daily soil-disruptive work was 
associated with earlier illness onset. We recommended 
further limiting dust generation and ensuring access to 
respiratory protection for all employees, practices the 






4:45 IS greeN eNergy gOOD FOr WOrkerS? aN evaluatION OF expOSure aND health at a 
WINDBlaDe maNuFacturINg FacIlIty — NOrth DakOta, 2013
Authors: Anna-Binney McCague, U. Alwis, B. Blount
Background: Ninety thousand workers in the United 
States are potentially exposed to styrene, which may 
lead to visual changes and respiratory disease. The 
manufacture of power-generating windlblades utilizes 
multiple styrene-containing products, but the risk to 
these workers is unknown. Our aim was to assess the 
relationship between styrene exposures and health among 
workers in a windblade manufacturing facility.
Methods: We interviewed 355 workers about their health 
history, symptoms, and jobs. We tested spirometry, color 
vision, and visual contrast. We collected end-of-shift 
urine samples and assayed for the styrene metabolites 
mandelic acid (MA), phenylglyoxylic acid (PGA), 
and N-acetyl-S-(1-phenyl-2-hydroxyethyl-L-cysteine 
+ N-acetyl-S-(2-phenyl-2-hydroxyethyl)-L-cysteine 
(PHEMA), using ultra-high-performance liquid 
chromatography coupled with electrospray ionization 
triple-quadrupole mass spectrometry. 
Results: Preliminary results indicate that mean biomarker 
levels (mg/g creatinine) of 37.2 MA, 29.6 PGA, and 0.29 
PHEMA were above the averages seen in the general 
population (0.36, 0.27, 0.001 respectively). The mean 
biomarker level (MA + PGA) among all workers was 
66.8 mg/g creatinine, below the biologic exposure index 
(BEI) of 400 mg/g creatinine. Though there was an excess 
of color blindness (n = 56; expected 22), there was no 
correlation with biomarkers. Spirometry outcomes and 
respiratory symptoms also did not correlate. Decreased 
visual contrast significantly correlated with log-
transformed biomarkers at medium spatial frequencies (p 
<.05).
Conclusions: Using a biological index of acute exposure, 
only visual contrast was associated with styrene exposure. 
Yet the high prevalence of color vision abnormalities 
remains unexplained. The healthy worker effect or 
cumulative exposures may be obscuring styrene’s impact 
on color vision and respiratory outcomes. Alternatively, 
the BEI may protect workers from respiratory disease but 
not from decreased contrast. Further exploration may 
clarify exposure risks in this population.








Wednesday, April 30, 2014
cONcurreNt SeSSION g1: vectOrBOrNe aND paraSItIc DISeaSeS
8:30–10:15am
Ravinia Ballroom
Moderators: Mark Eberhard and Kay Tomashek
8:35  FIrSt chIkuNguNya OutBreak IN mIcrONeSIa — yap State, FeDerateD StateS OF 
mIcrONeSIa, 2013
Authors: Daniel M. Pastula, H. Biggs, W. Hancock, M. 
Bel, M. Marfel, R. Lanciotti, A. Panella, T. Chen,  
J. Staples, M. Fischer, S. Hills.
Background: Chikungunya virus is a mosquito-borne 
alphavirus that can cause large outbreaks with fever and, 
often severe, polyarthralgia. In October 2013, laboratory-
confirmed chikungunya cases were identified among Yap 
residents, the first local transmission of chikungunya 
virus in Micronesia. We describe the preliminary 
epidemiological findings of this ongoing outbreak. 
Methods: We defined a case as a Yap resident who 
presented to a health care facility with acute onset of fever 
and arthralgia or arthritis on or after August 11 (onset 
date of first laboratory-confirmed case). Demographic 
and clinical data were collected at initial presentation 
using standard forms. We described continuous variables 
using median and range, and categorical variables using 
frequencies and proportions. We used Chi-squared tests 
to examine risk factors for severe disease.
Results: As of November 26th, 991 cases were reported 
from Yap (population 11,376) for an attack rate of 87 
per 1000. The outbreak initially was focused in the 
northeast but spread throughout the main islands and to 
three outer islands. Nine hundred nineteen (93%) cases 
had onset in 6 weeks from October 15‒November 26. 
Median age was 31 years (range: <1‒92) and 487 (49%) 
patients were male. Thirty-two of 846 (4%) patients were 
hospitalized; no deaths were reported. Patients aged ≥50 
years were more likely to have arthritis (15/156; 10% vs. 
24/558; 4%, P <.01) and be hospitalized (14/182; 8% vs. 
18/661; 3%, P <.01). 
Conclusions: The chikungunya outbreak in Yap has 
resulted in a high attack rate and rapid geographical 
spread. Active surveillance, public education on 
protection from mosquitoes, and vector control are 
needed to limit the impact of the ongoing outbreak and 








8:55  DeNgue OutBreak — mOmBaSa, keNya, 2013
Authors: Esther M. Ellis, J. Neatherlin, A. Mohamed,  
B. Fields, O. Mogeni, S. Patta, M. Delorey,  
B. Torres-Velasquez, H. Margolis, K. Tomashek,  
J. Montgomery
Background: Dengue is endemic in Africa where an 
estimated 64 million dengue virus (DENV) infections 
occurred in 2010. Few outbreaks have been reported 
from East Africa since dengue was first detected in 
the late 1800s. Following detection of an outbreak 
in Mombasa, Kenya in mid-2013, an investigation 
was conducted to determine the incidence of DENV 
infection.
Methods: A stratified multistage sample of households 
was selected from the Tudor community in Mombasa 
where recent dengue was reported. Household residents 
were asked to provide blood specimens and medical 
and travel histories. Blood was tested for anti-DENV 
IgM antibodies and DENV by RT-PCR. Sample-based 
estimates incorporated probabilities for selection of 
households and standard errors used a finite population 
correction. 
Results: Of 1,489 persons interviewed from 720 
households, 194 (13%) had evidence of current (n = 93) 
or recent (n = 101) DENV infection, with a sample-based 
estimate of 12% (95% CI: 9–14). Of 194 DENV positive 
participants, 83 (43%) reported an acute febrile illness 
in the past month; three (4%) were hospitalized and two 
(2%) had bleeding manifestations. DENV-1 (n = 46), 
DENV-2 (n = 45) and DENV-1/2 co-infections (n = 2) 
were detected. Risk factors for infection included travel 
out of Kenya in the last six months (P = .02), having 
mosquito breeding containers in the yard (P = .04), and 
having a febrile household member in the last month 
(P<.001).
Conclusions: Our investigation documented the only 
dengue outbreak in Mombasa since 1982 and the first of 
four reported outbreaks in sub-Saharan Africa in 2013. 
Initiatives to enhance dengue surveillance and clinical 
and public awareness are ongoing to reduce risk of 
infection and improve medical outcomes.
9:15  FactOrS aSSOcIateD WIth DeNgue mOrtalIty — puertO rIcO, 2010
Authors: Dana L. Thomas, J. Pérez-Padilla,  
B. Torres-Velasquez, A. Rivera, B.J. Biggerstaff, T. Sharp, 
D. Arguello, H.S. Margolis, K.M. Tomashek
Background: Dengue, a potentially fatal acute febrile 
illness, is endemic in Puerto Rico. In 2010 an epidemic 
occurred in which >26,000 suspected cases and 39 
laboratory positive fatal cases (1 death per 100,000 
residents) were reported. Most studies compare fatal 
dengue cases to non-severe cases, potentially biasing 
results. To improve specificity of factors associated with 
mortality, we compared fatal dengue cases to survivors of 
severe dengue.
Methods: All hospitalized, laboratory-positive dengue 
case-patients reported to the passive surveillance system 
in 2010 were included in a two-stage, stratified random 
sample. Fatal cases (cases) were matched 1:1–4 by final 
admitting hospital and age to available non-fatal severe 
dengue cases (controls). Severe dengue was defined using 
current WHO classification including severe plasma 
leakage, hemorrhage or organ failure. Conditional logistic 
regression, parametric and non-parametric analyses were 
performed using STATA and R to evaluate differences in 
effect sizes. 
Results: Among 31 cases and 72 controls, all age 
groups were represented and no gender differences 
were seen. Cases were more likely than controls to have 
comorbidities (odds ratio [OR] 4.6; 95% confidence 
interval [CI] 1.4–14.4) with diabetes, pulmonary, 
rheumatologic, and mental health diseases being most 
prevalent. Controls were more likely than cases to 
be admitted at initial presentation (OR 2.5; 95% CI 
1.0–7.0); median duration of their hospitalization was 
twice as long as cases (4 vs 2 days; p<0.01). Nonetheless, 
nosocomial infections were more frequent among cases 
(OR 10.2; 95% CI 2.0–52.5).
Conclusions: Delayed hospital admission of severe 
dengue patients, especially those with pre-existing 
comorbidities, was associated with mortality during the 
2010 epidemic in Puerto Rico. Aligning clinician dengue 
management practices with current practice guidelines 
may be the most effective countermeasure.








9:35 atOvaquONe-prOguaNIl-reSIStaNt malarIa IN tWO travelerS returNINg FrOm the Same 
SIte — NIgerIa, 2012–2013
Authors: Mateusz M. Plucinski, C.S. Huber, S. Akinyi,  
W. Dalton, M. Eschete, K. Grady, L. Flannery,  
B.A. Mathison, V. Udhayakumar, P. Arguin, J.W. Barnwell
Background: Atovaquone-proguanil (AP) is the most 
common treatment for uncomplicated malaria in the 
U.S.. Although generally highly effective, there have been 
sporadic reports of AP treatment failures in Plasmodium 
falciparum malaria infections, generally associated 
with mutations in the cytb gene. Atovaquone-proguanil 
treatment failures in two returning travelers were 
reported at a Louisiana hospital 7 months apart; they had 
stayed in the same compound in Rivers State, Nigeria, 
suggesting the possibility of transmission of AP-resistant 
strains.
Methods: The two travelers were interviewed and 
medical records were reviewed. We genotyped parasites 
using microsatellite genotyping and sequenced the entire 
mitochondrial genome from pretreatment (day 0) and 
day of failure (day 34) samples from both patients. We 
analyzed day 0 and day of failure samples for the presence 
of mutations in the genes encoding the molecular targets 
for atovaquone and proguanil.
Results: Case interviews confirmed that both travelers, 
non-compliant on their doxycycline prophylaxis, likely 
contracted the infections in the same compound in 
Nigeria. Review of medical records confirmed adequate 
treatment dosing of AP. Molecular analysis showed that 
the travelers had unrelated parasite genotypes and had 
different day 0 mitochondrial genomes. On day 0, both 
travelers had proguanil-resistant genotypes but wild-
type, atovaquone-sensitive, cytb sequences. Day of failure 
samples exhibited mutations in cytb for both travelers, 
including a previously unreported mutation in one 
traveler.
Conclusions: Despite the two infections likely having 
been contracted in the same site in Nigeria, genetic 
analysis showed that the infections were unrelated. 
The mutations may have arisen independently during 
treatment. Our results highlight the importance of 
investigating unusual instances of imported malaria, 
including genotyping parasites and sequencing genes 
associated with antimalarial resistance to guide CDC 
recommendations.
9:55 prevaleNce OF strongyloidEs stErcoralis aNtIBODIeS amONg a rural appalachIaN 
pOpulatION — keNtucky, 2013
Authors: Elizabeth S. Russell, E. Bosserman, R. Marshall, 
S. Davis, A. Beaudoin, S. Handali, I. Mcauliffe,  
D. Woodhall
Background: Studies from the early 1980’s indicated that 
Rural Appalachia had a high prevalence of Strongyloides 
stercoralis infection. Infection is often asymptomatic but 
can last for decades, causing serious systemic disease 
in immunosuppressed patients, or stunted growth and 
delayed cognitive development in children. Infection 
occurs when larvae penetrates skin exposed to stool-
contaminated soil. We investigated S. stercoralis antibody 
prevalence and risk factors among Remote Area Medical 
(RAM) clinic patients in Appalachian Kentucky.
Methods: We conducted a cross-sectional study; 
all persons presenting to 2 eastern Kentucky RAM 
clinics, which provide free dental, vision, and medical 
services, during 2 weekend clinics were asked to provide 
demographics, international travel, and their home 
plumbing system information collected on a paper-based 
survey. Serum was collected for S. stercoralis antibody 
testing. Fisher’s exact and t-tests were used to analyze 
dichotomous and continuous risk factors, respectively.
Results: Among 1,584 RAM clinic patients, 384 (24%) 
participated. Seven of 379 (1.8%) with adequate 
laboratory samples were antibody-positive (patients 
aged: 21–69 years). We found no statistically significant 
difference in reported travel to a suspected S. stercoralis-
endemic country (12% among antibody-negative 
patients, 14% among antibody-positive patients; P = 
0.58), reported outdoor toilet use (2.2%, 14%; P = 0.16), 
or age (P = 0.46).
Conclusions: The lack of a significant association 
between antibody-positivity and travel and the wide 
positive-participant age range indicate these infections 
might have originated from within Kentucky. Studies 
including stool sample testing for current infection 
should be conducted, as should educational campaigns 
to diagnose and treat infection and prevent further 












8:35 ScaBIeS aND BacterIal SuperINFectION amONg chIlDreN — amerIcaN SamOa, 2011
Authors: Laura S. Edison, A. Beaudoin, C.E. Introcaso,  
L. Goh, C. Van Beneden
Background: Scabies, a highly pruritic and contagious 
mite infestation of the skin, is endemic in tropical 
regions. Delayed treatment can lead to bacterial 
superinfection, and treatment of close contacts is 
necessary to prevent reinfestation. We described 
scabies incidence and superinfection among children 
in American Samoa (AS) to support scabies control 
recommendations.
Methods: We reviewed 2011 pharmacy records from 
the only AS pharmacy to identify children aged ≤14 
years with filled prescriptions for permethrin, the only 
scabicide available. Identified children’s medical records 
were reviewed for physician-diagnosed scabies during 
January 1–December 31, 2011. We calculated scabies 
incidence, bacterial superinfection prevalence, and 
reinfestation prevalence during 14 days–12 months 
after first diagnosis. We used log binomial regression to 
calculate incidence ratios (IRs) for scabies by age.
Results: Medical record review identified 613 children 
with scabies (incidence: 31.6/1,000 children ≤14 years); 
358 (58.4%) were male; 353 (57.6%) had a bacterial 
superinfection, and 94 (15.3%) had ≥1 reinfestation. 
Scabies incidence varied significantly among the 9 main 
island counties (range: 14.8–48.9/1,000). Children aged 
<1 year had the highest incidence (100.2/1,000). Children 
aged 0–4 years (incidence: 54.5/1,000; IR: 5.1; CI: 
4.0–6.5) and 5–9 years (incidence: 27.7/1,000; IR: 2.4; CI: 
1.9–3.2) had a significantly higher scabies incidence than 
children aged 10–14 years (incidence: 11.5/1,000).
Conclusions: Investigating why certain AS counties 
have a lower scabies incidence can help support 
recommendations for improving scabies control in 
counties with a higher incidence. The high prevalence 
of bacterial superinfection and frequent reinfestations 
highlight the importance of diagnosing and treating 
patients and their close contacts at the first signs of 
infection. Interventions targeting infants and young 
children who have frequent close family contact should 
be considered.








8:55 FuNgal SeNSItIzatION NOt aSSOcIateD WIth pOOr OutcOmeS IN chIlDreN WIth aSthma: 
Data FrOm the 2005–2006 NatIONal health aND NutrItION examINatION Survey
Authors: Kenneth B. Quinto, K. Schoendorf, S. Lukacs,  
L. Akinbami
Background: Sensitization to fungal allergens is 
associated with severe asthma. Poor asthma outcomes 
impair quality of life for children and their families. 
We examined the association between poor asthma 
outcomes and sensitization to fungal allergens versus 
other aeroallergens in a nationally representative sample 
of children with asthma.
Methods: Using 2005–2006 National Health and 
Nutrition Examination Survey data for 349 children 
ages 6–19 years with asthma, we defined sensitization 
as immunoglobulin E antibody ≥0.35 kU/L for 
15 aeroallergens including two fungi Aspergillus 
and Alternaria. Children were characterized into 
three mutually exclusive groups: sensitization to 
fungi, regardless of other aeroallergen sensitization; 
sensitization to common aeroallergens with no fungal 
sensitization; no sensitization. Outcomes from wheezing 
included reported sleep disturbance, limited activity, 
missed school days, ≥1 asthma attack, and emergency 
department or urgent care (ED/UC) visit within 
12 months. For each outcome, multivariate logistic 
regression models (SUDAAN software) adjusted for 
gender, age, race, and income.
Results: 30.2% of children with asthma were sensitized 
to fungi, 26.5% to non fungal aeroallergens, and 43.4% 
to no allergens. Children with fungal sensitization did 
not have worse asthma outcomes than those without 
aeroallergen sensitization (e.g., asthma attacks adjusted 
odds ratio [aOR]: 1.1; 95% confidence interval [CI]: 0.4–
2.8). However, sensitization to non fungal aeroallergens 
increased odds of ED/UC asthma visit (aOR: 2.62; 95% CI: 
1.0–6.6) and disturbed sleep (aOR: 2.59; 95% CI: 1.6–6.5).
Conclusions: Past studies suggest that severe asthma 
is associated with fungal sensitization. We found 
fungal sensitization was not associated with poor 
asthma outcomes. Sensitization to other aeroallergens 
was associated with worse outcome, however. Fungal 
sensitization may not universally identify children at risk 
for poor asthma outcomes.
9:15 prevaleNce aND cOrrelateS OF OverWeIght aND OBeSIty amONg 5th graDerS — maINe 
INtegrateD yOuth health Survey, 2009
Authors: Leigh Ann Miller, S.L. Huston, S. Park,  
T.A. Garrett
Background: Childhood obesity is associated with 
adverse health outcomes. However, data are limited 
regarding associations between health behaviors and 
childhood obesity among Maine children. We analyzed 
data from the 2009 Maine Integrated Youth Health 
Survey (MIYHS) to characterize prevalence and 
correlates of childhood overweight and obesity.
Methods: MIYHS collects data from public school 
5th graders on self-reported behaviors and calculates 
body mass index (BMI) from measured height and 
weight. Data were weighted and analyzed for complex 
survey design. We determined prevalence of each 
BMI category per CDC age- and sex-specific growth 
charts: underweight (<5th percentile), normal weight 
(5th–<85th), overweight (85th–<95th), and obese (≥95th). 
We determined prevalence of 4 health-related behaviors: 
fruit and vegetable intake, sugar-sweetened beverage 
(SSB) intake, physical activity, and television viewing. We 
used multivariate logistic regression to estimate adjusted 
odds ratios (aORs) and 95% confidence intervals (CIs), 
controlling for sex, race, and bullying status (as a proxy 
for mental health status).
Results: Among 2,986 students with complete data, 7% 
were underweight, 53% normal weight, 17% overweight, 
and 23% obese. On a per-day basis, 28% reported 
consuming fruits/vegetables ≥5 times, 23% consuming 
no SSBs, 72% watching television ≤2 hours, and 25% 
reporting ≥1 hour physical activity; only 2% reported all 
4 optimal behaviors. In multivariate analysis, watching 
television >2 hours/day was the only variable associated 
with overweight (aOR: 1.5; CI: 1.1–1.9) or obesity (aOR: 
1.6; CI: 1.3–2.0).
Conclusions: Overweight and obesity are common 
among Maine 5th graders. Targeted interventions, 
including school-based interventions, might be helpful 
ways to improve dietary and physical activity behaviors. 
Our findings can shape intervention efforts for 








9:35 WIllINgNeSS tO pay FOr mIcrONutrIeNt pOWDer SupplemeNtS FOr chIlDreN —  
Nepal, 2011
Authors: Rajni Gunnala, C. Perrine, G. Subedi,  
S. Mebrahtu, P. Dahal, M. Jefferds
Background: Home fortification with micronutrient 
powders (MNP) has been implemented in several 
Nepali districts to combat the high burden of childhood 
micronutrient deficiencies. A 2011 pilot project gave 
free MNP to children aged 6–23 months. We describe 
willingness to pay (WTP) for MNP and pricing attitudes 
to explore potential for parental purchase of MNP for 
older vulnerable children aged 2–5 years. 
Methods: Surveys representative of children aged 6–23 
months were conducted in 2 Nepali districts 3 months 
after pilot implementation. Caretakers were asked about 
their WTP for MNP for children aged 2–5 years and 
attitude about a suggested price (150 Nepali Rupees/6 
month supply, ~U.S.$2.10). Chi-square testing assessed 
WTP and price attitudes by demographics and WTP by 
MNP intervention exposure and MNP knowledge. 
Results: Of caretakers surveyed (n = 731), 78% expressed 
WTP for MNP, and 66% had positive attitudes toward 
the suggested price. WTP and positive price attitude 
were associated with higher wealth quintiles and higher 
maternal education. Urban residence was associated 
with positive pricing attitude. Those with exposure to 
educational or printed materials about MNP during 
intervention were more likely to show WTP than those 
who had not (83.3% vs. 73.5% and 85.2% vs. 75.6% 
respectively; both P =.02). Those who reported awareness 
of barriers to MNP use were less likely to report WTP 
than those with none (66.3% vs. 92.4%; P <.01).
Conclusions: WTP and positive price attitude indicate 
potential for parental purchase of MNP for children aged 
2–5 years in Nepal. Studies have demonstrated MNP 
can improve deficiencies and decrease morbidity in this 
age group. Further studies can determine if stated WTP 
translates into actual purchase.
9:55 aDOleSceNt SuBStaNce uSe aND the aSSOcIatION WIth a SchOOl-BaSeD SOcIOecONOmIc 
meaSure — WaShINgtON State, 2012
Authors: Mandy Stahre, L. Bensley, J. VanEenwyk,  
N. Kuiper
Background: National data indicate approximately 
half of all high school students report current 
addictive substance use. Results are mixed on whether 
neighborhood socioeconomic status influences 
adolescent substance use. Certain characteristics of 
schools might be associated with increases in substance 
use. Better understanding of this association might help 
communities and schools prioritize substance abuse 
prevention programs.
Methods: Using data from the 2012 Washington State 
Healthy Youth Survey (a biennial school-based survey 
of health behaviors of 6th, 8th, 10th, and 12th graders), we 
compared rates of alcohol, cigarette, and nonmedical 
prescription opioid use with the proportions of students 
eligible at each school for free or reduced price lunches 
(FRPL). For 10th graders, we assessed accessibility of 
each substance and associations of FRPL eligibility 
proportions by using logistic regression adjusted for 
sex and race/ethnicity. All analyses used SUDAAN® to 
account for clustering of students by school.
Results: Substance use prevalence increased with grade 
across substances, the largest for alcohol increasing from 
3% among 6th graders to 37% among 12th graders. As 
FRPL eligibility proportions increased, so did substance 
use prevalence within grades. The most common ways 
10th graders obtained each substance were cigarettes, 
borrowed (33%) or gave someone money to buy (28%); 
alcohol, received from an older friend or sibling (36%) 
or drank at a family celebration with parent’s permission 
(21%); and prescription opioids, obtained from a friend 
(31%) or used own prescription (26%). Accessibility to 
substances was not associated with school-based FRPL 
proportions.
Conclusions: Substance use, but not how they obtained 
substances, increased with higher proportions of students 
being FRPL-eligible, which highlights the need for 
increased focus of evidence-based strategies to prevent 
youth initiation in low-income communities.
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10:50 meaSleS pOSt-campaIgN vaccINatION cOverage — equateur aND prOvINce OrIeNtale, 
DemOcratIc repuBlIc OF the cONgO, 2013
Authors: Jennifer B. Harris, R. Obama, T. Coulibaly,  
A. Diaha, J. Ngo Ndjan, M. Alleman, K. Kretsinger
Background: Measles remains a leading cause of child 
mortality despite declining global incidence. In the 
Democratic Republic of the Congo, all 9-month old 
children should receive measles-containing vaccine 
(MCV). Suboptimal vaccination resulted in an outbreak 
of >300,000 suspected cases during 2010–2013. The 
Ministry of Health conducted localized outbreak 
response immunization and is implementing phased 
vaccination campaigns nationwide, targeting all children 
6 months–9 years old. The campaigns started in October 
2013 in the provinces with the largest outbreaks, 
Equateur and Province Orientale. We conducted a post-
campaign vaccination coverage survey. 
Methods: We selected 30 clusters per district in these 
provinces’ 12 districts using probability proportional 
to size sampling and 10 households per cluster 
following World Health Organization cluster survey 
recommendations. We interviewed parents of all 
campaign-eligible children to ascertain receipt of MCV 
before and during the campaign. One child per age 
group (<1 year, 1–4 years, 5–9 years) per household was 
randomly selected for analysis. We estimated vaccination 
coverage and 95% confidence intervals (CI), accounting 
for clustering and age-stratum weights. 
Results: We surveyed 11,650 children from 3613 
households. Province-level campaign MCV coverage was 
96% (CI: 95%–97%) in Equateur and 96% (CI: 94%–97%) 
in Province Orientale. District-level estimates ranged 
from 89% (CI: 82%–93%) to 98% (CI: 95%–99%). Among 
one year-olds, 12% (CI: 9%–16%) in Equateur and 6% 
(CI: 4%–9%) in Province Orientale first received MCV 
through the campaign. 
Conclusions: High campaign MCV coverage should 
reduce measles transmission in these provinces. However, 
the proportion of one year-olds that first received MCV 
during the campaign highlights the need to strengthen 
routine immunization services and the importance of 








11:10 reaSONS FOr lOW INFlueNza vaccINatION cOverage amONg aDultS IN puertO rIcO, 
INFlueNza SeaSON, 2013–14
Authors: Carmen S. Arriola, M. Mercado-Crespo,  
B. Rivera, R. Serrano, N. Macklin, A. Rivera, C. Bish,  
S. Graitcer, M. Lacen, C. Bridges, E. Kennedy 
Background: Vaccination prevents influenza and its 
complications. Influenza vaccination coverage among 
adults in Puerto Rico (PR) is low compared to the 50 
U.S. states (17.2% vs. 36.2%). Little is known about 
Puerto Ricans’ attitudes and practices regarding influenza 
vaccination. Identifying influenza vaccination attitudes 
and practices is necessary to identify interventions to 
increase vaccination coverage. 
Methods: A random-digit-dialing telephone survey 
(50%/50% landline/cellphone) was conducted November 
19-25, 2013. Questions were asked about vaccine 
receipt and attitudes and practices regarding influenza 
vaccination. Data were weighted to reflect sampling 
design and adjustments for non-response. 
Results: The response rate was 53%; 232 surveys were 
completed. The respondents’ median age was 55.5 
years; 51 (22%) reported having received the 2013-14 
influenza vaccine. Among 177 adults who received 
medical care since July 2013, 40% (95% CI: 33-48%) 
were recommended and 18% (95% CI: 13-25%) offered 
influenza vaccination. Among 180 unvaccinated 
respondents, 52% (95% CI: 44-59%) believed they 
had “somewhat low or very low” chances of influenza 
illness; 52% (95% CI: 44-59%) responded that they “will 
probably or will definitely not get the vaccine”, with 
the most frequent reason cited as “safety/side effects 
concerns” (39%; 95% CI: 29-49%) followed by “not 
wanting or needing the vaccine” (32%; 95% CI: 23-43%). 
Conclusions: Physician practices (failure of providers to 
recommend and/or offer vaccine) and patient attitudes 
(low perceived risk of influenza virus infection) may have 
contributed to low vaccination rates during the 2013-
14 season. Providers and public health groups should 
strongly recommend influenza vaccination, provide these 
vaccinations or refer patients for vaccination, and educate 
patients on the risk of influenza illness.
11:30 DetectINg the reemergeNce OF WIlD pOlIOvIruS type 1 IN SyrIa thrOugh aN early 
WarNINg alert aND reSpONSe NetWOrk, july – OctOBer 2013 
Authors: Miriam L. Shiferaw, M. Al Saad, F. Husain,  
A. Ridpath, T. Handzel, M. Brennan, D. Ehrhardt
Background: Wild poliovirus (WPV) was last identified 
in Syria in 1999. Since the start of the conflict in March 
2011, routine polio vaccination coverage dropped from 
99% in 2011 to 65% in 2012. Communicable disease 
surveillance has also largely been disrupted. In response 
to gaps in surveillance coverage in opposition controlled 
areas of northern Syria (NS), the Assistance Coordination 
Unit established an Early Warning Alert and Response 
Network (EWARN) in July 2013 to detect 10 epidemic-
prone diseases, including polio. 
Methods: EWARN had two components: immediate 
reporting of alerts signaling potential outbreaks from 
communities and weekly reporting and epidemiological 
trend analysis of EWARN priority syndromes, including 
acute flaccid paralysis (AFP), from selected health 
facilities. District level surveillance officers in seven NS 
governorates investigated alerts and implemented initial 
response activities. Investigations of AFP cases included 
collection of two stool specimens, 24 hours apart, and 
transportation by reverse cold chain to a World Health 
Organization-accredited laboratory for poliovirus testing. 
Results: On October 5, the EWARN detected a cluster of 
22 AFP cases in Deir-ez-Zor governorate with onset of 
paralysis from August 23 to October 8; 21 (95.5%) had 
paralysis in one limb. Stool specimens were collected 
from three (13.6%) case-patients. Active conflict and 
population movement impeded investigation of other 
cases. WPV type 1 was isolated from all three case-
patients. The mean age of case-patients with polio was 29 
months (range: 22-36 months); all had incomplete polio 
vaccination (<3 doses).
Conclusions: The detection of WPV in Syria signifies a 
public health emergency and underscores the importance 
of EWARN implementation and strengthening in 
conflict settings. Enhanced AFP surveillance is needed in 
neighboring countries to detect and control further  
WPV spread. 








11:50 DIphtherIa OutBreak IN laO peOpleS DemOcratIc repuBlIc (pDr) 2012–2013: a 
FaIlure OF rOutINe ImmuNIzatION
Authors: Carolyn Sein, A. MacNeil, C. Soulaphy,  
P. Souliphone, R. Reyburn, A. Ramirez-Gonzalez,  
J.L. Goodson, M. Watkins, K. Wannemuehler, T.S.P. Tiwari
Background: As a result of increased coverage with 
diphtheria-tetanus-pertussis vaccine (DTP), global 
reported diphtheria cases decreased from 98,000 to 
4,489 during 1980–2012. Where population immunity 
is low, outbreaks can occur. We investigated a diphtheria 
outbreak in Lao PDR that began in April 2012. 
Methods: We reviewed diphtheria surveillance data 
reported from January 1, 2012–May 31, 2013. A 
diphtheria case was defined as a respiratory illness 
consisting of pharyngitis, tonsillitis, or laryngitis, and an 
adherent tonsillar, or nasopharyngeal pseudomembrane. 
To identify risk factors for diphtheria, we conducted a 
case-control study with two aged-matched neighborhood 
controls per case in Houaphan province, using bivariate 
analysis to calculate matched odds ratio (mOR) with 95% 
confidence intervals (CI). Reasons for non-vaccination 
among unvaccinated persons were assessed.
Results: During the study period, 62 cases and 12 deaths 
were reported in 7 of 17 provinces. Among case-patients, 
37 (60%) were 5–14 years old, 5(8%) had received 3 
DTP doses (DTP3), and 21 (34%) had received no DTP 
doses. Fifty-two (84%) cases were reported in Houaphan 
province. Among case-control enrollees, 5/42 (12%) cases 
and 20/79 (25%) controls had received DTP3 (mOR = 
0.4, CI = 0.1-1.7). Among 20 cases and 38 controls with 
no DTP dose, 43% of cases and 40% of controls had lack 
of access to routine immunization services, and 57% of 
cases and 60% of controls had a missed opportunity for 
vaccination at a clinic visit. 
Conclusions: Suboptimal DTP3 coverage likely 
contributed to the outbreak. Strengthening access to 
routine immunization services and reducing missed 
opportunities are needed to prevent future outbreaks. We 
also recommended a 3-round interim DTP campaign to 
raise population immunity.




10:50 mOther’S returN tO WOrk aND meetINg her 6-mONth BreaStFeeDINg INteNtION — 
uNIteD StateS, 2005–2007
Authors: Kelsey R. Mirkovic, C. Perrine, K. Scanlon,  
L. Grummer-Strawn
Background: Breastfeeding provides numerous health 
benefits for infants and mothers; however, many infants 
are not breastfed as long as recommended or desired by 
mother. Maternal employment has been cited as a barrier 
to breastfeeding. We assessed whether maternity leave 
duration and return-status (full-time [FT], part-time 
[PT]) were associated with not meeting intentions to 
breastfeed ≥6 months.
Methods: We used data from the Infant Feeding Practices 
Survey II, a cohort study. Analyses were limited to 
women employed prenatally who intended to breastfeed 
≥6 months (n = 963). We used multivariable logistic 
regression to assess the relationship between maternity 
leave duration and return-status (<6 weeks/FT, <6 weeks/
PT, 6–¬<12 weeks/FT, 6–<12 weeks/PT, ≥12 weeks–<6 
months/FT, ≥12 weeks–<6 months/PT, not working by 6 
months) and meeting 6-month breastfeeding intention.
Results: Forty-one percent of mothers did not meet 
their 6-month breastfeeding intention. Compared with 
mothers not working by 6 months, mothers who returned 
to work <6 weeks/FT had 5.44 times the odds (95% 
confidence interval [CI]: 2.64–11.20) of not meeting their 
intention. Odds of not meeting intentions were higher 
among mothers who returned anytime <6 months at FT 
or PT status (<6 weeks/PT adjusted odds ratio [aOR]: 
1.98, CI: 1.14–3.43; 6–<12 weeks/FT aOR: 2.64, CI: 
1.73–4.02; 6–<12 weeks/PT aOR: 1.56, CI: 1.00–2.44; 
12 weeks–<6 months/FT aOR: 3.45, CI: 2.10–5.64; ≥12 
weeks–<6 months/PT aOR: 1.80, CI: 1.02–3.18).
Conclusions: Returning to work before 6 months 
may reduce a mother’s ability to meet her intention to 
breastfeed for at least 6 months. Longer maternity leave 
and part-time return schedules may help more women 








11:10 treNDS IN geStatIONal WeIght gaIN: reSultS FrOm the pregNaNcy rISk aSSeSSmeNt 
mONItOrINg SyStem — 2000–2009
Authors: Jonetta L. Johnson, S. Farr, P. Dietz, A. Sharma, 
W. Barfield, C. Robbins
Background: Excessive and inadequate gestational 
weight gains (GWG) are associated with adverse 
maternal and infant outcomes. Although prevalence of 
prepregnancy obesity has increased, current trends in 
GWG are unknown. We estimate current population-
based trends of GWG.
Methods: We analyzed data from the Pregnancy Risk 
Assessment Monitoring System for 95,025 women who 
delivered live births in 14 states during 2000–2009. 
We modeled GWG in pounds, as a continuous and 
3-level categorical variable: inadequate, appropriate and 
excessive gain, according to 1990 Institute of Medicine 
(IOM) recommendations. We examined adjusted trends 
in mean GWG by using multivariable linear regression, 
and we examined inadequate or excessive GWG 
compared with appropriate GWG by using multivariable 
multinomial logistic regression.
Results: There was a 0.9 biennial percentage point 
increase in the percentage of women with excessive gain 
during 2000–2001 (43%) to 2008–2009 (46%) (P trend 
<.01). The percentage of women with appropriate gain 
decreased 1.1 percentage points biennially (2000–2001: 
38%; 2008–2009: 34%; P trend <.01). From 2000‒2001 
to 2008‒2009, the adjusted odds of excessive (odds 
ratio [OR]: 1.1; 95% confidence interval [CI]: 1.0–1.2) 
and inadequate gain (OR: 1.1; CI: 1.0–1.2) increased 
significantly. Mean GWG did not change during 2000–
2009.
Conclusions: Appropriate GWG decreased while mean 
GWG remained unchanged. This may be due to more 
women entering pregnancy overweight and obese, yet 
gaining outside their GWG guidelines. Compared with 
1990 guidelines, 2009 guidelines recommend less GWG 
for obese women. Thus, a higher percentage of women 
may have excessive GWG if current trends continue. 
Efforts are needed to develop and implement strategies to 
ensure that women enter pregnancy at a healthy weight 
and achieve recommended GWG.
11:30 vItamIN k DeFIcIeNcy BleeDINg IN INFaNtS NOt receIvINg vItamIN k prOphylaxIS — 
teNNeSSee, 2013
Authors: Lauren H. Marcewicz, J. Clayton, M. Maenner, 
E. Odom, E. Okoroh, A. Grant, A. Goodman,  
D. Christensen, J. Traylor, A. Miller, M. Warren
Background: Infants not receiving intramuscular 
vitamin K prophylaxis at birth are 81 times more likely 
than prophylaxed infants to develop vitamin K deficiency 
bleeding (VKDB), a severe coagulopathy. In 2013, five 
infants with VKDB presented to Hospital X in Tennessee; 
by parental choice, none had received vitamin K. A 
case-control study investigated additional risk factors 
for VKDB; structured interviews with parents assessed 
reasons for opting out of vitamin K. 
Methods: Our case definition included infants born 
in Tennessee in 2013 who presented at age 2-24 weeks 
with symptomatic hemorrhage and had laboratory 
confirmation of and no medical conditions predisposing 
to VKDB. Healthy control infants (n=12) were born 
in 2013 at a Nashville-area tertiary care center, did not 
receive vitamin K, and were exclusively breastfed. Infant 
and maternal medical histories and reasons for opting 
out of vitamin K were obtained through medical record 
review and parental interviews; Fisher’s exact tests 
assessed associations between potential risk factors and 
VKDB.
Results: Four infants met case criteria. All case but no 
control mothers reported a history of easy bruising, 
heavy periods, or both (p <0.01). No other factors were 
significantly associated with VKDB. All parents (n=16) 
expressed concerns about vitamin K that centered on 
additional ingredients (44%), dosage (28%), and possible 
cancer risk (28%).
Conclusions: Undiagnosed bleeding disorders may 
have contributed to VKDB among infants not receiving 
vitamin K, but small sample size and potential recall 
bias limit the interpretation of this finding. Parents of 
cases and controls commonly endorsed non-evidence 
based concerns about vitamin K; public health efforts 
to provide information about vitamin K should address 
these concerns while conveying the severe consequences 
of opting out of prophylaxis.








11:50 vItamIN k reFuSal rateS aND pareNtal attItuDeS — teNNeSSee, 2013
Authors: Joshua L. Clayton, L. Marcewicz, J. Traylor,  
A. Grant, J. Dunn, T. Jones, W. Schaffner, M. Warren
Background: Late vitamin K deficiency bleeding 
(VKDB) manifests at 2 weeks–6 months of age, primarily 
as intracranial hemorrhage; risk increases without 
vitamin K prophylaxis. Reported incidence is 4.4–7.2 
cases/100,000 births among infants without prophylaxis. 
During 2013, four VKDB cases were reported in 
Nashville (25/100,000 births). We investigated to 
determine the rates and predictors of vitamin K refusal.
Methods: We examined the 2013 birth cohort at 
a Nashville children’s hospital (Hospital A) and 5 
freestanding birthing centers (over-representing birthing 
centers) to identify vitamin K refusers, determine refusal 
rates, and perform a vitamin K knowledge survey. 
We randomly sampled births from Nashville’s largest 
obstetrics hospital (Hospital B) for vitamin K nonreceipt 
rates during 2011–2013.
Results: We identified 104 vitamin K refusers at Hospital 
A (rate: 2.7%) and 83 at 5 birthing centers (rate: 28%; 
range: 15%–83%). Vitamin K nonreceipt rates at Hospital 
B were 3.2% (95% confidence interval [CI]: 1.3–6.5) in 
2013, 3.7% (95% CI: 1.4–8.0) in 2012, and 2.3% (95% CI: 
0.6–6.1) in 2011. Of 102 vitamin K refusers surveyed, 
47 (46%) responded; 31/47 (66%) identified bleeding 
as a risk of refusing prophylaxis. The leading reasons 
for refusal were desire for a natural birthing process 
(43%) and believing prophylaxis was unnecessary (43%). 
Hepatitis B vaccine and erythromycin eye ointment were 
also refused by 65% of respondents.
Conclusions: Vitamin K refusal rates varied appreciably 
between Hospital A and birthing centers; a consistent 
proportion of newborns at Hospital B did not receive 
vitamin K. The majority of vitamin K refusers surveyed 
also refused several other preventive care measures. 
Health care providers should discuss risk of VKDB with 
parents early in pregnancy.




Moderator: Mary Kamb 
The goal of this session is for the EIS Program to gain feedback on the challenges and opportunities facing EIS officers 
as they enter the epidemiology workforce. Some areas that will be addressed are the skill sets that EIS officers currently 
gain going to be the right ones in the future? What skills make an EIS officer the best hire? Do EISOs currently have 
those skills when they complete EIS? 
Representatives for the CDC CIOs and for the state and local perspective will briefly describe their needs for an 
EIS officer and the challenges and opportunities for public health work including surveillance and electronic data. 
Following this there will be opportunities for questions and open discussion with the audience. The EIS Alumni 
Association will help moderate the session and provide the alumni perspective.
This session will allow the EIS Program to give timely program updates, receive stakeholder input, learn of concerns 
and challenges, and is complementary to other special sessions sponsored during the conference by centers.
Speakers: 
 • CIO representative: David L. Swerdlow 
 • State/local Health Departments: Tim Jones and Laurene Mascola 
 • Acting EIS Chief: Diana Bensyl
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1:35 Where’S the tB? uNDerStaNDINg lOW tB caSe NOtIFIcatION rateS — haItI, 2013. 
Authors: Stephanie J. Salyer, D. Fitter, R. Milo,  
C. Blanton, J.L. Ho, H. Geffrard, W. Morose, B.J. Marston
Background: While an estimated 30,000 TB cases occur 
annually in Haiti, only about 14,000 were registered 
nationally each year from 2009 to 2011. To assess quality 
of surveillance including whether underreporting from 
sites to the national level contributes to low national case 
registration, we conducted a nationally representative 
evaluation of TB surveillance. 
Methods: We collected 2010 and 2012 case totals, 
reviewed lab registries, and abstracted individual case TB 
reports from 32/363 treatment sites randomly selected 
after stratification/weighting toward higher-volume 
sites. We compared site results to national databases 
maintained by an NGO partner (International Child Care 
[ICC]) for 2010 and 2012, and the National TB Program 
(PNLT) for 2012 only. 
Results: Case registries were available at 30/32 (2010) and 
all 32 sites (2012). Totals of 3711 (2010) and 4143 (2012) 
cases were reported at the sites. Case totals per site were 
higher in site registries than in the national databases 
by 361 (9.7%) (ICC 2010), 28 (0.8%) (ICC 2012), and 
31 (0.8%) cases (PNLT 2012). Of abstracted individual 
cases, 6.8%–11.8% per site/year were not recorded in 
national databases. For abstracted cases, final treatment 
determination was missing from the ICC database in 
55.4% (2010) and 33.9% (2012) of cases, and not available 
from the PNLT database. Based on laboratory registers, 
10.0% of TB suspects initiated, but did not complete TB 
testing; 6.7% of these had initial positive AFB smears. 
Conclusions: Currently, registered TB cases are being 
effectively reported to the national level in Haiti. 
Improvement in case notification will require improved 
case detection and diagnosis. 
1:55 challeNgeS IN DetectINg malarIa OutBreakS IN aN epIDemIc-prONe regION — kuaNDO 
kuBaNgO prOvINce, aNgOla, 2013
Authors: Magdalena M. Paczkowski, S. Nasr, Y. Ricardo, 
R. Kiniffo, A. Macedo de Oliveira
Background: Malaria outbreak detection is difficult in 
epidemic-prone regions of malaria-endemic countries 
because routine surveillance is tailored to areas with 
stable transmission. Outbreak detection delays can lead 
to increased morbidity and mortality, while erroneous 
alerts waste already limited resources. Angola recently 
implemented an epidemic prevention and response 
system (EPRS) to detect outbreaks using national malaria 
surveillance system data. EPRS determines if monthly 
reported laboratory-confirmed cases exceed an outbreak 
threshold created from 5-year historical data. We assessed 
EPRS’s attributes, including its outbreak detection 
usefulness. 
Methods: We reviewed patient registries in a convenience 
sample of 4 health facilities in Kuando Kubango, an 
epidemic-prone province. We evaluated EPRS’s analytic 
methods, compared the number of reported malaria cases 
with those in registries, and reviewed EPRS-detected 
outbreaks during January–June 2013. 
Results: Contrary to expectation, historical data used to 
generate outbreak threshold and monthly reported data 
were based mainly on clinical diagnoses, not laboratory 
results. We could not estimate the proportion of 
laboratory-confirmed cases reported because laboratory 
testing was inconsistent and registries were incomplete. 
Using clinical cases instead, we found the number of 
reported cases in June 2013 to be 30% to 446% of cases 
documented in registries. During January–June 2013, 
EPRS detected 5 suspected malaria outbreaks, only 1 of 
which was confirmed. 
Conclusions: The outbreak detection capability of EPRS 
is limited. EPRS data are hampered by inconsistent 
laboratory testing, and the outbreak threshold is based 
on clinical information. Weekly, rather than monthly, 
data reporting and analysis would facilitate timely 
outbreak detection and response. Laboratory testing 
and its documentation in registries should be improved, 
and alternative outbreak detection methods, such as 
the proportion of laboratory-positive tests, should be 
considered.








2:15 pathOgeN-SpecIFIc mOrtalIty amONg INFaNtS aND yOuNg chIlDreN WIth mODerate-tO-
Severe DIarrhea  — WeSterN keNya, 2008–2011
Authors: Allison T. Walker, R. Omore, F. Moke,  
J. Ochieng, T. Farag, D. Nasrin, S. Panchalingam,  
J. Nataro, K. Kotloff, M. Levine, X. Lu, J. Oundo,  
M. Parsons, C. Bopp, K. Laserson, E. Mintz, R. Breiman, 
C. O’Reilly
Background: Diarrhea is a leading cause of childhood 
morbidity and mortality in sub-Saharan Africa; one 
in ten child deaths in the first 5 years of life is due 
to diarrheal disease. We assessed pathogen-specific 
mortality following an episode of moderate-to-severe 
diarrhea (MSD) in children enrolled in the Global 
Enteric Multicenter Study in western Kenya.
Methods: We recruited children <5 years old presenting 
to sentinel health facilities with MSD. Stool specimens 
collected at enrollment were tested for bacterial, 
parasitic and viral enteric pathogens. Survival status was 
determined at 60 days. We calculated unadjusted exact 
odds ratios (OR) and 95% confidence intervals (CI) using 
simple logistic regression models. 
Results: From 2008 to 2011, 1,476 children with MSD 
were enrolled; 52 (3.5%) died. Nineteen (37%) children 
died at health facilities (7 at enrollment) and 33 (63%) 
died at home. Case-fatality rates by age stratum were 4.5% 
(<12 months), 3.1% (12–23 months), and 2.3% (24–59 
months). Pathogens associated with increased risk of case-
fatality were Shigella dysenteriae (OR: 7.2; CI: 1.3–27.8), 
non-typhoidal Salmonella (OR: 2.8; CI: 1.0–6.6), typical 
enteropathogenic Escherichia coli (OR: 2.6; CI: 1.1-5.5), 
and enterotoxigenic E. coli producing heat-stable toxin 
(OR: 2.5; CI: 1.1–5.2). Children who died were more 
likely (at enrollment) to have bipedal edema (OR 22.5; CI: 
8.0–60.6), clinical under-nutrition (OR 11.9; CI: 6.4–22.2), 
thin, sparse and straight hair (OR 11.2; CI: 5.5–21.9), and 
flaky skin (OR 16.5; CI: 7.5–35.0). 
Conclusions: Malnutrition and four bacterial pathogens 
for which no vaccines are available were associated with 
increased risk of mortality from MSD. In the near-term, 
optimizing nutritional status and water, sanitation, and 
hygiene interventions are urgent priorities for childhood 
diarrheal mortality reduction in Kenya.
2:35 ceramIc Water FIlterS aND reDucINg the BurDeN OF DIarrheal DISeaSe IN INFaNtS — 
WeSterN keNya, 2013
Authors: Jamae F. Morris, C. Schneeberger, P. Jaron,  
F. Moke, J. Juma, J.B. Ochieng, R. Omore, T. Ayers,  
J. Murphy, J. Priest, L. Xiao, B. Fields, J. Montgomery,  
J. Vulule, E. Mintz, V. Hill, C.E. O’Reilly
Background: Unsafe drinking water consumption is 
a risk factor for diarrhea, the leading cause of death in 
sub-Saharan African children. Ceramic water filters 
(CWFs) remove or inactivate waterborne diarrheal 
pathogens in drinking water through size exclusion and 
silver exposure. We examined the effectiveness of CWFs 
to improve drinking water quality and prevent infantile 
diarrhea in rural western Kenya. 
Methods: A randomized, controlled intervention trial 
was conducted among 240 households with infants 
4-10 months old. Each household was randomized 
into an intervention or control group with or without 
CWFs, respectively. Trained interviewers performed a 
baseline survey and visited households weekly for 26 
weeks to document recent onset of diarrhea, respiratory 
infection, and febrile illness in infants. Source and filtered 
water samples were tested to monitor Escherichia coli 
concentrations, measured as most probable number 
(MPN). Person-time incidence rates were calculated per 
person-weeks of observation. 
Results: Households reported using surface water 
(36.3%), public taps (29.2%), or rainwater (17.1%) as 
their primary drinking water sources. Self-reported 
filter use among intervention households was 99.7% 
across weeks observed. Compared with the control 
group, intervention households reported fewer diarrheal 
episodes (8.9 vs. 10.9, p=0.22) and fewer health facility 
visits for diarrhea (1.1 vs. 2.5, p<0.01). The incidence of 
respiratory infection (0.34 vs. 0.30, p=0.45) and febrile 
illness (1.02 vs. 0.93, p=0.56) remained similar. E. coli 
were detected in 100% of source water samples (median 
concentration 426 MPN/100mL; range <10 – 1.4x104 
MPN/100mL) and in only 29% of filtered water samples 
(median concentration 7.4 MPN/100mL; range <1.0 – 
>2420 MPN/100mL). 
Conclusions: Households using CFWs had improved 
water quality and reported lower incidence and 









2:55 INtegratINg Water treatmeNt INtO aNteNatal care: Impact ON uSe OF reprODuctIve 
health ServIceS aND hOuSehOlD Water treatmeNt By pregNaNt WOmeN —  
ugaNDa, 2013
Authors: Almea M. Matanock, T. Anderson,  
M. Mutabazi, L. Likicho, C. Kakande, T. Emeetai, X. Lu,  
T. Ayers, R. Quick
Background: In Uganda, high maternal and neonatal 
mortality rates reflect underutilization of reproductive 
health services; high diarrhea risk among children 
results from poor access to safe water. To incentivize 
household water treatment and reproductive health 
service use, water treatment kits (buckets and packets 
of flocculant-disinfectant powder) were provided at first 
antenatal visits. Packet refills were distributed at follow-
up antenatal visits, health facility deliveries, and postnatal 
check-ups.
Methods: We evaluated this intervention with a cross-
sectional survey and maternal passbook review of a 
random sample of women from participating health 
facilities who received reproductive health care in 2013 
after project launch (intervention group) and in 2012 
before project launch (comparison group). We used Chi-
Square test statistic to compare groups.
Results: We surveyed 226 intervention group women 
and 207 comparison group women. A higher percentage 
of intervention than comparison group women reported 
treating drinking water on the day of the survey (41.1% 
vs 24.3%, P=.007), and had detectable chlorine residual, 
an objective measure of treatment, in their stored water 
(13.5% vs 3.8%, P=.002). Of 226 intervention group 
women, 222 (98.2%) received hygiene kits but only 101 
(45.5%) received refill packets. Among 282 women with 
maternal passbooks, similar percentages of intervention 
and comparison group women had 4+ antenatal visits 
(43.4% vs 38.7%, P=.43), health facility deliveries (38.6 
vs 40%, P=.82), and postnatal visits (9% vs 4.7%, P=.26) 
recorded.
Conclusions: Intervention group women were more 
likely than comparison group women to treat their 
drinking water, but had similar low use of reproductive 
health services. Although hygiene kit coverage at first 
antenatal visit was high, inadequate distribution of, or 
low demand for, refill packets may have contributed to 
limited program impact.
3:15 uSe OF capture-recapture methODOlOgy tO characterIze NeONatal mOrtalIty rateS IN 
FarchaNa reFugee camp — chaD, 2013
Authors: Rachel T. Idowu, D. Morof, G. Affana,  
B. Tomczyk, C. Blanton, N. Cornier
Background: Reliable estimates of neonatal mortality 
rates (NMR) are lacking in refugee camps. We used 
capture-recapture (CRC) to estimate NMR in Farchana 
refugee camp from February 2012–January 2013. 
Methods: We identified live births, stillbirths, and 
neonatal deaths (NND) occurring between 24 February 
2012–4 January 2013. Capture involved review of the 
camp health facility’s Health Information System (HIS). 
Recapture consisted of an exhaustive household survey 
of women of reproductive age (WRA) and review of 
non-facility health registers (community health worker 
and Hebrew Immigrant Aid Society). “Total NND” was 
NND counted during CRC plus unidentified NND not 
detected during CRC (estimated using contingency 
table proportions). NMR was calculated using live births 
identified in the WRA survey.
Results: The survey of 4,995 WRA identified 817 live 
births. HIS had 1 NND (capture). Thirteen unique NND 
were identified through recapture: 8 from survey plus 
7 from the health registers minus 2 deaths that were 
found in multiple sources. Using the NND found in 
the HIS alone, the NMR would be 1.22 NND/1000 live 
births. Using unidentified NND estimated from CRC 
contingency tables, we calculated that 40 “Total NND” 
occurred in Farchana during the study period, yielding 
an estimated NMR of 49 deaths/1000 live births. 
Conclusions: Health registers differentially captured 
NND. A WRA survey partially improved NND 
identification. Over half of “Total NND” may have been 
unidentified by any data source. HIS captured only 1 
NND, indicating the Farchana health facility has poor 
sensitivity to detect NND. Further reliance on the HIS 
registry alone will severely underestimate Farchana NMR 
and perhaps other camps where HIS is used. Unreliable 
NMR estimates may negatively impact mortality 
reduction programs.








CONCURRENT SESSION I2: Health Care
1:30–3:35pm
Dunwoody Suite
Moderators: Joseph Perz and Marion Kainer
1:35 rISk FactOrS FOr INvaSIve mEthicillin-rEsistant staphylococcus aurEus INFectION aFter 
DIScharge FrOm acute-care hOSpItalS — uNIteD StateS, 2011–2013
Authors: Lauren Epstein, A.J. Kallen, R. Belflower,  
Y. Mu, J. Scott, G. Dumyati, C. Felsen, S. Petit,  
K. Yousey-Hindes, J. Nadle, L. Pasutti, R. Lynfield,  
L. Warnke, W. Schaffner, K. Leib, S.K. Fridkin, F.C. Lessa
Background: Great strides have been made in reducing 
methicillin-resistant Staphylococcus aureus (MRSA) 
infections in U.S. hospitals. However, the decreases in 
MRSA infections among recently discharged patients 
have been less substantial. In 2011, an estimated 38,000 
invasive MRSA infections occurred among persons 
discharged from U.S. hospitals in the prior 12 weeks. 
We assessed risk factors for developing invasive MRSA 
infections after an acute care hospitalization to inform 
new prevention strategies. 
Methods: We conducted a matched case-control study. 
A case was defined as MRSA cultured from a normally 
sterile body site in a patient discharged from an acute 
care hospital within the prior 12 weeks. Eligible cases 
were identified from 15 hospitals across 6 U.S. states. For 
each case, two controls matched on hospital, month of 
discharge and age were selected. Medical record review 
and telephone interviews were conducted to assess 
exposures during the hospitalization and post-discharge 
periods. Conditional logistic regression was performed 
to identify independent risk factors for post-discharge 
invasive MRSA infections.
Results: From February 1, 2011 through March 31, 
2013, 194 cases and 388 matched controls were enrolled. 
Among the cases, 152 (78%) developed blood stream 
infections. After controlling for gender, comorbidities 
and recent history of MRSA colonization, the 
independent predictors of invasive MRSA infections were 
post-discharge surgical procedures (mOR=4.7, P=.04), 
insertion of central venous catheters (CVC) during the 
post-discharge period (mOR=3.4, P=.03), discharge to a 
long term care facility (LTCF) (mOR=3.3, P=<.001), and 
discharge with an invasive device other than CVC (mOR 
2.5, P=.007). 
Conclusions: Additional efforts to prevent post-discharge 
invasive MRSA infections should include improving 
infection prevention practices in LTCFs and improving 
the insertion and maintenance of invasive devices in 








1:55 perIpheral jOINt INFectIONS aSSOcIateD WIth cONtamINateD preServatIve-Free 
methylpreDNISOlONe acetate INjectIONS — mIchIgaN, OctOBer 2012–OctOBer 2013
Authors: Mawuli K. Nyaku, J. McFadden, J. Collins,  
C. Miller, J. Fiedler, S. Johnson, B. Brennan, J. Coyle,  
R. Heyding, A. Malani, C. Ledtke, J. Finks
Background: Fungal infection from a contaminated 
injection is rare (~4/10,000 injections) and can result in 
permanent joint damage if untreated. Infection associated 
with the 2012 nationwide fungal meningitis outbreak 
caused by contaminated methylprednisolone acetate 
(CMPA) injections continue to be reported. Michigan 
has reported 25/33 of U.S.-reported peripheral joint 
infections (PJIs). We describe the epidemiologic and 
clinical characteristics of affected Michigan patients.
Methods: A probable case was defined as osteomyelitis 
or worsening inflammatory arthritis of a peripheral joint 
after CMPA injection after May 21, 2012. Confirmed 
cases also had a fungal pathogen detected through direct 
microscopy, culture, or polymerase chain reaction of 
synovial fluid, or histopathology of joint tissue. Cases 
were identified through active surveillance or patients 
self-reporting symptoms; clinical information was 
obtained through medical record review. All patients had 
magnetic resonance imaging (MRI).
Results: Among the 22 probable and 3 confirmed cases, 
all presented with joint pain; however, 15 (60%) were 
among patients with symptoms unchanged from before 
their infection. Twenty-three patients had ≥1 underlying 
chronic condition, including renal insufficiency, diabetes, 
cardiovascular disease, and immunosuppression. Twenty-
four had surgical treatment for infection, including 
incision and drainage, arthroscopic debridement, clavicle 
resection, and hip arthroplasty. Median joint aspirate 
white blood cell count at diagnosis was 717 cells/µL 
(range: 9–24,000). Median days from last injection to first 
MRI joint infection evidence was 70 (range: 22–171). 
Patients had received a median of 1 (range: 1–3) CMPA 
injection.
Conclusions: Approximately half of Michigan PJIs 
occurred among patients without new symptoms who 
later required surgical treatment. A higher index of 
suspicion should be maintained for patients who  
received PJIs in the absence of a gold standard for  
case identification.
2:15 NatIONal eStImateS OF INSulIN-relateD hypOglycemIa aND errOrS (IheS) leaDINg tO 
emergeNcy DepartmeNt (eD) vISItS aND hOSpItalIzatIONS — uNIteD StateS, 2007–2011
Authors: Andrew Geller, N. Shehab, M. Lovegrove,  
S. Kegler, K. Weidenbach, G. Ryan, L. Hampton,  
D. Budnitz
Background: National prevalence of diabetes mellitus 
(DM) is increasing, and the number of insulin-treated 
DM patients has risen 50% over the last decade; one-third 
of DM patients currently use insulin. Insulin therapy and 
associated hypoglycemia risks are challenging aspects of 
DM therapy. Data describing high-risk populations and 
circumstances involved in IHEs can inform approaches 
to glycemic targets.
Methods: We estimated ED visits for IHEs from National 
Electronic Injury Surveillance System — Cooperative 
Adverse Drug Event Surveillance data (2007–2011) and 
insulin use from National Health Interview Survey data 
(2007–2011).
Results: Based on 8,100 cases, an estimated 97,648 (95% 
confidence interval [CI]: 64,410–130,887) ED visits for 
IHEs occurred annually. Severe neurologic sequelae 
(hypoglycemia-associated shock, loss of consciousness, 
or seizure; hypoglycemia-associated injury or fall; or 
hypoglycemia-associated altered mental status) were 
documented in an estimated 60.6% (CI: 51.3%–69.9%) 
of ED visits for IHEs. Almost one-third of ED visits 
(29.3% [CI: 21.8%–36.8%]) resulted in hospitalization. 
Blood glucose levels ≤50 mg/dL were recorded in over 
one-half (53.4%) of cases. Insulin-treated DM patients 
aged ≥80 years were more than twice as likely to visit the 
ED (rate ratio: 2.5; CI: 1.5–4.3) and nearly five times as 
likely to be hospitalized (rate ratio: 4.9; CI: 2.6–9.1) for 
IHEs than those aged 45–64 years. The most commonly-
identified IHE precipitants were reduced food intake and 
administration of the wrong insulin product.
Conclusions: Rates of ED visits and hospitalizations 
for IHEs were highest in patients aged ≥80 years; risks 
of hypoglycemic sequelae in this age group should 
be considered in decisions to prescribe and intensify 
insulin. Meal-planning and insulin product mix-up 
misadventures are important potential targets for 
hypoglycemia prevention efforts.








2:35 cluSter OF staphylococcus aurEus SeptIc arthrItIS caSeS aFter INtra-artIcular 
INjectION OF autOlOgOuS platelet-rIch plaSma — NOrth carOlINa, OctOBer 2013
Authors: Sarah K. Rhea, S.E. Morrison, L. Weaver,  
V. Albrecht, K. Anderson, D. Nguyen, Z. Moore
Background: On October 18, the North Carolina 
Division of Public Health was notified of 2 patients 
requiring surgical debridement for Staphylococcus 
aureus (SA) septic arthritis after receiving intra-articular 
injections at the same outpatient facility. Both patients 
received injections containing autologous platelet-
rich plasma and a human placental tissue-derived 
allograft product, an unproven alternative therapy for 
osteoarthritis. We investigated to determine a source and 
prevent further infections.
Methods: We visited the facility, reviewed information 
about patients who had received similar injections, 
interviewed the physician, and assessed infection control 
practices. We performed bacterial cultures on nasal and 
throat swabs collected from medical personnel involved 
in the procedure and compared these isolates with 
patient synovial fluid isolates by using pulsed-field gel 
electrophoresis (PFGE).
Results: Preparation of injection materials was a 
multistep process involving extensive manipulations 
in the procedure room. We observed opportunities 
for contamination of injection materials and supplies. 
Face masks were used inconsistently. SA carriage was 
identified among 3 of 4 medical personnel involved 
in the procedure. SA from the physician’s throat was 
indistinguishable from both patients’ synovial fluid 
isolates by PFGE; SA from 2 other personnel did not 
match patient isolates. No additional infections were 
identified among 7 other patients who had received 
similar injections since the facility opened in July.
Conclusions: Although we were unable to discern 
respiratory droplet versus contact transmission in 
this cluster, the preparation of injection materials for 
this unproven therapy offered ample opportunity for 
SA transmission. This investigation highlights the 
importance of using accepted safe practices for sterile 
compounding when performing extensive manipulations 
of injection materials.
2:55 the eFFect OF havINg a meDIcal hOme aND repOrteD FamIly FINaNcIal BurDeN amONg 
chIlDreN WIth SpecIal health care NeeDS — kaNSaS, 2009–2010
Authors: Suparna Bagchi, J. Kim, K. Bisgard,  
B. Robinson, I. Trevino-Garrison, D.C. Hunt
Background: One in 5 households in the United States 
include ≥1 children with special healthcare needs 
(CSHCN); 21% of CSHCN live in families who reported 
financial burden (FB) meeting the child’s healthcare 
needs. Prior studies demonstrated reduced FB association 
with receiving care within a MH. The relationship 
between these factors among CSHCN in Kansas has not 
been explored; therefore, we assessed the association 
between having a MH and reported FB.
Methods: Kansas data (n = 787 CSHCN; parent-reported 
telephone survey) from the 2009–2010 National Survey 
of CSHCN were analyzed. Factors associated with 
reported FB (dichotomous variable Yes/No) included: 
healthcare through a MH (19-item composite measure) 
and covariates [e.g. child‘s age, sex, functional limitations, 
family structure, household education level, federal poverty 
level (FPL), insurance type, and access to healthcare] were 
assessed using weighted logistic regression.
Results: Overall, 49.4% CSHCN had received healthcare 
through a MH; 26.3% CSHCN lived in families that 
reported FB. Lack of a MH was associated with increased 
FB (adjusted odds ratio [aOR]: 1.84; 95% confidence 
interval [CI]: 1.08–3.17). Higher FB was reported among 
CSHCN living in families ≤200% FPL versus >400% FPL 
(aOR: 2.64: 95% CI: 1.21–5.75) and those having barriers 
accessing healthcare (aOR: 2.82: 95% CI: 1.64–4.84). 
CSHCN with no versus ≥3 functional difficulties (aOR: 
0.06: 95% CI: 0.02–0.21), daily activities unaffected versus 
moderately/consistently affected (aOR: 0.49: 95% CI: 
0.27–0.91), and with either public or private insurance 
versus uninsured (aOR: 0.28: 95% CI: 0.10–0.76) lived in 
families reporting less FB.
Conclusions: MH absence was associated with increased 
family FB among Kansas CSHCN. Our findings provide 









3:15 INFectION cONtrOl practIceS aND multIDrug-reSIStaNt acinEtobactEr baumannii 
OutBreak IN a hOSpItal — puertO rIcO, 2013
Authors: Nora Chea, K. Pringle, S. Irving, A. Kerk,  
A. Kallen, A. Laufer, L. Pollack, H. Moulton-Meissner,  
A. Shams, A. Ferreira, B. Rivera, J. Rullan
Background: Multidrug-resistant Acinetobacter 
baumannii (MDR-Ab) infections are associated with high 
mortality rates (≥50%), and organisms are able to survive 
on environmental surfaces, facilitating transmission. 
In August 2013, the Puerto Rico Department of Health 
(DOH) requested assistance from CDC to assist 
investigating and controlling an outbreak of MDR-Ab 
infections in a hospital. 
Methods: Case-patients were defined as individuals with 
a clinical or surveillance culture positive for MDR-Ab 
at the hospital during July 1, 2012 to August 24, 2013. A 
subset of case-patient records were reviewed to identify 
common exposures and in-hospital transmissions (first 
positive MDR-Ab culture >3 days after admission). 
Admission prevalence was the percent of MDR-Ab 
culture-positive patients within three days of admission. 
Infection control practices were observed. Environmental 
cultures were collected and compared to case-patient 
isolates using pulsed-field gel electrophoresis (PFGE). 
Results: Of 129 case-patients, 68 (all case-patients from 
January to August 2013) underwent record review, of 
which 57 (84%) were intubated, 42 (62%) had portable 
x-rays, and 31 (45.5%) had positive sputum cultures. 
In-hospital transmissions averaged one per week (range: 
0–4); monthly admission prevalence was <1%. Adherence 
to hand hygiene and Contact Precautions was 39% 
and 74%, respectively. High-touch surfaces were often 
missed during room cleaning. MDR-Ab were recovered 
from cultures of portable x-ray, patient room, and faucet 
used to rinse laryngoscope blades. PFGE indicated 
four clusters, of which one contained indistinguishable 
case-patient and environmental isolates. No further 
MDR-Ab transmission was identified after a DOH Task 
Force oversaw the hospital implementation of CDC-
recommended interventions. 
Conclusions: A large, polyclonal outbreak of hospital-
acquired MDR-Ab occurred at the hospital with 
suboptimal adherence to infection control. The outbreak 
was stopped after rigorous improvement of infection 
control.








SeSSION j:  
alexaNDer D. laNgmuIr memOrIal lecture aND receptION
3:50–5:20pm
Ravinia Ballroom
Moderators: Pattie Simone and Denise Koo
Presentation of the Alexander D. Langmuir Prize Manuscript Award  
and the Distinguished Friend of EIS Award
EIS in an Era of Data, Technology, and Urban Transformations  
SPEAKER: Martín-J. Sepúlveda, MD, FACP
Martín-J. Sepúlveda, MD, FACP, is an IBM Fellow and Vice President of Health Systems and 
Policy Research in the Research Division of the IBM Corporation. He collaborates in research 
with a diverse global team of computational, informatics and other IBM scientists for population 
health improvement through health systems and health care innovation. The targets for our work 
are high impact opportunities in complex systems such as cities to improve health and health 
value (cost, quality, and equity) using data and advanced analytics to improve planning, resource 
use, and allocation. A second major research area is human performance optimization in 
enterprises through novel analytics combining human capital, health, and community data sets.
Before this, he served as IBM VP for Integrated Health Services and led health policy and strategy, health benefits 
and clinical care program design and delivery, occupational and behavioral health, wellness and productivity for IBM 
globally. He has extensive global experience and competency in population and public health, noncommunicable 
diseases prevention, health policy/strategy and funding, primary care and care program redesign, process and quality 
improvement, health systems, and workforce health and productivity. 
He is a Fellow of the American College of Physicians, the American College of Preventive Medicine, and the American 
College of Occupational and Environmental Medicine. He was elected an honorary member of the American 
Academy of Family Medicine and serves on the Institute of Medicine’s Population Health and Public Health Practice 
Board, the American Board of Internal Medicine Foundation, the Commonwealth Fund Commission for a High 
Performance Health System and the Council on Health Research for Economic Development. He is chair of the Global 
Business Group on Health and chair of the Institute for Health Benefits Innovation Research at the Employee Benefits 
Research Institute. 
He received his MD and MPH degrees from Harvard University. He completed residencies in internal medicine at the 
University of California San Francisco Hospitals, Occupational/Environmental Medicine at the National Institute for 
Occupational Safety and Health, trained in the Epidemic Intelligence Service of the U.S. Centers for Disease Control, 
and completed a fellowship in internal medicine at the University of Iowa Hospitals and Clinics. He has authored 
over 20 peer reviewed scientific publications, worked on numerous Institute of Medicine and other committees and 












7:30–10:00 Oral Presentations and Awards
Ravinia Ballroom
See supplement for complete list of presenters and abstracts.
7:45 reemergeNce OF raBIeS ON aN ISlaND NatION: a ONce IN a lIFetIme eveNt, Or aN 
INDIcatION OF mOre tO cOme?
Authors: Ryan M. Wallace, J. Doty, N. Vora,  
S. Recuenco, A. Velasco-Villa, R. Franka,  
J.D. Blanton, D. Carroll, I. Damon, K. Christian,  
H. Wu, S. Chang, F.Y. Chang
Background: Rabies virus variants evolved to circulate 
primarily in specific reservoir species; these mammalian 
species are found on all continents except Antarctica. 
The canine variant is responsible for most human 
deaths worldwide. Canine rabies was eliminated from 
Taiwan in 1961 and the island was assumed to be 
free of rabies virus. In 2012 Taiwan discovered rabies 
viruses in Formosan Ferret Badgers. Taiwan CDC 
requested U.S. CDC assistance: identifying the source 
of rabies, implementing rabies surveillance systems, and 
developing disease prevention strategies.
Methods: Wildlife surveillance data were analyzed for 
spatial, temporal, and phylogenetic trends. Site visits 
were conducted to identify potential animal reservoirs 
and high risk human populations. Rabies surveillance 
methods were reviewed and protocols discussed with 
local and national health authorities. 
Results: Historical wildlife surveillance data suggest a 
fatal disease epizootic in ferret badgers began as early as 
2006. Phylogenetic analysis of rabies virus from ferret 
badgers in 2012 suggests that this variant is a descendent 
of the canine rabies virus variant eliminated from Taiwan 
in 1961. Spatial analysis of rabid ferret badgers suggests 
a natural barrier may be preventing spread into northern 
Taiwan.
Conclusions: In the 51 years during which Taiwan 
was considered rabies-free, no terrestrial wildlife 
rabies testing was conducted. Limited wildlife rabies 
surveillance is likely true for many other countries and 
island territories, which currently are considered rabies-
free. Vaccination of dogs should be prioritized, as they 
may be a vector to human exposure after interaction with 
ferret badgers. Additional surveillance studies are needed 
to determine the true extent of disease spread. Primary 
disease prevention among potentially exposed humans 
and domestic animals is crucial and wildlife management 
options should be investigated.







Thursday, May 1, 2014
SeSSION l: DONalD c. mackel memOrIal aWarD FINalIStS
8:30–10:15am
Ravinia Ballroom
Moderators: Steve Monroe and Rachel Kaufmann
8:35 OutBreak OF NeW DelhI metallO-ß-lactamaSe-prODucINg carBapeNem-reSIStaNt 
eNterOBacterIaceae at a hOSpItal — IllINOIS, 2013
Authors: Jennifer C. Hunter, L. Epstein, M.A. Arwady,  
V. Tsai, M.M. Frias, L. Stein, M. Gribogiannis,  
H. Moulton-Meissner, J.K. Rasheed, B. Kitchel,  
J.J. Avillan, A. Laufer, A.Y. Guh, J. Conway,  
B.M. Limbago, M.O. Vernon, A. Kallen
Background: Carbapenem-resistant Enterobacteriaceae 
(CRE) are an emerging threat; these bacteria inactivate 
“last resort” carbapenem antimicrobials and can cause 
infection with high mortality (40%). During March–
July 2013, an Illinois hospital identified 8 patients with 
CRE caused by an antibiotic resistance mechanism 
rarely found in the United States, New Delhi metallo-β-
lactamase (NDM). An investigation was conducted to 
understand and prevent further transmission.
Methods: A case was an NDM-producing CRE isolated 
from a patient in Illinois after January 1, 2013. To identify 
CRE risk factors, hospital cases were compared to 
controls selected from patients at the same hospital with 
negative surveillance cultures. Infection control practices 
were assessed; environmental sampling was performed. 
Case and environmental isolate relatedness was 
determined by pulsed-field gel electrophoresis (PFGE). 
Subsequent case-finding, using surveillance cultures, was 
initiated based on preliminary findings.
Results: Initially, 9 case-patients were identified; 8 were 
treated at the hospital. History of endoscopy with a 
duodenoscope was strongly associated with case-status 
(6/8 [75%] versus 1/27 [4%]; odds ratio: 78.0; 95% CI: 
6.0–>999). No lapses in duodenoscope reprocessing 
were identified; however, NDM-producing Escherichia 
coli was recovered from the reprocessed duodenoscope 
and was highly related (>95%) to all case isolates by 
PFGE. Forty-nine of 96 patients with exposure to this 
duodenoscope underwent surveillance cultures; NDM-
producing E. coli matching the outbreak strain was 
recovered from 22 (45%), resulting in 31 total cases. The 
duodendoscope was removed from service.
Conclusions: Surveillance and environmental cultures 
were essential in characterizing transmission of NDM-
producing E. coli through endoscopy. While improperly 
reprocessed endoscopes can transmit bacteria, no 
reprocessing breaches were identified. A better 
understanding of duodenoscope design and reprocessing 








8:55 hOSpItal-aSSOcIateD OutBreak OF mIDDle eaSt reSpIratOry SyNDrOme cOrONavIruS 
(merS-cOv) — jOrDaN, 2012
Authors: Brian S. Rha, M. Al-Abdallat, D. Payne,  
S. Alqasrawi, R. Tohme, G. Abedi, M. Al Nsour, I. Iblan, 
N. Jaarour, N. Farag, A. Haddadin, T. Al-Sanouri,  
A. Tamin, J. Harcourt, D. Kuhar, D. Swerdlow, X. Lu,  
M. Pallansch, S. Gerber, L. Haynes, and the Jordan  
MERS-CoV Investigation Team
Background: In April 2012, the Jordan Ministry of 
Health (JMoH) investigated a hospital outbreak of 13 
cases of pneumonia of unknown etiology. Two cases 
were fatal and later confirmed by real-time polymerase 
chain reaction (PCR) as the first detected cases of Middle 
East Respiratory Syndrome coronavirus (MERS-CoV), 
an emerging virus with high mortality. We sought to 
determine if additional cases of MERS-CoV had occurred 
in this outbreak, and to describe their characteristics.
Methods: In May 2013, we collected serum specimens 
and standardized information from available members 
of the JMoH-investigated outbreak, household contacts, 
and healthcare personnel through interviews and medical 
chart reviews. Using newly developed CDC serologic 
tests for anti-MERS-CoV antibodies, we screened for past 
infection with an enzyme-linked immunosorbent assay, 
and confirmed diagnosis with an immunofluorescence or 
microneutralization assay. 
Results: Of the 124 subjects investigated, seven 
individuals tested positive for MERS-CoV by at least two 
serologic assays, all who had respiratory illness during 
the outbreak; six were members of the JMoH-investigated 
outbreak, one was a household contact. Including the two 
fatal cases, the nine positive case-subjects (by PCR and/or 
serology) were relatively healthy prior to illness without 
serious comorbidities; the overall case fatality rate was 
22%. Six case-subjects were healthcare workers at the 
outbreak hospital, yielding an attack rate of 10% among 
potentially exposed outbreak hospital personnel. 
Conclusions: New serologic assays identified previously 
undetected cases of MERS-CoV in the first described 
outbreak in the world, one year after it occurred. Assay 
results were consistent with clinical findings among 
previously relatively healthy subjects and documented a 
lower case fatality rate than reported elsewhere. Serologic 
assays are essential tools for diagnosing MERS-CoV 
infections and understanding its epidemiology. 
9:15 pantoEa BlOODStream INFectION OutBreak at aN ONcOlOgy clINIc — IllINOIS,  
2012–2013
Authors: Brian R. Yablon, R. Dantes, V. Tsai, R. Lim,  
H. Moulton-Meissner, M. Arduino, M. Patel, M. Vernon, 
Y. Grant-Greene, D. Christiansen, C. Conover, A. Kallen, 
A. Guh
Background: Pantoea species are gram-negative bacteria 
inhabiting plants, soil, and water that uncommonly 
cause human infections. During August 2012–February 
2013, an outpatient oncology clinic (Clinic A) identified 
8 patients with Pantoea species bloodstream infections, 
prompting an investigation to control the outbreak.
Methods: Cases were defined as Pantoea species 
isolation from blood or catheter tip cultures of Clinic 
A patients during July 2012–May 2013. We reviewed 
Clinic A’s medical charts and laboratory records and 
examined infection prevention practices and the water 
system. Environmental samples were collected for 
culture. Clinical and environmental Pantoea isolates 
were compared by using pulsed-field gel electrophoresis 
(PFGE).
Results: Twelve Pantoea agglomerans cases were 
identified; median age was 65 (range: 41–78) years. 
All patients had malignancies; 11/12 had indwelling 
vascular access. The only common exposure was receipt 
of intravenous infusions at Clinic A. Deficiencies in 
parenteral medication preparation and handling were 
identified (e.g., suboptimal hand hygiene, placing 
infusates near sinks with potential for splash-back 
contamination). Inspection revealed substantial dead 
space piping in building plumbing and inadequate 
chlorine residual in sink tap water. P. agglomerans were 
isolated from composite surface swabs of 6 separate 
sinks and an ice machine; the isolate from the clinic 
pharmacy sink (in the medication preparation area) was 
indistinguishable by PFGE from 7/9 available patient 
isolates.
Conclusions: Water system irregularities contributing to 
tap water contamination during parenteral medication 
preparation or handling likely caused these Pantoea 
bloodstream infections. Products compounded in this 
outpatient clinic propagated a health care–associated 
outbreak, underscoring the importance of adhering to 
recommended practices for medication preparation and 
handling. Further efforts are needed to understand the 
role of water system maintenance in infection prevention.







9:35 NOvel, IllIcIt FeNtaNyl-aNalOg cauSeS 14 OverDOSe DeathS — rhODe ISlaND, 2013
Authors: Matthew J. Lozier, L. Ogilvie, C. Martin,  
L. Lewis
Background: The United States is experiencing an opioid 
abuse epidemic, with opioid overdose deaths quadrupling 
between 1999 and 2010. The introduction of more potent 
illicit opioids increases overdose risk. We characterized 
a cluster of overdose deaths involving acetyl fentanyl, a 
novel illicitly-produced opioid about four times more 
potent than heroin.
Methods: We abstracted data from the Rhode Island 
(RI) Medical Examiner Database for illicit drug 
overdose deaths (IDOD) during March 2012–March 
2013, and from post-mortem toxicology reports for 
acetyl fentanyl overdose deaths (AFODs). AFODs, 
a subset of IDODs, were defined by identification of 
acetyl fentanyl or 4-Anilino-n-phenethylpiperidine by 
gas chromatography/mass spectrometry (GC/MS). We 
performed a case-case risk factor analysis comparing 
AFODs to other IDODs.
Results: In March 2013, 10 AFODs contributed to a 
significant increase in total IDODs (n = 20) compared 
to the previous year monthly average (mean = 8.9; 
P<.001). Fourteen AFODs occurred during March–May 
2013; decedents were 19–57 years old and 71% male. 
AFODs were more likely than other IDODs to occur in 
a northern RI city (43% vs. 8%; P<.001). No other risk 
factor differences were identified. GC/MS toxicology 
results for 12 AFODs showed various mixtures of other 
drugs, including cocaine (64%), other opioids (36%), and 
ethanol (36%); all AFODs tested negative for fentanyl. No 
AFODs have occurred in RI since May 2013. 
Conclusions: This is the first time acetyl fentanyl has 
been identified in illicit drug use and overdose deaths. 
Without RI’s extensive toxicology testing, the cause of the 
outbreak might have gone unidentified. This investigation 
increased awareness of and laboratory capacity to identify 
acetyl fentanyl nationally, leading to confirmation of six 
AFODs in two other states.
9:55 tWO cattle herDSmeN INFecteD WIth a NOvel SpecIeS OF OrthOpOxvIruS — geOrgIa 
(cOuNtry), 2013
Authors: Neil M. Vora, Y. Li, M. Geleishvili, G. Emerson, 
G. Maghlakelidze, A. Navdarashvili, S. Panayampalli,  
N. Gallardo-Romero, I. Damon, E. Maes, M. Reynolds,  
J. Morgan, D. Carroll
Background: Cessation of routine smallpox vaccination 
has created opportunities for the emergence of 
orthopoxviruses previously suppressed by vaccine-
derived immunity. With the exception of variola (agent of 
smallpox), Orthopoxvirus infections such as cowpox are 
often associated with animals. In July 2013, CDC tested 
diagnostic specimens from two herdsmen in Georgia 
(country) suspected of having cowpox after contact with 
ill cattle. 
Methods: Sera were tested for Orthopoxvirus IgM and 
IgG antibodies. Nucleic acid was extracted from swabs 
of cutaneous lesions and screened for non-variola 
orthopoxviruses using quantitative real-time polymerase 
chain reaction (qPCR). Positive samples underwent 
additional qPCR reactions for identification of known 
Orthopoxvirus species. 
Results: Orthopoxvirus IgM and IgG antibodies were 
detected. Nucleic acid screening of lesion samples 
for non-variola orthopoxviruses was positive, but 
subsequent reactions failed to assign the virus to a known 
Orthopoxvirus species. Phylogenetic analysis of a 500-
base pair DNA sequence representing the Orthopoxvirus 
DNA-dependent RNA polymerase gene confirmed a 
novel virus. To determine disease transmissibility and 
identify additional human cases, an epidemiologic 
investigation was conducted in the region where the 
herdsmen lived. Both herdsmen denied history of 
smallpox vaccination. Fifty-five persons who had contact 
with the herdsmen or with cattle were interviewed. 
Five of nine (56%) interviewees born after cessation of 
routine smallpox vaccination in Georgia in 1980 had 
Orthopoxvirus IgG antibodies. An additional human case 
from a different region in Georgia was identified through 
testing of specimens originally submitted for anthrax 
diagnostics in 2010.
Conclusions: Orthopoxviruses are anticipated to 
emerge in the absence of routine smallpox vaccination 
and should be considered in persons who experience 
cutaneous lesions after animal contact. As highlighted 












10:50 metaBOlIc ScOre aND carDIOvaScular DISeaSe mOrtalIty amONg u.S. aDultS ageD 18 
yearS Or OlDer: a Structural equatION mODelINg apprOach — NatIONal health aND 
NutrItION examINatION Survey III lINkeD mOrtalIty FIle, uNIteD StateS, 1988–2006
Authors: Carla I. Mercado, Q. Yang, E. Ford, E. Gregg,  
A. Valderrama
Background: Metabolic syndrome (MetS) is defined as 
having abnormal values for ≥3 metabolic components 
(blood pressure [BP], waist circumference [WC], HDL 
cholesterol, triglycerides [TG], and fasting glucose [FG]). 
Cardiovascular disease (CVD) risk may vary based on 
cut-points or which components are present. We used 
a novel analytic approach to calculate a metabolic score 
and tested its association with CVD mortality risk. 
Methods: Using structural equation modeling, a 
continuous metabolic score was estimated from 
measured BP (systolic [SBP] and diastolic [DBP]), 
WC, HDL, TG, and FG for 7,791 participants in the 
National Health and Nutrition Examination Survey III, 
1988–1994. Data were linked with the National Death 
Index to determine mortality status and cause of death 
through December 31, 2006. Associations between each 
continuous component, metabolic score, and MetS with 
CVD mortality were tested using Cox proportional 
hazard ratios adjusted for sociodemographic 
characteristics and health behaviors. 
Results: Among men, continuous components associated 
with CVD mortality were SBP (adjusted hazard ratio, 
1.24 [95% confidence interval: 1.11–1.38]), DBP (1.36 
[1.15–1.61]), and TG (1.01 [1.01–1.02]). Among women, 
SBP (1.21 [1.11–1.32]) and DBP (1.28 [1.06–1.54]) were 
associated with CVD mortality. MetS was not associated 
with CVD mortality. Significant associations between 
metabolic score and CVD mortality were found among 
men (1.43 [1.07–1.90]) and women (1.34 [1.07–1.69]). 
In subgroup analysis among women, associations were 
greater among Mexican-American (2.84 [1.46–5.53]) and 
non-Hispanic blacks [2.14 (1.48–3.08)] compared with 
non-Hispanic whites (1.26 [1.001–1.59]). 
Conclusions: The metabolic score was a better CVD 
mortality predictor and risk assessment tool than 
MetS. Using novel statistical methods with continuous 
components may clarify the CVD mortality risk 
associated with MetS. 







11:10 SteveNS-jOhNSON SyNDrOme aSSOcIateD WIth mycoplasma pnEumoniaE INFectION — 
cOlOraDO, 2013
Authors: Louise K. Francois Watkins, A. Demirjian,  
X. Lin, D. Olsen, T. Foo, L. Miller, A. Benitez, M. Diaz,  
J. Winchell, N. Shang, P. Kutty
Background: On November 21, 2013, CDC was notified 
of a cluster of Colorado children with Stevens-Johnson 
syndrome (SJS) and concurrent Mycoplasma pneumoniae 
(Mp) infection. SJS is rare (annual incidence 1–2 per 
million) and characterized by severe mucocutaneous 
blistering, potentially resulting in blindness or death. 
Mp, a common bacterial etiology of pneumonia, is 
the most frequent infectious trigger of SJS in children; 
however, an outbreak of Mp-associated SJS has never 
been documented. We evaluated the epidemiology of this 
unique occurrence.
Methods: A case was defined as an inpatient aged 5–21 
years with clinician-diagnosed SJS, and considered 
“confirmed” when laboratory testing was Mp-positive by 
quantitative polymerase chain reaction, and “possible” 
if the patient had antecedent pneumonia without 
confirmatory Mp testing. We reviewed discharge records 
from five Colorado referral hospitals and examined 
hospital and statewide case counts of SJS and bacterial 
(either etiology unknown or Mp-specific) pneumonia 
by ICD-9 code over five years. We used cumulative sum 
(CU.S.UM) analysis to detect existence of an outbreak, 
assuming an outbreak rate three times baseline and an 
average detection time of five months.
Results: Eight Mp-associated SJS cases were identified 
August–November, 2013 (five confirmed, three possible). 
Case-patient median age was 14 years (range: 8–16), five 
were male, two required ICU care, and four required 
ophthalmologic surgery. Bacterial pneumonia reached 
a five-year peak in October 2013, and the CU.S.UM 
crossed the detection limit in November 2013, indicating 
a statistically-significant rise above baseline. 
Conclusions: This is the first documented Mp-associated 
SJS outbreak. Initial analysis suggests that a large 
community burden of Mp was a contributing factor. 
CU.S.UM analysis is useful in the detection of outbreaks 
of rare, intermittent disease.
11:30 prevaleNce aSSeSSmeNt OF NODDINg SyNDrOme — ugaNDa, 2013
Authors: Preetha J. Iyengar, J. Wamala, J. Ratto,  
C. Blanton, M. Muggaga, S. Becknell, R. Downing,  
S. Bunga, J. Sejvar, I. Makumbi
Background: Nodding syndrome (NS) is a seizure 
disorder of unknown etiology resulting in neurological 
deterioration. It is reported in defined regions of three 
sub-Saharan African countries, and predominantly affects 
children aged 3–18 years. In Uganda, cases and deaths 
are reported in large numbers; however no prevalence 
assessment has been performed.
Methods: We performed single stage cluster sampling to 
select case-caregiver pairs from self-identified reported 
head nodding cases. A cluster was defined as a parish, 
which contains multiple villages. Probability proportional 
to size sampling was used to select clusters. Cases 
were selected using simple random sampling without 
replacement. Trained healthcare workers administered 
standardized questionnaires including questions on 
demographics and NS symptoms. Prevalence was 
calculated by age at time of interview and weighted 
to account for unequal probabilities of selection, 
non-response, and calibration to the known age-sex 
distribution. An international consensus case definition 
was implemented and modified to classify cases; probable 
cases were a subset of suspected cases. 
Results: The response rate was 75% (547/725); 3 cases 
were excluded. Median age of cases at time of interview 
was 13.9 years (range 1.2–45.2 years); 53% (286/544) 
were male. Most cases (90% [489/544]) were 5–18 years 
old. In this group (projected population 248,243), there 
were an estimated 1,782 (95% CI 1,552–2,011) suspected 
cases, yielding a prevalence of 7.2 per 1000 population 
(95% CI 6.3–8.1). The number of probable cases was 
estimated to be 1,687 (CI 1,463–1,912), yielding a 
prevalence of 6.8 per 1000 population (95% CI 5.9–7.7). 
Conclusions: These results provide the most 
comprehensive and evidence-driven assessment of NS 
burden in the region. This information offers a critical 








11:50 aN autOmateD claSSIFIcatION algOrIthm FOr the SurveIllaNce OF autISm  
Spectrum DISOrDer
Authors: Matthew J. Maenner, L. Schieve, D. Christensen, 
M. Yeargin-Allsopp
Background: The Autism and Developmental 
Disabilities Monitoring (ADDM) Network conducts 
population-based surveillance of Autism Spectrum 
Disorder (ASD) among 8-year old children in multiple 
U.S. sites. Each ADDM site collects special education 
records and medical records from providers who conduct 
developmental evaluations. Information is abstracted 
from developmental evaluations that contain descriptions 
of behaviors consistent with ASD. Trained clinicians then 
review all abstracted evaluations to determine whether 
the child meets the ASD surveillance case criteria. 
The number of abstracted evaluations has dramatically 
increased since the year 2000, affecting the resources and 
timeliness of the surveillance system. In this study, we 
developed and evaluated a computer algorithm to classify 
whether a child meets ADDM ASD case criteria using 
words and phrases contained in developmental evaluations. 
Methods: We assessed 1,165 children with a total 
of 5,396 evaluations from the Georgia ADDM site. 
We concatenated each child’s abstracted evaluations, 
processed the text (stemming), and counted the 
occurrence of all words and 2-3-word phrases 
(tokenization). A random forest algorithm constructed 
10,000 classification trees using these words and phrases 
to predict ASD case status. We validated its performance 
using subsets of data that were not used to construct a 
given tree (out-of-bag sample).
Results: The algorithm predicted ASD case statuses that 
were 85% concordant with the clinician-determined 
case statuses (82.4% sensitivity, 87.9% predictive value 
positive). The area under the resulting receiver-operator 
characteristic curve was 0.925.
Conclusions: This algorithm could be incorporated into 
the ADDM surveillance methodology to efficiently “filter 
out” records that are unlikely to meet ASD case criteria. 
This methodology also has broader public health utility 
for epidemiological studies of ASD or other conditions 
ascertained through extensive manual chart review.





This special session will provide an overview of CDC’s response to the humanitarian crisis in Syria and neighboring 
countries. The challenges as well as lessons learned will also be described.
The Syrian conflict is an ongoing armed crisis. Peaceful protests in spring 2011 triggered a violent response by the 
Assad government; conflict has since escalated to a national civil war. Since the start of the conflict more than 2.3 
million people have fled Syria to Lebanon, Jordan, Iraq, Egypt, and Turkey. Current estimates suggest that over  
9.3 million people, nearly half of the Syrian population,  are in need of humanitarian assistance. The humanitarian 
situation continues to deteriorate. The conflict has resulted in significant destruction of the Syrian health system. An 
outbreak of polio was confirmed in Syria in 2013, the first in the country in 14 years. In addition, outbreaks of measles, 
hepatitis, and tuberculosis threaten the displaced population and host populations. 
The Syria crisis and associated public health threats triggered CDC-wide response. Through deployment of EIS officers 
and subject matter experts from multiple CDC centers and offices, and in collaboration with international partners, 
CDC provided technical assistance in disease surveillance, mass immunization campaigns, and outbreak investigation 
and response. This special session is an opportunity to discuss how epidemiology, as well as collaboration with 
international partners, was used to improve the public health response in these situations and what this means for 
similar situations in the future.
Speakers:
 • Introductions and Overview of Refugee Crisis in Syria. Mike Gerber
 • Overview of CDC Activities in Response to Syria Crisis. Muireann Brennan
 • Implementing an Early Warning Disease Surveillance System in Northern Syria. Alison Ridpath
 • Polio, Partners, and Politics in Syria. Allison Walker







cONcurreNt SeSSION N1: reSpIratOry DISeaSeS
1:30–3:15pm
Ravinia Ballroom
Moderators: Cyndy Whitney and Seema Jain
1:35 legIONNaIre’S DISeaSe OutBreak aSSOcIateD WIth a cOOlINg tOWer at a lONg-term-
care FacIlIty — OhIO, 2013
Authors: Celia L. Quinn, C. Lucas, A. Demirjian,  
L. Francois Watkins, S. Tomczyk, S. Eitneiar, S. Brewer, 
M. DiOrio, L. Hicks, L. Garrison
Background: On July 9, the Ohio Department of Health 
was notified of 2 long-term–care facility residents 
with Legionnaires’ disease (LD, a pneumonia resulting 
from inhalation of Legionella-contaminated water). We 
investigated to identify the outbreak source and prevent 
further cases.
Methods: On July 10, we requested all facility residents 
with respiratory symptoms be tested for Legionella. Local 
health departments assessed facility exposure among 
community LD cases. Outbreak cases were defined as 
pneumonia since May 1 with positive Legionella urine 
antigen test (UAT) or respiratory culture among persons 
who lived at, worked in, or visited the facility 2–10 days 
before symptom onset. We interviewed patients, assessed 
the environment, and cultured environmental samples. 
Positive cultures underwent serotyping, monoclonal 
antibody (MAb) testing, and sequence-based typing 
(SBT).
Results: We identified 39 LD cases; 6 patients died. 
Residents lived in 4 buildings; no common potable 
water source was identified. All patients were positive 
for Legionella pneumophila serogroup 1 (Lp1) by UAT. 
Among 15 patients with respiratory cultures, 14 were 
negative, and 1 was positive for Lp1. Water samples and 
swabs from a cooling tower serving 1 building and from 
another building’s potable water were positive for Lp1, 
both with matching MAb and SBT to the patient isolate; 
the patient had not been exposed to the potable water 
source. Six cases were identified among residents of a 
third building where no environmental Legionella was 
isolated. An electronic control system turned off cooling 
tower pumps during periods of low demand, preventing 
delivery of disinfectant by a timed-release system.
Conclusions: A cooling tower relying on timed-release 
disinfection was the principal outbreak source. Tower 








1:55 tImINg OF hIghly pathOgeNIc avIaN INFlueNza a (h5N1) pOultry OutBreakS, humaN 
INFlueNza a (h5N1) caSeS, aND SeaSONal INFlueNza epIDemIcS — WOrlDWIDe,  
2004–2013
Authors: Lizette O. Durand, P. Glew, D. Gross,  
M. Kasper, S. Trock, I.K. Kim, J.S. Bresee, R. Donis,  
T.M. Uyeki, M.A. Widdowson, E. Azziz-Baumgartner
Background: During January 2004–June 2013, highly 
pathogenic avian influenza (HPAI) A (H5N1) caused 
>6,000 outbreaks among poultry and 629 H5N1 cases 
among humans. We analyzed public data to determine 
the month and season of HPAI H5N1 poultry outbreaks 
and H5N1 human cases and assessed correlation with 
ambient temperatures.
Methods: We quantified HPAI H5N1 poultry outbreaks 
reported to the World Organization for Animal 
Health and laboratory-confirmed H5N1 human and 
seasonal influenza cases reported to the World Health 
Organization. We examined the association between 
HPAI H5N1 poultry outbreaks and H5N1 human 
cases by month. We determined whether H5N1 human 
cases overlapped with seasonal influenza epidemics. 
Using national temperature data, we performed linear 
regression to explore seasonality of HPAI H5N1 poultry 
outbreaks or H5N1 human cases.
Results: Bangladesh, Cambodia, China, Egypt, Indonesia, 
Thailand, Turkey, and Vietnam reported >95% of H5N1 
human cases and 83% of HPAI H5N1 poultry outbreaks. 
Among 708 country-months, ≥1 H5N1 human cases 
were reported in 72/233 (31%) country-months when 
≥1 HPAI H5N1 poultry outbreak occurred versus 
30/475 (6%) country-months when no poultry outbreaks 
occurred (P<.001). Human H5N1 cases occurred during 
53/254 (21%) months when seasonal influenza was 
epidemic. Two hundred nineteen/264 (83%) H5N1 
human cases and 4,645/5,682 (82%) HPAI H5N1 poultry 
outbreaks occurred during November–March. For 
each 2.2°C temperature decrease, one additional HPAI 
H5N1 poultry outbreak was reported; for each 0.4°C 
temperature decrease, one additional H5N1 human case 
was reported (P<.04).
Conclusions: Public health and agricultural programs 
should anticipate and prepare for controlling HPAI H5N1 
among poultry and humans during November–March 
(cooler months) when these outbreaks typically occur 
and frequently overlap with seasonal influenza epidemics.
2:15 Impact OF chaNgeS IN DIagNOStIc teStINg ON eStImateD INFlueNza-aSSOcIateD 
hOSpItalIzatION rateS IN the INFlueNza hOSpItalIzatION SurveIllaNce NetWOrk (FluSurv-
Net): uNIteD StateS, 2003–2013
Authors: Alexander J. Millman, C. Reed, P. Kirby,  
D. Aragon, J. Meek, M. Farley, P. Ryan, J. Collins,  
R. Lynfield, J. Baumbach, S. Zansky, N. Bennett,  
B. Fowler, A. Thomas, M. Lindegren, M. Spencer,  
L. Finelli, S. Chaves
Background: In the U.S., influenza-associated 
hospitalization rates are used to evaluate annual disease 
burden and the impact of influenza vaccination. Accurate 
estimation requires laboratory confirmation and may 
have changed with increasing use of highly sensitive 
molecular assays since the 2009 pandemic. We examined 
the effect of changing test sensitivity on estimations of 
influenza-associated hospitalization rates. 
Methods: We used data from FluSurv-NET, a national, 
population-based surveillance system, and captured 
diagnostic test type by age and season. We obtained 
sensitivity ranges for each diagnostic test type from 
literature review. Crude rates by age group were 
calculated and adjusted based on test sensitivity using 
bootstrap techniques.
Results: Crude influenza-associated hospitalization rates 
per 100,000 persons varied by season from 7.3–50.1 
in children <18 years, 3.4–28.2 in adults 18–49 years, 
and 8.9–94.7 in adults ≥ 50 years. Test sensitivity varied 
by age group; the lowest being in adults ≥50 years. 
Midpoint sensitivity estimates by age group ranged from 
88.9–94% for reverse transcription polymerase chain 
reaction (RT-PCR); 34.2–81.3% for culture, 64.7–65.2% 
for direct fluorescence antibody, and 26.1–66.7% for 
rapid tests. The mix of testing methods changed over 
time, with RT-PCR use increasing from <10% during 
2003–2009 to ~70% during 2009–2013. After accounting 
for test sensitivity, we found hospitalization rates were 
underestimated by ~35% during 2003–2008 vs. ~20% 
during 2009–2013 among children <18 and adults 18–49 
years; and by ~70% during 2003–2008 vs ~50% during 
2009–2013 in adults ≥50 years. 
Conclusions: Crude rates underestimate influenza-
associated hospitalizations, especially in adults ≥50 years. 
Rate adjustments may improve the accuracy of disease 
burden estimates, which may affect assessments of the 
impact of influenza vaccination.







2:35 rapID urINe aNtIgeN teStINg FOr strEptococcus pnEumoniaE IN aDultS WIth cOmmuNIty-
acquIreD pNeumONIa: clINIcal uSe aND BarrIerS
Authors: Aaron M. Harris, S. Beekmann, P. Polgreen,  
M. Moore
Background: Streptococcus pneumoniae (pneumococcus) 
is the most common bacterial etiology of community 
acquired pneumonia (CAP) in adults, a leading cause of 
death. However, the majority of pneumococcal CAP is 
diagnosed by blood culture, which likely underestimates 
the burden of disease. FDA-approved rapid urine antigen 
(UAg) tests can also diagnose pneumococcal pneumonia 
but the frequency of their use in routine clinical care is 
unknown. 
Methods: We performed a web-based survey of 
practicing infectious disease physician members of 
the Infectious Disease Society of America’s Emerging 
Infections Network (EIN), regarding their use of UAg. 
We queried 1,287 EIN members regarding the frequency 
and clinical setting of UAg use and how results influence 
clinical decision-making. Descriptive analysis was 
performed using SAS. 
Results: Of 493 (38%) eligible responses, 319 (65%) 
routinely use the pneumococcal UAg test; 485 (98%) 
use blood cultures. For UAg users, 71% had access to 
UAg in their lab, the remainder use outside laboratories. 
Reasons listed for non-use [174 (35%)] included: lack 
of availability (46%), timeliness (33%), reliability (12%), 
antibiotic susceptibility results (7%), and high cost 
(9%). The UAg test was used more frequently in severe 
CAP patients: 94% intensive care unit (ICU), 85% in 
hospitalized non-ICU, and 15% in ambulatory settings. 
Over 80% reported that UAg results influenced clinical 
decision-making, including ordering fewer diagnostic 
tests and shortening or narrowing antibiotic therapy. 
Conclusions: Physicians with ready access to the UAg test 
use it more frequently, and subsequently tailor antibiotic 
therapy. UAg use may improve the accuracy of non-
bacteremic pneumococcal CAP incidence estimates.
2:55 aSSeSSINg the BurDeN OF peDIatrIc acute rheumatIc Fever aND rheumatIc heart DISeaSe 
— amerIcaN SamOa, 2011–2012
Authors: Amanda L. Beaudoin, L. Edison, C.E. Introcaso, 
L.M.L. Goh, C. Van Beneden
Background: In August 2013, LBJ Tropical Medical 
Center and the American Samoa (AS) health department 
notified CDC of a perceived high burden of pediatric 
acute rheumatic fever (ARF) and rheumatic heart disease 
(RHD). ARF is an immunologically mediated sequela of 
inadequately treated group A Streptococcus pharyngitis 
and, potentially, pyoderma. Recurrent or severe ARF can 
cause permanent cardiac damage and RHD. Long-term 
prophylactic penicillin injections post-ARF diagnosis 
can prevent RHD. We aimed to describe pediatric ARF 
and RHD and prophylaxis in AS and the pyoderma-ARF 
association.
Methods: We used ICD-9 codes and hospital prophylaxis 
registries from AS’s only medical system to identify all 
patients aged ≤18 years with a physician-recorded ARF 
or RHD diagnosis during 2011–2012. We recorded 
penicillin compliance and pre-ARF pharyngitis and 
pyoderma diagnoses (<6weeks preceding) for cases. 
Two age- and sex-matched control subjects per case-
patient were selected from non-ARF/RHD patients 
examined during 2011–2012. We calculated ARF 
2011–2012 incidence and RHD prevalence by using 
2010 U.S. Census data. We used univariate statistical 
tests and conditional logistic regression for case-control 
comparisons.
Results: During 2013, RHD prevalence was 3.2 
cases/1,000 children. ARF incidence was 1.1 (2011) 
and 1.5 (2012) cases/1,000. Of 65 children with ARF, a 
total of 32 (49%) subsequently received RHD diagnoses. 
Median ARF diagnosis age was 11 (range: 2–18) years. 
Pharyngitis history was more common among case-
patients (18%) than control subjects (0%; P <0.01), 
but preceding pyoderma was not. Post-ARF penicillin 
prophylaxis compliance (65%) was suboptimal.
Conclusions: RHD causes considerable childhood 
morbidity in AS. Although the pyoderma-ARF 
association remains unclear, attempts to curb AS’s 
RHD burden should address improved pharyngitis 












1:35 hepatItIS a OutBreak aSSOcIateD WIth cONSumptION OF ImpOrteD pOmegraNate arIlS — 
multIple WeSterN u.S. StateS, 2013
Authors: Erin Epson, A. Cronquist, M. Cameron-Adams, 
D. Selvage, Y. Khudyakov, K. Lamba, A. Kimura,  
R. Sowadsky, R. Hassan, C. McNeil, K. Bisgard,  
M. Collier
Background: Before 2013, the most recent large 
common-source hepatitis A virus (HAV) outbreak in 
the United States occurred in 2003 in association with 
genotype 1A1 HAV-contaminated Mexican-grown 
produce (601 cases, 25.6% [124/485] hospitalized, and 3 
deaths). During May 2013, HAV illnesses among persons 
who had consumed Retailer A food were investigated to 
determine the magnitude of the outbreak, identify the 
vehicle, and prevent further illness.
Methods: A confirmed outbreak-related case was 
acute hepatitis symptoms and positive anti-HAV IgM 
during March 31–August 12 in a person who had either 
consumed the suspect product or had the outbreak HAV 
genotype. Serum or stool specimens were submitted to 
CDC for HAV sequencing. Patients were interviewed 
regarding demographic, clinical, and food exposure 
information; food was collected from patients’ homes. 
Retailer A purchase histories were reviewed; traceback 
and trace-forward investigations were initiated.
Results: We identified 165 confirmed cases in 10 states; 
91 (55%) patients were female, median age was 46 
(range: <1–84) with 112 (68%) aged ≥40 years; 72 (44%) 
were hospitalized; none died, but one required liver 
transplantation. Genotype IB HAV was identified from 
117 patients; a frozen berry and pomegranate aril product 
from Retailer A was reportedly consumed by 153 patients 
and found in 40 patient homes. Traceback investigations 
identified pomegranate arils imported from Turkey as 
the common component in all product lots from patient 
homes; the product was voluntarily recalled.
Conclusions: This outbreak was the largest common-
source foodborne HAV outbreak in the United States 
in 10 years and had a higher hospitalization rate than 
previous outbreaks. Genotype IB, uncommon in the 
United States, is endemic in Turkey; safety of imported 
food is an on-going concern.
1:55 hepatItIS B vaccINe reSpONSe amONg INFaNtS BOrN tO hepatItIS B SurFace aNtIgeN-
pOSItIve WOmeN — uNIteD StateS, 2008–2013
Authors: Stephen C. Ko, S. Schillie, N. Nelson,  
S. Veselsky, T. Murphy
Background: Annually, an estimated 25,000 infants are 
at risk for perinatal hepatitis B virus (HBV) infection 
in the United States. Perinatal HBV infection results in 
chronic disease in 90% of infected infants. To prevent 
perinatal infection, postexposure prophylaxis consists of 
hepatitis B vaccination (HepB) and hepatitis B immune 
globulin. Postvaccination serologic testing (PVST) is 
recommended at ≥9 months, infants not responding to 
initial vaccination are revaccinated. We evaluated factors 
influencing initial vaccine nonresponse in a cohort of 
infants born to hepatitis B surface antigen (HBsAg)-
positive women.
Methods: Infants were enrolled in the Enhanced 
Perinatal Hepatitis B Prevention Program from 2008 to 
2013, a 5-state project assessing programmatic outcomes 
among infants. Initial vaccine nonresponse was defined 
as antibody to HBsAg <10 mIU/mL at PVST. Variables 
associated with nonresponse were identified using 
multivariable analyses.
Results: Of the 16,704 infants born to HBsAg-positive 
mothers, 8,654 infants with at least 3 doses of vaccine 
received PVST, and 8,199 (94.7%) responded to initial 
vaccination series. An additional 199 infants responded 
to revaccination (cumulative response rate: 94.8%). 
Controlled for maternal and infant demographics, PVST 
>6 months from last vaccination dose was associated with 
nonresponse (odds ratio [OR]: 2.7; confidence interval 
[CI]: 2.0–3.6); receipt of a 4th dose improved response 
(OR: 0.5; CI: 0.3–0.8). The proportion of infants not 
responding increased from 2% at 1–2 months PVST to 
21.6% at 15–16 months PVST.
Conclusions: Of infants born to HBsAg–positive 
mothers, 95% responded to HepB, but rates declined with 
longer interval between the final HepB dose and PVST. 
To avoid unnecessary revaccination, the optimal timing 
of PVST is within 1–2 months after final HepB dose. 







2:15 reactIvatION aND traNSmISSION OF hepatItIS B vIruS FrOm aN hIv-pOSItIve hemODIalySIS 
patIeNt — NOrth carOlINa, 2013
Authors: Sarah K. Rhea, R. Pace, V. Mobley,  
J. MacFarquhar, E. Robinson, T. Hayden, H. Thai,  
P.R. Patel, A. Moorman, J.T. Brooks, Z. Moore
Background: Hepatitis B virus (HBV) transmission in 
U.S. hemodialysis (HD) facilities has not been reported 
in >10 years. In March 2013, the North Carolina Division 
of Public Health was notified of a new HBV infection in 
an HD patient with no other identified risk factors. We 
investigated this event to identify other exposed patients 
and prevent additional infections.
Methods: We reviewed medical records, interviewed 
the index patient (Patient 1) regarding hepatitis B 
risk factors, performed HBV molecular analysis, and 
observed infection control practices at the HD facility.
Results: Patient 1, a nonresponder to HBV vaccination, 
was consistently surface antigen (HBsAg)-negative 
until a positive result in March 2013. Patient 1’s only 
identified hepatitis B risk factor was HD. The HD facility 
had no other patients with known active HBV infection. 
One patient (Patient 2) had evidence of resolved HBV 
infection. Patient 2, who was HIV-positive and on 
antiretroviral therapy, tested newly HBsAg-positive in 
April 2013, indicating HBV reactivation. In July 2013, 
both patients had HBV viral loads >1.1 × 108 IU/mL. 
HBV whole genome sequences indicated 99.9% genetic 
homology. No obvious infection control breaches were 
observed. However, Patient 1 followed Patient 2 at the 
same HD station 3 times weekly during May 2012–March 
2013. Patient 1 remained HIV-negative. Additional 
testing revealed no new HBV infections among 108 other 
patients receiving HD at the facility.
Conclusions: As the first reported HD-related HBV 
transmission from a patient with reactivation, this case 
underscores challenges in identifying HD patients who 
reactivate; it also might have policy implications for 
expanded HBV testing among HD patients with resolved 
infection. HIV transmission did not occur in this 
circumstance.
2:35 health care-aSSOcIateD hepatItIS c vIruS OutBreak IN a SkIlleD care FacIlIty —  
NOrth DakOta, 2013
Authors: Dinorah L. Calles, M. Collier, A. Suryaprasad, F. 
Xu, A. Moorman, Y. Khudyakov, L. Ganova-Raeva,  
J. Forbi, G. Xia, S. Lee-Kwan, L. Cooley, R. Allison, S. Ko, 
A. Kolwaite, C. Ross, T. Miller, T. Brosz, L. VanderBusch, 
F. Salzer, S. Weninger
Background: Hepatitis C virus (HCV) infection is the 
most common bloodborne infection in the United States, 
with 16,500 new infections estimated in 2011. Health 
care–associated exposure attributable to infection control 
lapses is a recognized transmission route. In March 2013, 
the North Dakota Department of Health was notified 
of 3 HCV cases among residents in a skilled care facility 
(Facility A). We initiated an investigation to identify 
additional cases and the exposure source to prevent 
further transmission.
Methods: A confirmed case was HCV infection in any 
resident of Facility A during January 2011–September 
2013, matching the outbreak strain by quasispecies (QS) 
analysis. Additional case-finding occurred through 
serologic screening. We abstracted patient charts and 
performed a case-control study to identify risk factors 
associated with infection.
Results: By December 10, 2013, a total of 44 confirmed 
cases had been identified. QS analyses revealed that all 
case-patients were related by transmission (97.4%–100% 
nucleotide identity). Preliminary analyses indicated 32 
/44 (73%) case-patients were exposed to a podiatrist 
who provided care at Facility A. Additionally, 38/44 
(86%) case-patients had received care by a phlebotomist 
under laboratory contract. In preliminary multivariate 
logistic regression, receipt of podiatry (adjusted odds 
ratio [aOR]: 11.1; 95% confidence interval [CI]: 2.9–42.5) 
and phlebotomy (aOR: 7.5; 95% CI: 1.4–39.3) remained 
independently associated with HCV.
Conclusions: Preliminarily, HCV transmission was 
associated with receipt of podiatry and phlebotomy at 
Facility A. Infection control breaches sufficient to account 
for the outbreak were not identified. Recommendations 
for strict adherence to Standard Precautions and 
consultation with a certified infection preventionist have 
been provided to the facility administration. Case-finding 
continues among additional populations potentially 







2:55 SuSceptIBIlIty tO, aND rISk FactOrS FOr, hepatItIS e vIruS INFectION amONg a reFugee 
pOpulatION —  SOuth SuDaN, 2012
Authors: Miriam L. Shiferaw, M. Patrick, G. Gerbi,  
C. Blanton , B. Dineen, N. Marano, K. Thomson,  
F. Rigamonti, S. Gikunju, L.W. Waiboci, E. Teshale,  
T. Handzel
Background: Hepatitis E Virus (HEV) infection causes 
outbreaks in areas with poor water, sanitation and 
hygiene (WASH) conditions. In September 2012, an 
HEV outbreak was confirmed in a refugee camp in South 
Sudan. At the time, 668 suspected/confirmed cases and 
22 deaths were reported among 15,000 refugees. CDC 
was asked to assess the prevalence of infection and risk 
factors for HEV. 
Methods: A cross-sectional serosurvey was conducted 
in November 2012. Two individuals ≥3 years were 
randomly selected from a simple random sample of 
households. Serum for anti-HEV antibody testing along 
with information on hygiene practices and exposures was 
collected from each participant. Risk factors for HEV 
infection were identified through a nested case-control; 
cases were IgM positive while unmatched controls were 
negative for both IgM and IgG. 
Results: A total of 443 individuals participated in the 
serosurvey; 21.7% had recent HEV infection (IgM 
positive), 24.1% had past infection (IgG positive), 
and 54.3% had no evidence of infection (IgM and IgG 
negative). A total of 106 cases and 215 controls were 
included in the nested case-control analysis. Individuals 
reporting close contact with a person with jaundice and 
those taking care of animals had 1.8 (95% CI: 1.1, 3.1) 
and 2.3 (95% CI: 1.03, 4.9) times the odds, respectively, of 
recent HEV infection compared to those unexposed. 
Conclusions: Over 50% of refugees in the camp were 
susceptible to HEV infection four months after the start 
of the outbreak, highlighting the risk for continued 
transmission. Personal contact may play a role in HEV 
transmission in this setting. The role of animal caretaking 
needs further investigation. Hygiene interventions should 
be scaled up in the face of an HEV outbreak. 
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EIS Officers, Class of 2012
Abanyie, Francisca – CGH
Adams, Laura* – DSEPD/EWB
Agaku, Israel* – NCCDPHP
Ahmad, Nina* – DSEPD/EWB
Alami, Negar (Nikki)* – NCHHSTP
Anderson, Tara* – NCEZID
Bagchi, Suparna* – DSEPD/EWB
Beaudoin, Amanda* – DSEPD/EWB
Brinker, Kimberly* – NIOSH
Canon, Abbey* – DSEPD/EWB
Choi, Mary* – DSEPD/EWB
Cooley, Laura – NCHHSTP
Demirjian, Alicia* – NCIRD
Djawe, Kpandja* – NCHHSTP
Doker, Thomas* – NCEZID
Durand, Lizette* NCIRD
Edison, Laura* – DSEPD/EWB
Ellis, Esther* – NCEZID
Epson, Erin* – DSEPD/EWB
Geller, Andrew* – NCEZID
Gerbi, Gemechu* – NCHHSTP
Gilbert, Leah* – NCIPC
Gunnala, Rajni* – NCCDPHP
Harris, Aaron* – NCIRD
Havers, Fiona* – NCIRD
Hickox, Kaci* – DSEPD/EWB
Idowu, Rachel* – CGH
Irving, Shalon – NCCDPHP
Iyengar, Preetha* – CGH
Johnson, Candice* – NIOSH
Johnson, Jonetta* – NCCDPHP
Kamiya, Hajime* – NCIRD
Ko, Stephen* – NCHHSTP
Kumar, Gayathri – NCCDPHP
Landman, Keren* – CGH
Lebo, Emmaculate – NCIRD
Lederer, Philip – CGH
Leshem, Eyal* – NCIRD
Levri, Kara* – DSEPD/EWB
Lind, Jennifer – NCCDPHP
Lloyd, Spencer – CGH
Lowe, Michael – NCCDPHP
Lozier, Matthew* – NCEH
McCague, Anna-Binney* – NIOSH
Mercado, Carla* – NCCDPHP
Miller, Leigh Ann* – DSEPD/EWB
Morris, Jamae* – NCEZID 
Nakao, Jolene* – NCEZID
Nguyen, Von – NCEZID
Nnadi, Chimeremma – NCHHSTP
Nyaku, Mawuli* – DSEPD/EWB
Osadebe, Lynda* – NCEZID
Patton, Monica – NCHHSTP
Plucinski, Mateusz* – CGH
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Purfield, Anne – NCEZID
Quinn, Celia* – DSEPD/EWB
Quinto, Kenneth* – NCHS
Rha, Brian* – NCIRD 
Ridpath, Alison* – DSEPD/EWB  
Ross, Christine – NCHHSTP
Russell, Elizabeth* – DSEPD/EWB
Salyer, Stephanie* – CGH
Schafer, Ilana – NCEZID 
Schwitters, Amee – CGH 
Sein, Carolyn* – CGH 
Shiferaw, Miriam* – CGH
Shumate, Alice* – DSEPD/EWB
Stahre, Mandy* – DSEPD/EWB
Thomas, Dana* – NCEZID 
Thompson-Paul, Angela – NCHHSTP 
Todd, Suzanne – NCEZID 
Vora, Neil* – NCEZID
Wallace, Ryan* – NCEZID
Watson, Joanna* – DSEPD/EWB
Wilken, Jason* – DSEPD/EWB 
Woodring, Joseph – NCHS 
Yablon, Brian* – DSEPD/EWB 
Yuen, Courtney – NCHHSTP
* Presenting EIS Officers
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EIS Officers, Class of 2013
Adam, Jessica* – DSEPD/EWB
Apata, Ibironko – CGH
Arriola, Carmen* – NCIRD
Arwady, Allison* – DSEPD/EWB
Ayscue, Patrick* – DSEPD/EWB
Basler, Colin* – NCEZID
Biggs, Holly – NCEZID
Blackley, David* – NIOSH
Bowen, Ginny – NCHHSTP
Breakwell, Lucy – NCIRD
Calles, Dinorah* – DSEPD/EWB
Chatham-Stephens, Kevin* – NCEH
Chea, Nora* – NCEZID
Chevalier, Michelle – NCCDPHP
Clayton, Joshua* – DSEPD/EWB
Dahl-Thomasson, Erica* – DSEPD/EWB
DeSilva, Malini* – DSEPD/EWB
Dixon, Meredith – CGH
Dynes, Michelle – CGH
Epstein, Lauren* – NCEZID
Fechter-Leggett, Ethan – NCEH
Forrester, Joseph* – NCEZID
Francois-Watkins, Louise* – NCIRD
Harris, Jennifer* – CGH
Harvey, Reid* – NCEZID
Hastings, Deborah* – DSEPD/EWB
Hsu, Joy* – NCEH
Hunter, Jennifer* – NCEZID
Jacobs Slifka, Kara – NCEZID
Kiebler, Craig – NCEZID
Koirala, Samir* – DSEPD/EWB
Lee-Kwan, Seung Hee – NCCDPHP
Lester, Laura* – DSEPD/EWB
Levy, Benjamin – NCIPC
Lin, Xia (Michelle)* – NCHHSTP
Luvsansharav, Ulzii – NCEZID
Maenner, Matthew* – NCBDDD
Marcewicz, Lauren* – NCBDDD
Marcinkevage, Jessica* – DSEPD/EWB
Matanock, Almea* – NCEZID
McGee, Sasha* – DSEPD/EWB
McNamara, Lucy* – NCIRD
Meiman, Jonathan* – DSEPD/EWB
Mercado-Crespo, Melissa* – NCIPC
Merrill, Rebecca – NCCDPHP
Millman, Alexander* – NCIRD
Mirkovic, Kelsey* – NCCDPHP
Moturi, Edna – CGH
Mullins, Jocelyn* – DSEPD/EWB
Nolen, Leisha – NCEZID
Nyangoma, Edith* – NCEZID
Oboho, Ikwo – NCIRD
Ogunmoyero, Oluwatosin – NCCDPHP
Olayinka, Olaniyi* – NCEH
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Paczkowski, Magdalena* – CGH
Painter, Julia* – NCEZID
Pastula, Daniel* – NCEZID
Perkins, Kiran – NCCDPHP
Perti, Tara*  – DSEPD/EWB
Petersen, Emily – NCCDPHP
Petrosky, Emiko* – NCHHSTP
Phillips, Raina – CGH
Pringle, Kimberly* – NCIRD
Puckett, Mary* – NCCDPHP
Reaves, Erik* – NCHHSTP
Rhea, Sarah* – DSEPD/EWB
Rosenthal, Mariana* – DSEPD/EWB
Schnabel, David* – DSEPD/EWB
Sharma, Aditya* – NCHHSTP
Socias, Christina – NIOSH
Sumner, Steven* – NCIPC
Tomczyk, Sara* – NCIRD
Vallabhaneni, Snigdha* – NCEZID
Volkmann, Tyson* – NCHHSTP
Walker, Alison* – NCEZID 
Wendorf, Kristen* – DSEPD/EWB 
Whitfield, Geoffrey* – NCEH 
Williams, Candice* – DSEPD/EWB
Wilson, Nana – CGH 
Wu, Hsiu – NCHHSTP 
Yacisin, Kari* – DSEPD/EWB
* Presenting EIS Officers
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Incoming EIS Officers, Class of 2014
Adams, Monica PhD, MPH
Aliabadi, Negar MD, MS
Angelo, Kristina DO, MPHTM
Appiah, Grace MD, MHS
Attfield, Kathleen ScD
Beer, Karlyn PhD, MS
Benowitz, Isaac MD
Bicking Kinsey, Cara PhD, MS, MPH
Browne, Lauren MD, MS
Casey, Megan BSN, MPH
Cherry, Cara DVM, MPH
Crowe, Samuel PhD, MA, MPH
Curran, Kathryn PhD, MHS
Dunn, Angela C MD, MPH
Edens, William PhD
Elbadawi, Lina MD, MSPH 
Fisher, Emily MD
Folaranmi, Temitope MBChB, MPH, MPP
Foster, Monique MD, MPH
Galang, Romeo MD. MPH
Gleason, Brigette MD, MPH
Gokhale, Runa MD
Greiner, Ashley MD, MPH
Grigg, Cheri DVM, MPH
Hagan, Jose MD, MS
Hancock-Allen, Jessica MSN, SM
Harrist, Alexia MD, PhD
Hennessey, Morgan DVM, MPH
Hsu, Christopher MD, PhD, MPH
Jackson, Sandra PhD, MPH
Jones, Jefferson MD, MPH
Jordan, John MD, MPH
Kamali, Amanda MD
Karwowski, Mateusz MD, MPH
Kasper, Amelia MD, MHS
Kirking, Hannah MD
Kobayashi, Miwako MD, MPH
Kulkarni, Prathit MD
Levine, Rebecca PhD, MPH
Lullo, Carolyn PhD, MS
Lyman, Meghan MD
Martin, Iman PhD, MSc, MPH
Midgley, Claire PhD, MSc, MSc
Mindra, Godwin MBChB, MPH
Namuyinga, Ruth MBChB, MPH
Narra, Rupa MD
Nelson, Jennifer MD, MPH
Nerlander, Maximilian MBBS 
Ng’eno, Bernadette,  MD, MBChB
Nguyen, Duong (Tony) DO
Oduyebo, Titilope MD, MPH
Omura, John MD, MPH
Parham, Mary DVM, MSVPH
Patel, Monita PhD, MPH
Pathmanathan, Ishani MD, MPH
Paulin, Heather MD, MPH
Pearce, Meghan PhD, MPH
Pieracci, Emily DVM, MPH
Plumb, Ian MBBS, MSc,  MA
Qin, Jin ScD, MS
Robyn, Misha DVM, MPH
Rolfes, Melissa PhD, MPH
Scott, Colleen DPH, MPH
Singh, Tushar MD, PhD, MSc
Smith, Charnetta MD, MPH
Soeters, Heidi PhD, MPH
Spies, Erica PhD, MS
Stehling-Ariza, Tasha PhD, MPH
Summers, Aimee PhD, MHS
Talley, Pamela MD, MPH
Twentyman, Evelyn MD, MPH
Vanderende, Kristin PhD, MSN
Vanfrank, Brenna MD, MSPH
Victory, Kerton PhD, MSc
Walker, Tiffany MD
Westercamp, Matthew PhD, MS
Westercamp, Nelli PhD, MBA, MPH
Wong, Jacklyn PhD, MS
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